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 “Where the world ceases to be the scene 
of our personal hopes and wishes,  
where we face it as free beings admiring, 
asking and observing, there we enter the 
realm of Art and Science.” 
Albert Einstein 
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Nel corso di alcuni anni il nostro gruppo di ricerca, ispirandosi alla struttura dei 
composti naturali anfotericina B e squalamina, ha sintetizzato una serie di composti 
che incorporano gli elementi strutturali fondamentali di questi due ionofori naturali: 
un’unità idrofobica rigida, una catena idrofilica (modulo di conduzione) e uno o due 
gruppi terminali polari. 
L’attività di questi composti nel trasporto di ioni attraverso il doppio strato 
fosfolipidico è stata investigata utilizzando liposomi come modelli di membrana e 
metodologie basate sulla spettroscopia NMR e su tecniche spettrofluorimetriche 
mediante l’utilizzo di  probe fluorescenti. 
Tra i composti sintetizzati, un analogo formato da un ottapeptide di Aib (acido 
α-amminoisobutirrico) Z-protetto all’ N-terminale (unità idrofobica) e legato tramite 
il C-terminale ad un gruppo amminico di una diammina derivata dall’esaetilenglicole 
(modulo di conduzione e gruppo terminale polare), ha mostrato di avere un’attività 
ionoforica molto elevata nei confronti del trasporto di cationi sodio. 
La comprensione del motivo di questa alta ed inaspettata attività è stata quindi 
uno degli scopi principali di questo lavoro di Tesi, in cui sono stati studiati analoghi 
con catena alchilica a lunghezza variabile al posto del gruppo Z, già 
precedentemente sintetizzati, per valutare l’effetto idrofobico del sostituente. Dopo 
aver raccolto una prima serie di dati, per comprendere la rilevanza della presenza 
dell’anello aromatico sullo ionoforo modello, è stata sintetizzata e studiata una serie 
di analoghi che portano un diverso gruppo aromatico al posto del gruppo Z.  
Il secondo e più generale scopo di questo lavoro di Tesi è stato l’inizio di uno  
studio sull’attività ionoforica di composti strutturalmente diversi al fine di 
razionalizzare le caratteristiche strutturali necessarie per ottenere composti attivi 
come trasportatori di ioni. A questo scopo è stata iniziata un’intensa collaborazione 
con diversi gruppi di ricerca che hanno sintetizzato una serie di possibili ionofori.  
Il gruppo del Prof. De Riccardis dell’Università di Salerno ha sintetizzato una 
serie di composti calixarenici sostituiti con catene spermidiniche e una serie di  α-
ciclopeptoidi formati da un numero variabile di  N-benzilossietilglicine. 
Il gruppo della Prof. Montesarchio dell’Università di Napoli ha preparato degli 
oligosaccaridi ciclici, legati da legami fosfodiesterei a ponte, chiamati CyPLOS 
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(Cyclic Phosphate-Linked OligoSaccharide macrocycles). 
Infine il gruppo del Prof. Casnati dell’Università di Parma ha sintetizzato una 
serie di calixareni sostituiti con un numero variabile di gruppi guanidinio. 
Tutti questi composti sono stati preparati allo scopo di poter effettuare un 
ampio studio concernente il rapporto struttura/attività e poter quindi definire i 
requisiti strutturali minimi per ottenere un composto con attività ionoforica. 
Accanto ai risultati ottenuti per ogni singola classe di composti, che sono 
illustrati e discussi in dettaglio nel terzo capitolo della Tesi, la possibilità di studiare 
un così ampio spettro di composti utilizzando le stesse condizioni sperimentali, ci ha 
permesso di ottenere delle considerazioni generali sulla natura dell’attività ionoforica 
ponendo le basi per la progettazione di nuove strutture che possano mostrare 
maggiore attività e/o selettività. 
Un altro importante risultato ottenuto durante questo lavoro di Tesi è stato 
l’acquisizione di esperienza nell’utilizzo di molte tecniche atte ad investigare l’attività 
ionoforica su liposomi come modelli di membrana. In particolare, è stato 
approfondita la conoscenza di tecniche comprendenti l’uso di probe fluorescenti che 
hanno mostrato di essere valide e di facile utilizzo per ottenere dati riguardanti vari 
aspetti dell’attività ionoforica come ad esempio le sequenze di selettività. 
Tuttavia, utilizzando esperimenti su liposomi, rimane molto difficile ottenere 
l’evidenza sperimentale della distinzione tra un meccanismo di trasporto tramite 
canale e altri tipi di meccanismi (es. carrier). Per questo motivo i dati ottenuti da 
questo tipo di esperimenti dovrebbero essere integrati da dati ottenuti per via 
elettrofisiologica e il nostro gruppo di ricerca si sta muovendo proprio in questa 
direzione. 
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Taking inspiration from the natural ionophores amphotericin B and 
squalamine, during the past years our group synthesized a series of compounds that 
incorporate the fundamental structural elements of these natural ion transporters: a 
rigid hydrophobic unit, a hydrophilic chain (conduction module) and one or two 
polar head groups. 
The ionophoric activity of these artificial ionophores was investigated using 
liposomes as membrane models, and the measurements have been conducted by 
NMR spectroscopy and spectrofluorimetric techniques involving the use of 
fluorimetric probes. Among the compounds synthesized, an analogue having an N-
terminus Z-protected α-aminoisobutyric acid (Aib) octapeptide (hydrophobic unit) 
linked, at the C-terminus, to one aminic moiety of a diamine derived by 
exa(ethylene)glycol (conduction module and polar head), was found to have an 
impressive activity in Na+ transport. 
The understanding of the reasons for such high and unexpected activity was 
therefore one of the main subjects of this Thesis work in which alkyl (instead of the 
Z-group) analogues of this compound, already prepared in our group, were studied 
to evaluate the hydrophobic effect of the substituent. 
After a first collection of data, a new series of analogues carrying a different 
aromatic group in place of the Z-group were synthesized and studied in order to 
asses the relevance of the aromatic substitution in the model ionophore. 
The second and more general subject of this Thesis work was the beginning of 
an investigation of structurally different compounds aimed to define common 
structural requirements for ionophoric activity. In this contest we have collaborated 
with several research groups which have synthesized the putative ionophore. 
Prof. De Riccardis and co-workers at Salerno University synthesized a series of 
spermidine calixarenic compounds as well as a series of cyclic α-peptoids formed by 
a variable number of N-benzyloxyethylglycines. 
The group of Prof. Montesarchio at Napoli University prepared novel cyclic 
oligosaccharide analogues, 4,6-linked through phosphodiester bonds, named 
CyPLOS (Cyclic Phosphate-Linked OligoSaccharide macrocycles). 
Finally the group of Prof. Casnati at Parma University synthesized a series of 
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guanidinium calixarene conjugates. 
All these compounds have been prepared in the framework of a long standing 
collaboration which has as ultimate objective a broad structure/activity investigation 
aimed to define the structural requirements for ionophoric activity. 
Beside the results obtained in the study of each single class of compounds 
which will be illustrated and discussed in detail in the third chapter of this Thesis 
work, the possibility to investigate the ionophoric properties of such a broad bunch 
of compounds under the same set of experimental condition allowed us to draw 
more general considerations and put the basis for the design of new ionophores 
with enhanced activity and/or selectivity. 
A further important result of this Thesis work is the acquisition of expertise in 
several techniques used for the study of the ionophoric activity in liposomes. In 
particular we have exploited methodologies based on the use of fluorescent probes 
which have proved to give valid and user friendly entries to important features such 
as for example selectivity sequences. Ironically, it is the experimental evidence for 
the existence of ion channels as such (rather than the presence of alternative modes 
of transport) that remains most difficult to obtain in vesicles. For this reason these 
types of measurement should be paralleled with electrophysiological data and we are 
now moving in this direction. 
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1.1   BIOLOGICAL MEMBRANES 
Membranes are barriers that surround the cytoplasm of cells and physically 
separate the intracellular components from the extracellular environment. (Figure 
1.1) They prevent the content of the cell from being lost and they also prevent 
intrusion of inappropriate chemical species. The critical importance of this function 
is evident from the typical asymmetry of a cell: for example the concentration of 
sodium cation is 150 mM outside and 10 mM inside the cell, in contrast, potassium 
cation is 5 mM outside and 150 mM inside1. This clearly means that a membrane 
has to be able to maintain specific ion concentrations inside cell, to sustain a 
concentration gradient, and prevent lysis due to the osmotic pressure. 
 
Figure 1.1. Illustration of a cell membrane portion. 
Membrane composition is largely various depending on the organism type and, 
inside one organism, on the cell type. In any case, cell membranes are made by three 
classes of amphipathic lipids: phospholipids, glycolipids and steroids. The relative 
composition of each class is related to the type of cell, but in the majority of cases 
phospholipids are the most abundant. 
Phospholipids structure can be described as a polar “head” carrying two 
hydrophobic “tails”. This particular shape permits to phospholipids to aggregate in 
water forming a double layer with the hydrophobic tails facing each other and the 
hydrophilic heads exposed to the aqueous solution, as shown in Figure 1.1.  
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Among phospholipids, phosphoglycerides are the major components of 
biological membranes. Their structure is based on sn-glycerol-3-phosphate, esterified 
to two fatty acids, saturated or unsaturated. The simplest glycerophospholipids are 
phosphatidic acids which are not substituted at the phosphoryl group, but they are 
slightly represented in membranes. Their derivatives esterified at the phosphate 
group by polar alcohols such as choline, serine, glycerol and inositol are more 
frequently found in membranes. Some examples of these structures are illustrated in 
Figure 1.2. 
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Figure 1.2. Examples of phospholipids and sphingolipids present in membranes. 
Other lipid components of membranes are sphingolipids, which are derivatives 
of the amino alcohol sphingosine esterified to a fatty acid. Among them, 
sphingomyelins which bear also a phosphocoline or phosphoetanolamine moiety are 
considered also a subgroup of phospholipids. Sphingolipids without a phosphoryl 
group are called sphingoglycolipids (or simply glycolipids), such as cerebrosides and 
gangliosides. The formers have a head group consisting in a single sugar residue, the 
latters have a more complex head group formed by an oligosaccharide2 (Figure 1.2).  
Among steroids, cholesterol is a very important component of animal plasma 
membranes (Figure 1.3). Its polar hydroxyl group gives it a weak amphiphilic 
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character, whereas its fused ring system provides a greater rigidity than other 
membrane lipids. Therefore, it contributes to membrane fluidity properties.  
HO
H
H H
 
Figure 1.3. Structure and space-filling model of cholesterol 
The phospholipid double layer is a dynamic system since the long hydrocarbon 
chains have a large number of free rotational degrees. Below a characteristic 
transition temperature Tc the hydrocarbon chains are packed with all single bonds in 
a s-trans conformation (“gel” phase), whereas above Tc some bonds assume a s-cis 
conformation leading to an enhancement of the disorder of the double layer (“fluid” 
phase) (Figure 1.4). Membrane phase influences all the kinetic processes and 
permeability, which results higher in the fluid state. Cholesterol  decreases 
membrane fluidity due to the interference of its rigid ring system with the motion of 
the hydrocarbon chains; in addition it broadens the temperature range of the order-
disorder transition because it is able to insert between the hydrocarbon chains and 
hamper the chain package. 
Fluid phase Gel phase
 
Figure 1.4. Three-dimensional models of membrane in fluid and gel phase, respectively. 
Beside lipids the biological membrane contains other species and in particular 
proteins. The fluid mosaic model of Singer and Nicolson, suggests that membranes 
are dynamic structures in which the phospholipid bilayer is a fluid matrix, which 
behaves as a two-dimensional solvent for proteins. Proteins can be associated with 
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 6 
the surface of the bilayer or embedded in it, the formers are called peripheral 
proteins (or extrinsic proteins) and the latters integral proteins (or intrinsic proteins). 
Integral proteins have a hydrophobic domain which interacts with phospholipids 
chains anchoring the protein within the double layer and two hydrophilic domains 
which interact with intra- and extracellular medium; these proteins are frequently 
involved in the transport of specific substances or in the transmission of chemical 
signals.2 
 
1.2   ALTERATION OF MEMBRANE PERMEABILITY  
Biological membranes are semi-permeable as a result of the barrier properties 
of the lipid bilayer: they allow relatively free diffusion of small uncharged molecules 
and gases but they are highly impermeable to large polar molecules and ions (Figure 
1.5, on the left). The retention inside the cell of polar macromolecules such as 
proteins or DNA is fundamental for a cell but it is equally important to have access 
to polar solutes present in the environment, such as sugars, amino acids and ions.3 
Therefore cell wealth requires a fine control of the passage of substances through 
the double layer. There are several types of transport mechanisms: three of these, 
passive diffusion, facilitated and active transport, usually involve small molecules or 
ions (Figure 1.5, on the right). On the other side mechanisms called endo- and 
exocytosis are responsible of the transport of macromolecules, i.e. lipoproteins. 
  
Figure 1.5. Membrane permeability and possible transport mechanisms. 
A difference in the concentrations of a substance between the two sides of a 
membrane generates a gradient and consequently the molecules involved tend to 
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move from the high concentration to the low concentration region to equilibrate 
their concentration gradients. Passive diffusion and facilitated transport involve the 
passage of molecules in order to discharge the gradient, the former is a non-
mediated transport, the latter is mediated by specific molecules present in the 
bilayer. On the other hand, also a transport against gradient is possible and it is 
mediated by molecules, usually complex protein systems, which can couple such 
endergonic process to a sufficiently exergonic one to make it favourable. 
Facilitated transport can be mediated by proteins or other molecules which can 
open pores (channels) through the double layer, or by specific transporters, called 
carriers, which can host the guest-molecule and transfer it from one side of the 
membrane to the other (Figure 1.6). 
Carrier
Extracellular
medium
Intracellular
medium
Channel  
Figure 1.6. Ion transport modes in facilitated transport. 
In the latter case the transport rate is limited by diffusion of the host-guest 
complex within the double layer. In the case of channels the transport process is 
usually faster and the current hypothesis on the mechanism is that molecules or ions 
align themselves along the inside pore of the channel and then, in a “billiard ball” 
process, the molecule which enters at one side pushes the others and so the last one 
is forced to exit from the other side.1 
In endo- and exocytosis the cell engulfs some of its extra- or intracellular fluid, 
including macromolecules dissolved or suspended in it; in the first case a portion of 
the plasma membrane is invaginated and pinched off forming a membrane-bounded 
vesicle, in the second case the formed membrane-bound vesicles move to the cell 
surface where they fuse with the plasma membrane. 
For the scope of this Thesis, the facilitated transport is by far the more 
interesting, therefore in the next paragraphs some natural and artificial examples 
concerning this type of mechanism will be presented. 
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1.2.1   NATURAL SYSTEMS 
Ion transport is a typical supramolecular function which requires specific 
intermolecular interactions between the transporters and transported ions in order 
to compensate for the loss of hydration energy during the translocation process 
across the phospholipid bilayer. In Nature ion transporters are usually large protein 
complexes consisting of a central channel portion that spans the double layer and 
additional regions on one or both sides of the membrane that control access to the 
channel region. The ion conducting portion of natural ion channels is typically a 
bundle of four to seven protein helices surrounded by an outer layer of protein 
helices which are in contact with the membrane lipids.3 
1.2.1.1    Natural cation transporters 
The acetylcholine receptor is one of the most studied ion channel proteins. 
This protein forms ligand-gated channels that are selective for cations with a 
diameter smaller than about 7 Å. In the proposed model the channel is composed 
of five homologous α-helices which contain several conserved serine residues lining 
the pore. The hydroxyl group of this residue might serve to solvate the cations 
during the permeation across the channel. In addition, the model suggests the 
presence of several negatively charged residues near the entrance of the channel 
which may serve to increase the local concentration of cations, thereby increasing 
their conductance relative to anions.4 
A breakthrough description of the structure of the bacterial potassium channel 
KcsA has been recently obtained using X-ray diffraction thanks to the work of the 
Nobel Price Laureate R. MacKinnon.5 In the KcsA K+ channel structure four 
subunits surround a central ion pathway that crosses the membrane (Figure 1.7a). 
Two of the four subunits are shown in Figure 1.7b together with electron density 
from K+ ions and water along the pore. Near the center of the membrane the ion 
pathway is very wide, forming a cavity about 10 Ǻ in diameter with a hydrated K+ 
ion at its center. Each subunit directs the C-terminal end of a “pore helix” (shown 
in red) toward the ion. The C-terminal end of an α-helix is associated with a 
negative “end charge” as a result of carbonyl oxygen atoms that do not participate 
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in secondary-structure hydrogen bonding, so the pore helices are directed as if to 
stabilize the K+ ion in the cavity. In this way the K+ channel lowers the membrane 
dielectric barrier by hydrating a K+ ion deep inside the membrane, and by stabilizing 
it with charges at the ends of the α-helix. The K+/Na+ selectivity of the KcsA K+ 
channel originates in the so called selectivity filter. Figure 1.7c shows the structure 
of this selectivity filter located in the extracellular third of the ion pathway (the 
yellow part in Figure 1.7b). In the sequence TVGYG which lines the selectivity filter 
the main-chain carbonyl oxygen atoms point toward the ions along the pore 
forming a narrow tube in which are present four equally spaced K+-binding sites. 
Each binding site is a cage formed by eight oxygen atoms on the vertices of a cube, 
or a twisted cube, arranged in a similar manner to the water molecules surrounding 
the hydrated K+ ion in the cavity. The Na+ ion is apparently too small for these K+-
sized binding sites, so its dehydration energy is not compensated. 
(a) (b) 
 
(c) 
Figure 1.7. a) A ribbon representation of the KcsA K+ channel with its four subunits colored differently. The 
channel is oriented with the extracellular solution on top. b) The KcsA K+ channel with front and back 
subunits removed. The pore helices are shown in red and selectivity filter in yellow; the electron density along 
the ion pathway is shown in a blue mesh. c) Detailed structure of the K+-selectivity filter (two subunits). 
Oxygen atoms (red) coordinate K+ ions (green spheres). 
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Porins represent another example of polypeptides with ionophoric activity: 
these integral proteins are found in the outer membranes of Gram-negative bacteria 
and are somewhat special because they contain β-sheet structures, in contrast to the 
α-helices of the majority of membrane proteins. These structures are disposed to 
form a pore that reminds a barrel (actually this protein-shape is called β-barrel) 
which has non-polar residues on the outer surface and the inner cavity lined mainly 
by polar and charged residues. An unifying characteristic of the β-barrel pores is 
their large cross-section (~12 Å), in fact, unlike the above-mentioned acetylcholine 
receptor, porins allow the diffusion of a variety of molecules with molecular weights 
smaller than 600 Da (Figure 1.8).6,7 
 
Figure 1.8. Three-dimensional structure of a porin 
A peptide-based ionophore with a simpler structure is Gramicidin A, a 
pentadecapeptide isolated from Bacillus brevis consisting of an alternating sequence of 
D- and L- amino acids. The conducting pore, which is cation selective, is formed by 
a highly unusual “head-to-head” β-helical dimer structure that places all the amino 
acid side chains on the outside of the helix. The ions pass through the center of the 
helix and are solvated by the peptide amide carbonyls1 (Figure 1.9).  
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Figure 1.9. Three-dimensional model of gramicidin A, red spheres are water molecules. 
Helical structures of other types, usually α- or 310-, are found in shorter 
peptides with antibiotic activity related to ionophoric properties, such as peptaibols.8 
Peptaibols are characterized by the presence of the C-terminal residue reduced to 
alcohol, the acylation of the N-terminus and the presence of a relatively high 
number of α-aminoisobutyric acid (Aib) residues. Aib is a natural not proteinogenic 
Cα,α-disubstituted amino acid (Figure 1.10) which can promote the formation of 
helical structures even in short peptides (7-8 residues), due to the steric interaction 
involving the gem-methyl groups linked to the α-carbon.9 
 
H2N COOH
Aib  
Figure 1.10. Structure of α-aminoisobutyric acid. 
The amino acidic sequence of peptaibols is such to form amphipathic helices 
which favour the aggregation of peptides inside the membrane forming a cluster 
with the hydrophilic regions of the helices pointing inside and the hydrophobic ones 
outside,  in contact with the phospholipid alkyl chains. In the case of alamethicin, a 
19-mer peptaibols which has been intensely investigated,10 the bundle of monomers 
formed in membrane is long enough to span the whole membrane and to form a 
channel with ionophoric properties.  
Also shorter peptides belong to this antibiotics class. An example is Trichogin 
A IV,11,12 which is a linear 10-mer peptide containing a C-terminal amino alcohol 
and the N-terminus acylated by a fatty acid essential for the biological activity. This 
class of compounds, called lipopeptibols, is too short to span the whole membrane 
and, therefore, the mechanism of channel formation has to be appreciably different 
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from alamethicin’s. In this case the alignment of two peptide clusters present in the 
two membrane leaflets is, indeed, suggested. 
In Nature exist also ion transporters which don’t have a peptide structure. Two 
examples of this class of compounds are amphotericin B (AmB), a polyene 
macrolide, and squalamine, an aminosterol recently isolated from tissues of the 
dogfish shark Squalus acanthias.13,14 Both compounds are able to transport cations 
(Na+, K+) across the bilayer and have antifungal and antimicrobial properties 
(Figure 1.11).  
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Figure 1.11. Amphotericin B and squalamine structures. 
Although squalamine is totally chemically different from amphotericin B, they 
have some common structural elements: a rigid hydrophobic unit (polyenic in AmB, 
steroidal in squalamine); a hydrophilic chain (polyhydroxyl in AmB, polyaminic in 
squalamine) and two polar heads groups (carboxylate and ammonium in AmB, 
sulphate and ammonium in squalamine). AmB molecules are believed to aggregate 
in membrane creating a water-filled tube in which the hydroxyl portion of each 
molecule lines the inside of the pore, forming a hydrophilic channel, while the 
hydrophobic polyene section interacts with the lipid bilayer insulating the inner 
hydrophilic pore, in a barrel-stave motif. The macrocycle is not long enough to span 
the whole membrane, so it is supposed that two aggregates associate in an end-to-
end fashion to form a channel that spans completely the double layer, as shown in 
the three-dimensional model in Figure 1.12.15,16 
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Figure 1.12. Lateral (on the left) and above view of a three-dimensional model of AmB aggregates. The red 
molecules are cholesterol which is believed to stabilize the Amb aggregates. 
Squalamine is believed to act with a similar mechanism as AmB, with the 
sulphate and ammonium groups forming a salt-bridge which stabilizes a macrocyclic 
conformation that resembles AmB, as illustrated in Figure 1.11.17,18 
The above discussed examples describe systems with different complexity 
which form channels in the cell membrane. An example of natural cation carrier is 
valinomycin, a cyclic dodecadepsipeptide, formed by the repetition of the four-unit 
sequence D-valine, L-lactate, L-valine, D-hydroxyisovalerate which alternates amido 
and ester linkages. This carrier is able to complex and transport through the double 
layer K+ ions with a rate of up to 10,000 K+/sec and selectivity over Na+ up to 105 
(expressed as ratio of transport rates). (Figure 1.13) 
 
Figure 1.13. Valinomycin structure and space-filling model of K+-valinomycin complex. 
In the bracelet form, the ion sits in the centre of the complex surrounded by 
hydrophilic groups that line the cage. The ion is coordinated by six carbonyl 
oxygens from the valine groups. The polar groups of the valinomycin structure are 
positioned toward the center of the ring, whereas the nonpolar groups (the methyl 
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and isopropyl side chains) are directed outward from the ring. This hydrophilic 
interior with a hydrophobic exterior makes the molecule ideal for transporting an 
ion across a lipid membrane.2,19 
1.2.1.2    Natural anion transporters 
The naturally occurring anion transporters include a vast set of regulatory 
proteins involved in several metabolic processes. Recently, the crystal structures of 
two chloride channels, belonging the the family of ClC Cl- channel, has been 
published.20,21 ClC channels are dimeric, but each subunit has an independent pore 
created from several short helices that penetrate in the membrane. Funnel-shaped 
structures at the mouth of the channel allow ions to reach the selectivity filter, 
located at the midpoint of the bilayer. In the selectivity filter the chloride ions are 
stripped out of their hydration shell and are stabilized by multiple interactions 
involving the backbone peptide amides, by the side-chain hydroxy groups of a serine 
and a tyrosine residues, and by the electric dipole of two α-helices, pointing their 
positive ends towards the filter region (Figure 1.14).  
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Figure 1.14. Schematic representation of the ClC selectivity filter. 
Anion exchangers, cation-dependent Cl- cotransporters and Cl- channels play 
significant biological roles (stabilization of membrane potential, excitation, cell 
volume regulation, fluid transport, protein degradation in endosomal vesicles and, 
possibly, cell growth22 and their dysfunctions have been related to several genetic 
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diseases, the so-called anion “channelopathies”.23,24 The best known example is 
cystic fibrosis, which is caused by mutations in the cystic fibrosis transmembrane 
conductance regulator (CFTR) Cl- channel, responsible of the transport of water 
and salts across epithelia.25 The reduced fluxes across the cell membrane induce 
accumulation of thick mucus in ducts, leading to recurrent, and potentially deadly, 
airways clogging and block of the intestine. 
Among the family of ligand-gated ion channels glycine receptor (GlyR) is a 
notable one. GlyR is a membrane protein present in postsynaptic membranes. 
Binding of glycine activates a chloride conducting channel that in turn leads to 
synaptic inhibition by hyperpolarizing the postsynaptic cell. This channel is arranged 
as five subunits surrounding a central pore, with each subunit composed of four α 
helical transmembrane segments. They contain many hydroxylated amino acids, 
suitable for lining a hydrophilic ion conducting path (M2 segment).26  
While there are numerous examples of natural and artificial cation carriers, the 
examples of natural anion carriers are rare. One of the most known chloride carrier 
is the family of prodigions (Figure 1.15) a class of compounds displaying interesting 
antibiotic, antitumor and immunosuppressive activities.27 When protonated, 
prodigiosins bind the chloride ion and transport it across biological membrane with 
a carrier mechanism.  
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Figure 1.15. An example of prodigiosin structure. 
 
1.2.2   SYNTHETIC ION TRANSPORTERS 
The study of the chemistry of biological membranes and, in particular, of the 
natural systems which regulate their permeability has led to the design and synthesis 
of artificial systems that mimic the ionophoric activity of natural ones. The aim is, 
on one side, using less complex model systems, the study of the parameters that 
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control the permeation processes and, on the other side, the synthesis of new 
compounds having ionophoric and biological activity. In this contest the term 
“channel” and “pore” are often used as synonymous although they refer to 
functionally different systems. In particular, whereas synthetic ion channels are 
compounds made from abiotic scaffolds which transport inorganic ions across lipid 
bilayer membranes, synthetic pores are made to transport molecules. A pore can 
also serve as ion channel, whereas an ion channel is too small to act as pore. 
As described above ion channels insert into the membrane and form an ion-
conductance pathway. Thus, the minimal structural requirements for artificial ion 
channels are a membrane spanning structure, a lipophilic substructure which 
engages hydrophobic contacts with the phospholipid bilayer and a hydrophilic 
substructure which provides a polar corridor, stabilizing the desolvated ion during 
the crossing of the channel. A molecular shape that roughly fulfils these 
requirements is a facial amphipathic tubular structure, i.e. a molecule able to insert 
into the phospholipid bilayer without perturbing its lamellar structure and with 
hydrophobic subunits enclosing a polar conduct. Depending on the shape and the 
size of these molecules, different channel architectures can be obtained as shown in 
Figure 1.16.28,29 
UNIMOLECULAR
CHANNEL
Barrel - stave Barrel - hoop Barrel - rosette Micellar
SUPRAMOLECULAR CHANNELS  
Figure 1.16. Possible mechanism of channel formation. 
Considering that a phospholipid membrane has an overall thickness of about 
40 Å, with an hydrophobic core of about 30-35 Å, a macromolecule of such size 
may span completely the membrane and form an unimolecular channel. Channels 
may also derive from the cylindrical self-assembly of linear, ‘stave-like’ monomers 
into barrel-stave motif. In this supramolecular architecture, facial amphipathic rod-
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like molecules orient their hydrophobic face towards the phospholipid hydrocarbon 
chain, while the polar flank is aligned towards the channel inner walls. The shielding 
of the polar residues from the contact with the phospholipid hydrocarbon chains, is 
the driving force for the formation of such barrel-stave aggregates. Shorter 
monomers, which are not able to completely span the membrane, may form shorter 
barrels whose reciprocal alignment can originate a transmembrane channel. This 
kind of architecture is named barrel-rosette and, depending on the size of the 
assembling monomers, it may give different architectures showing two or more 
barrels stacked one over the other. A similar motif, but formed by the stacking of 
macrocyclic monomers, is the barrel-hoop channel. Careful design of the macrocycle 
allows to orient the polar groups inside and the nonpolar groups outside the 
macrocycle. A tubular aggregate is thus formed, presenting a lipophilic surface and a 
core made of polar residues. Finally there is another possible behaviour: molecules 
can form slightly ordered assemblies, vaguely similar to a poorly organized barrel-
rosette, that partially disrupt the continuity of the double layer; these shapes are often 
called carpet because the molecules interact with the membrane surface partially 
covering it and do not insert in the membrane like the other motifs.30,31 
As reported above, carriers constitute the other important class of membrane 
transporters. The minimum functional requirements to belong to this class of 
compounds are the ability to reversibly bind a substrate and the formation of a 
lipophilic complex able to freely diffuse across the membrane. In this context a too 
tight binding may be unproductive for the transport, leading to accumulation of the 
complex inside the membrane. Therefore, a delicate balance between complex 
formation and decomplexation is required. Moreover, respect to an ion channel, 
transport requires the carrier’s physical movement throughout the membrane and 
this usually reduces the rate of ion permeation which directly depends on membrane 
fluidity. 
Since the first example of a synthetic ion channel, a cyclodextrin derivative 
reported by Tabushi’s group in 1982,32 chemists have designed a variety of 
structurally different and effective ion conductors; in the next chapters some 
examples are reported. 
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1.2.2.1    Artificial cation transporters 
One way rather straightforward to synthesize a molecule which can span the 
entire thickness of the double layer is to use a readily affordable scaffold and 
decorate it with proper chains in order to obtain a balance between hydrophobic 
and hydrophilic moieties and a convenient length of the molecule.33  
The use of a calixarenic scaffold is one of the most represented examples: 
Cragg and co-workers recently reported the activity of a calix[6]arene decorated at 
three phenolic positions by the commercially available surfactant Triton® X-100. 
This compound transport Na+ across the double layer and the data indicate that it 
can operate as unimolecular channel at low concentrations whereas at higher 
concentrations it aggregates to form self-assembled structures (Figure 1.17).34 
AcO AcO
OAcOAc
OO
OO
O O
O OHN HN
HN NH
OHOH
HO HO
OOMe O
OMe
OMe O
O
O
9
O
O
9
O
O
9
OMe
OMe
OMe
OHHO
4
 
Figure 1.17. Examples of artificial cation channels based on calix[6]arene (left), calix[4]arene (centre) and 
resorcinarene (right) structures. 
Figure 1.17 reports also an example of a 1,3-alternate calix[4]arene decorated 
with four units of cholic acid which has shown interesting properties in proton and 
sodium transport forming an unimolecular channel. Additionally, the comparison of 
its activity with the analogue in cone conformation, which is not able to span the 
entire thickness of the double layer, suggests that the overall length plays a critical 
role in the ion transporting properties.102 
 
1. INTRODUCTION 
__________________________________________________________________________________________________________________________________________________________________________ 
 19
Resorcinarenes are another versatile platform structure: the molecule reported 
in Figure 1.17 which carries four facially amphiphilic cholates on the opposite side 
to the hydrophilic hydroxyl groups forms tail-to-tail barrel-hoop dimers in the double 
layer and is selective for K+.35 
Finally, a cucurbituril structure was employed to synthesize cation transporters: 
compounds illustrated in Figure 1.18 are macrocyclic cavitands comprising five or 
six glycoluril units and have a hydrophobic cavity accessible through two identical 
carbonyl-fringed portals; they are able to conduct cations through the bilayer and 
are selective for Li+.36 
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Figure 1.18. Cucurbiturls structures and x-ray diffraction models. 
Like in the case of cucurbiturils some structures can be chosen for their 
intrinsic affinity for cations and then modified to act as ion transporters.  
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Figure 1.19. Examples of oligocrown ionophores. 
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Gokel and coll. designed a series of oligocrowns linked through alkyl spacers 
between the crowns, the best activity was found for n = 12, with the molecule 
having a maximal length of 50 Å (Figure 1.19, left).37 
The group of Matile synthesized an ion channel placing azacrown modules 
along a rigid-rod p-octiphenyl scaffold, exploiting the lipophilicity of the phenyl 
groups and the azacrown affinity for cations (Figure 1.19, centre).38 In another case 
a semi-rigid α-helical scaffold, hydrophobic for the presence of leucine residues, was 
used to align crown ethers one on top of the other. It is interesting to observe that 
in the latter case the mechanism of action changes from carrier, to detergent to 
channel depending on the length of the peptide chain (Figure 1.19, right).39 
At the same time a variety of peptide systems was explored and, among these, 
oligopeptides which assume an α-helical conformation are very versatile because a 
careful peptide design permits to obtain amphipathic helices able to auto-assemble 
in the phospholipid bilayer. De Grado and coll.40 have synthesized a peptide with 
(LSSLLSL)3 sequence which assumes an α-helix conformation and thanks to the 
specific sequence of aminoacids all serine alcoholic residues face on one side of the 
helix and all leucine hydrocarbon ones on the other side, as shown in Figure 1.20. 
Inside the membrane six molecules aggregate forming a channel in a barrel-stave 
motif structurally resembling the acetylcholine receptor, with an estimated pore 
diameter of 8 Å. 
 
Figure 1.20. De Grado peptide, hydrophobic amino acids residues (leucine) in blue, hydrophilic in red 
(serine). 
In other cases, instead of the peptide structure, a steroidal group has been 
chosen to give to the molecule a hydrophobic character and alcohol, ether or 
polyether groups to give the hydrophilic one. The semi-rigid dimer,41 shown in 
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Figure 1.21, is long enough to span the entire length of the double layer and it is an 
example of facial amphipathic molecule, with all the alcoholic groups on the same 
side of the steroid subunit. This dimer forms aggregates in PC/PG (95:5) liposomes 
and promote Na+ transport. The supposed mechanism is the formation of a trimeric 
supramolecular species with a barrel-stave shape. Figure 1.21 shows another type of 
steroid dimer with the hydrophilic moiety formed by two polyether pendants 
separated from the hydrophobic unit;42 in this case the ionophoric activity towards 
Na+ is approximately 70% of AmB’s. 
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Figure 1.21. Examples of steroid dimers. 
Regen and coll. employed a steroid groups and a polyether chain to synthesize 
the compound shown in Figure 1.22,17 which have a structure resembling that of 
squalamine. This molecule is too short to span the whole double layer but the 
hypothesis is that it assumes a pseudo-macrocyclic conformation, stabilized by a salt 
bridge between the protonated amine and the anionic sulphate group, and that this 
conformation orients the molecules in the membrane, anchoring the headgroups at 
the membrane surface and dipping the sterol moiety in the phospholipid bilayer, 
then a number of these molecules aggregate to form a pore in a barrel-rosette fashion. 
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Figure 1.22. Regen’s squalamine analogue and a peptide-adamantano carrier. 
Finally the other compound illustrated in Figure 1.22 is an example of a 
peptide macrocycle with two adamantano bridges which acts as a carrier, transporting 
monovalent (Na+, K+) and divalent (Mg2+, Ca2++) cations.43 
1.2.2.2    Artificial anion transporters 
The first example of the use of bio-inspired peptides for the development of 
artificial anion channels has been reported in the early 1990s by the group of J. M. 
Tomich44. They investigated the α-helical peptide M2GlyR, a synthetic peptide 
mimicking the 23 amino acid sequence found in the second membrane-spanning 
region of the neuronal glycine receptor protein. The natural chloride channel is 
pentameric and this peptide sequence lines the walls of the channel. M2GlyR 
(PARVGLGITTVLTMTTQSSGSRA) inserts into synthetic lipid bilayers and 
associates in a barrel-stave fashion to form a peptide assembly made of four or five 
subunits. The observed Cl– conductances are similar to those observed for the 
native glycine receptor.  
A second family of peptide-based artificial anion transporters, has been 
reported by the group of G. W. Gokel.45 The central recognition module is typified 
by a short peptide inspired by the GKXGPXXH sequence, a highly conserved motif 
in the ClC family of chloride channels. In the prototype of this class of artificial 
ionophores this sequence has been mutated in the G3PG3 heptapeptide.46,47 The 
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other design elements included in the anionophore are a twin set of hydrophobic 
C18 alkyl chains governing the insertion into the phospholipid bilayer, a short 
spacer derived by diglycolic acid, mimicking the phospholipid’s midpolar (acyl 
glycerol) regime and a C-terminal liphophilic anchor, represented by the benzyl 
ester, grafting the peptide on the membrane surface (Figure 1.23). This compound 
transports chloride with high efficiency and good selectivity for anions respect to 
cations (selectivity higher than ten fold for Cl– over K+) and it is supposed to form 
channels made by the self-assembly of two monomers in membrane.48 
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Figure 1.23. Structure of Gokel’s peptide and proposed structure of the active dimer. 
A unique example of conjugation between naturally occurring motif and 
invention, is the class of tubular channels reported by the group of S. Matile.49 
These rigid rod β-barrels are formed by the self-assembling of rigid p-octiphenyl rod 
monomers decorated with short peptides in membranes. Once in membrane, these 
peptides interdigitate (in an antiparallel β-sheet fashion) with other peptides residues 
belonging to contiguous rods (Figure 1.24). Limited internal space drives the first 
amino acid towards the outer surface of the channel and the β-sheet structure places 
the followings in an alternate arrangement so that in a pentapeptide the second and 
the fourth amino acid side chains point inside to the channel, while the others point 
outside. In most of the cases, the external amino acids are hydrophobic (mainly 
leucine) to facilitate the incorporation of the barrel in the membrane, while variation 
of internal amino acids (histidine, lysine, aspartic acid, arginine, etc.) allows the 
tuning of the chemical properties of the internal surface of the channel. For 
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example, in presence of cationic lysine residues pointing inside, the channel 
transports selectively chloride over potassium.50 
More recently the group of Matile has prepared the rigid oligo-(p-phenylene)-
N,N-naphtalenediimides (NDI), shown in Figure 1.24. These compounds has been 
designed to be long enough to span the membrane and to have three π-acidic NDI 
binding sites for anions along their scaffold.51,52 The active structure appears to be 
dimeric and activity and selectivity depend on the two terminal amines substitution.  
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Figure 1.24. Matile’s rigid rod β-barrels and π-acidic NDI, structure and assembling mechanism. 
Chloride transport activity has been demonstrated also for the sterol-
spermidine conjugate shown in Figure 1.25. This molecule belongs to the family of 
compounds investigated by the group of Regen illustrated in the previous paragraph 
and it has a protonated polyaminic chain which is able to stabilize the passage of 
anions. In its pseudo-macrocycle conformation this molecule is a facial amphiphile 
with the polar spermidine chain lining the hydrophobic surface of the sterol subunit. 
Subsequent aggregation within each monolayer leaflet produce a continuous pore 
with a barrel-rosette architecture. Combined experimental evidences confirmed the 
ability to transport chloride through a H+/Cl– symport (or the kinetically equivalent 
OH–/Cl– antiport).53  
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Figure 1.25. Structure of Regen’s sterol-spermidine conjugate and cartoon of the proposed active dimer. 
Protonable amino moieties have been proposed as recognition elements for 
anions, also in the aminocyclodextrin derivative reported by the group of Gin.54 The 
ionophore was obtained decorating the lower rim of a β-cyclodextrin with seven ω-
amino pentabutyleneglycols. The system spans completely the membrane and acts 
as unimolecular channel. These compound demonstrates an efficient transport of 
sodium ion and, somehow unexpectedly, of halogens; interestingly, both the rates of 
cation and anion transport were found to be pH-dependent and to increase with the 
pH value.55  
A completely different approach to the design of anion channels has been 
proposed by the group of J. T. Davis. The 1,3-alternate calix[4]arene tetrabutyl 
amide reported in Figure 1.26 binds HCl in a ditopic fashion and the resulting 
complex self assembles to form a dimer, or a n-mer, in which HCl bridges, through 
one water molecule, two calix[4]arene macrocycles.56 The resulting structure forms a 
channel which transports H+ and Cl– with a symport mechanism. 
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Figure 1.26. J.T. Davis’ calix[4]arene amide derivative and cartoon of the dimeric self-assembled complex. 
Some years ago the group of M. R. Ghadiri reported the synthesis of large 
tubular channels able to transport glutamate (Figure 1.27).57 These channels were 
obtained from the self-assembling of cyclic peptides made of alternating L and D 
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amino acids. The cyclopeptides assemble as a stack of rings thanks to hydrogen 
bonding and form an elegant barrel-hoop architecture. 
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Figure 1.27. Ghadiri’s peptide nanotubes. 
It is not unusual in this field the modification of natural structures in order to 
enhance activity. In 2005 the group of J. L. Sessler58 and a collaborative effort from 
P. A. Gale and B. D. Smith59 led to the synthesis of anion carriers based on 
prodigiosins (Figure 1.28). On one hand, Sessler investigated prodigiosin analogues 
in which the dipyrromethene motif is maintained and variations are made in the 
substitution pattern, on the other hand, Gale and Smith used an amidopyrrole 
nucleus functionalyzed with an imidazole as prodigiosin mimic. Despite the 
structural diversity, the results obtained were similar. Both the classes of compounds 
transport Cl– and the efficiency of the process depends on the pH gradient across 
the membrane, among Sessler’s prodigiosin analogues the highest activity was 
observed for compound I, the most similar to the natural model.  
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Figure 1.28. Sessler’s (on the left) and Gale’s and Smith’s (on the right) prodigiosin mimics. 
A completely different approach to the design of anion transporters was 
developed by A. P. Davis and co-workers. They built new anion receptors based on 
a cholic acid skeleton. The tetracyclic steroidal framework, on one side, ensures 
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enough lipophilicity to guarantee interaction with membranes, and on the other side, 
thanks to the C-3, C-7 and C-12 substituents, it forms a pocket with a preorganized 
array of hydrogen bond donor groups, showing high affinity for anions.60,61 The so-
called cholapods are thus able to complex chloride, forming a highly lipophilic 
complex transporting it with a carrier -like mechanism (Figure 1.29). 
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Figure 1.29. A.P. Davis’s cholapods 
 
1.3   LIPOSOMES AS BIOLOGICAL MEMBRANE MODELS 
As previously described, phospholipids are amphipathic molecules with a 
hydrophilic portion made by a polar head containing a phosphate group and long 
alkyl chains as apolar tails. Phospholipids have low solubility in water but, thanks to 
their amphipathic nature, they aggregate spontaneously forming double layers in 
which the hydrophobic tails face each other and the hydrophilic ends are exposed to 
the aqueous medium. Through some techniques such as sonication or extrusion, it 
is possible to transform these spontaneous aggregates in liposomes, which are 
spherical vesicles with a membrane composed by a phospholipid double layer 
(Figure 1.30).  
 
Figure 1.30. Liposome section. 
In this way the liposome entraps in its interior an aqueous pool separated from 
the aqueous bulk by a phospholipid barrier which doesn’t permit the passage of ions 
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or polar molecules. For this reason liposomes are suitable models of biological 
membranes which allow the study of the transport of substrates across the double 
layer from the inner core water pool to the bulk water or vice-versa. 
Liposomes have an ordered structure and their degree of organization depends 
on temperature, like it happens for natural membranes. Their dimensions vary 
considerably and depend on the way they are prepared: their diameter is between 20 
nm and 500 nm and also multilayer liposomes, i.e. formed by two or more 
concentric double layers, can be obtained. Unilamellar liposomes of small 
dimensions, obtained by sonication (Small Unilamellar Vesicles, SUVs) or greater 
dimensions, obtained by extrusion (Large Unilamellar Vesicles, LUVs), are usually 
employed for membrane permeation studies.62,63 
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Taking inspiration from the AmB and squalamine structures, during the past 
years our group synthesized a series of compounds that incorporate the 
fundamental structural elements of these natural ion transporters: a rigid 
hydrophobic unit, a hydrophilic chain (conduction module) and two polar head 
groups. As conduction module we chose a polyether or a polyaminic chain, as polar 
heads a phosphate and an ammonium group, and to mimic the rigid hydrophobic 
unit we employed an α-aminoisobutyric acid (Aib) oligopeptide. 
The secondary structure adopted by a peptide chain is influenced by the type 
of α-amino acids present, by the interactions within the lateral chains and by the 
intramolecular hydrogen bondings involving carbonyl groups and amidic protons of 
the peptide scaffold. The obtainment of the conformational control of a peptide is 
not always straightforward, indeed, using proteinogenic amino acids helix structures 
are generally formed only in rather long peptide sequences (usually more than 16 
amino acids). On the other hand, shorter peptides with an organized structure are 
accessible using α,α-disubstituted amino acids. The archetype of these type of  
amino acids is Aib (see Figure 1.10). 
The presence of a high steric hindrance around Cα reduces the number of 
conformations that Aib can assume fostering the formation of helix structures even 
in short peptides. A 7-8 residues Aib oligopeptide results completely structured.9 
Usually, in such short sequences these peptides prefer a 310-helix conformation 
respect to an α-helix. (Figure 2.1) 
α-helix
310-helix
 
Figure 2.1. Models of α-helix (top) and 310-helix (bottom). 
The 310-helix is more stretched than an α-helix formed by the same number of 
residues. The 310-helix has a 6.29 Ǻ pitch and 3.63 residues per turn and it is 
stabilized by intramolecular hydrogen bondings between a C=O group of a residue 
in i position and a N-H group in i+4 position, thus forming 13 atoms cycles (C13 
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structures). The α-helix has a 5.67 Ǻ pitch and 3.24 residues per turn and it is 
stabilized by intramolecular hydrogen bondings between a C=O group of a residue 
in i position and a N-H group in i+3 position, thus forming 10 atoms cycles (C10 
structures).64 
Aib peptides appear really useful to be incorporated in the structure of an 
artificial ionophore, because they can form hydrophobic helix structures which 
would be able to strongly interact with a phospholipid membrane. Figure 2.2 shows 
the 310-helix conformation of an Aib octapeptide with all methyl groups pointing 
outside the helix originating a cylindrical and rigid hydrophobic structure which can 
interact with membrane phospholipids.   
 
Figure 2.2. 310-helix conformation of an Aib octapeptide. 
On the basis of these considerations our group designed and synthesized a 
series of analogues varying the length of the peptide (four or eight residues) and the 
nature and length of the conduction module (polyether or polyaminic). Among all 
the compounds synthesized, A8PE (Figure 2.3, on the left) showed the best 
ionophoric activity. 
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Figure 2.3. A8PE structure (left) and cartoon of its possible mechanism of action (right). 
The suggested mechanism of action for this compound was similar to that 
proposed for squalamine: a cluster arrangement in membrane of pseudo-macrocycles 
which are stabilized by the formation of a salt bridge between the polar head 
groups. (Figure 2.3, on the right). 
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In order to gain more information about the structural elements relevant for 
the ionophoric activity a series of analogues of A8PE carrying protecting groups 
which alternatively or contemporaneously “mask” the polar heads were prepared. 
Among this second family of analogues we found a compound with an impressive 
activity in Na+ transport. Its structure is reported in Figure 2.4. 
Z
N
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8 5
 
Figure 2.4. Structure of compound 1. 
The understanding of the reasons for such high and unexpected activity was 
therefore one of the main subjects of this Thesis work in which alkyl analogues of 1 
already prepared in our group were studied as well as new analogues were prepared 
and studied. In particular the alkyl analogues of Figure 2.5 were investigated in order 
to verify the effect of hydrophocity of the Z-group in respect to the 4-phosphate 
phenyl group of A8PE. 
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Figure 2.5. Structures of alkyl analogues of 1. 
On the other hand, a series of analogues carrying a different aromatic group in 
place of the Z-group (Figure 2.6) were synthesized and studied in order to asses the 
relevance of the aromatic substitution in ionophore 1.  
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Figure 2.6. Structures of aromatic analogues of 1. 
The second and more general subject of this Thesis work was the beginning of 
an investigation of structurally different compounds aimed to define common 
structural requirements for ionophoric activity. In this contest we have collaborated 
with several research groups which have synthesized the putative ionophore. 
Moreover, this investigation has required the acquisition of expertise in several 
techniques, mainly based on fluorescent probe, used for the investigation of 
ionophoric properties. In the following pages are listed the compounds studied. 
The group of Prof. De Riccardis at Salerno University prepared the 
spermidinic calix[4]arenes illustrated in Figure 2.7. 
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Figure 2.7. Structures of De Riccardis’ spermidinic calix[4]arenes. 
The same group prepared the cyclic α-peptoids A4-A10 shown in Figure 2.8. 
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Figure 2.8. Structures of De Riccardis’ cyclic α-peptoids. 
The group of Prof. Montesarchio at Napoli University prepared the Cyclic 
Phosphate-Linked OligoSaccharide macrocycles (CyPLOS) C1-C8 illustrated in 
Figure 2.9. 
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Figure 2.9. Structures of Montesarchio’s CyPLOS. 
The group of Prof. Casnati at Parma University prepared the guanidinium 
calix[4]arenes D1-D3 shown in Figure 2.10. 
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Figure 2.10. Structures of Casnati’s guanidinium calix[4]arenes. 
The ionophoric activity of all these compounds was investigated using 
liposomes as membrane models, and the measurements have been conducted by 
NMR spectroscopy and spectrofluorimetric techniques involving the use of 
fluorimetric probes.  
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3.1   SYNTHESIS 
In order to obtain new squalamine mimics based on 1 structure we need to 
synthesize the rigid hydrophobic unit (Aib octapeptide) and the conduction module 
(pentaoxa(etyhlene)diaminic chain). Then we had to perform the required couplings 
with the chosen aromatic moieties to obtain the final molecules 2-5.  
 
3.1.1   SYNTHESIS OF THE HYDROPHOBIC UNIT 
The rigid hydrophobic unit is an octapeptide made of α-aminoisobutyric acid 
(Aib), which is less reactive than natural aminoacids because of the presence of 
steric hindrance around Cα. Due to this reason the synthesis of these peptides is 
usually conducted in solution and the methodologies for the solid phase synthesis of 
peptides aren’t used. The octapeptide was synthesized following the Scheme 3.1: 
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Z-Aib-OH H-Aib-OtBu
Z-Aib2-OtBu
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Scheme 3.1. Reagents and conditions: a) Z-OSu, CH3CN/H2O 4:3, r.t., 24 h, 73%; b) isobutene, H2SO4, 
CH2Cl2, r.t., 67 h, 95%; c) H2(1 atm), Pd/C(5%), CH2Cl2, r.t., o.n., quant.; d) EDC, HOBt, Et3N, CH2Cl2, 
0°C – r.t., i.a., 3 dd., 82%; e) TFA/CH2Cl2 1:1, r.t., 6 h, quant.; f) EDC, CH3CN, 0°C – r.t., i.a., 48 h, 95%; g) 
H2(1 atm), Pd/C(5%), MeOH, r.t., o.n., 95%; h) CH3CN, reflux, 24 h, 86%; i) TFA/CH2Cl2 1:1, r.t., 4 h, 
quant.; j) EDC, CH3CN, 0°C – r.t., i.a., 24 h, 75%; k) H2(1 atm), Pd/C(5%), MeOH, r.t., o.n., 92%; l) 
CH3CN, reflux, 24 h, 86%. 
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The synthetic pathway follows the usual reactions of protection, deprotection, 
and condensation normally applied in the conventional peptide synthesis; however, 
these reactions, when involving these tetra-alpha-substituted amino acids, are slower 
and usually the yield is lower. The peptide was prepared using a convergent 
synthetic stategy and was asymmetrically protected at the N-terminus and C-
terminus using respectively the benzyloxycarbonyl group (Z), selectively removable 
by catalytic hydrogenation, and the tert-butyl ester, cleavable in acidic conditions. 
The first step of the synthesis is the condensation between Z-Aib-OH and H-Aib-
OtBu leading to the Z-Aib2-OtBu dipeptide. The coupling was made using a 
hydrosolubile carbodiimide, EDC and HOBt  as catalyst, and after three days at r.t. 
the desired product was obtained in 82% yield.  
The dipeptide was separately deprotected at C- and N-terminus and the two 
products were condensed to form Z-Aib4-OtBu, which was subjected to the same 
reaction scheme giving Z-Aib8OtBu. All these condensation steps were performed 
by activation of the C-terminus via oxazolone,65 which was reacted with the free N-
terminus reaction partner without need of other reagents and leading to yields above 
80%. The oxazolone was prepared from the proper Z-(Aib)n-OH precursor using 
EDC, at 0°C in anhydrous CH3CN, following the mechanism shown in Scheme 3.2. 
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Scheme 3.2. Mechanism of oxazolone formation. 
This C-terminus activation method is widely used with Cα,α-substituted amino 
acids, because, due to the absence of a Hα, there is no racemization (or 
epimerization) risk, which is instead present with natural amino acids.65 This 
advantage makes the oxazolone formation the method of choice for the activation 
of the C-terminus. Moreover, the absence of the racemization risk makes 
convenient the convergent synthesis approach thus reducing the total number of 
steps and consequently increasing the final yield. 
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3.1.2   SYNTHESIS OF THE CONDUCTION MODULE 
The pentaoxa(ethylene)diaminic Boc-monoprotected chain was synthesized 
starting from the corresponding commercial glycole which was converted in 
ditosylate through reaction with an excess of TsCl in basic conditions. Reaction of 
the ditosylate with NaN3 afforded the corresponding diazide, which was then 
reduced with PPh3 and H2O. The resulting diamine dihydrochloride was Boc 
monoprotected by reaction with Boc2O at 0°C in anhydrous MeOH in presence of 
Et3N (Scheme 3.3). A mixture of free diamine, mono protected amine and 
diprotected amine was obtained. To afford the pure monoprotected amine, the 
mixture was first dissolved in dichloromethane and washed with an acid aqueous 
solution to eliminate the diprotected amine, which remains in the organic phase. 
Then the aqueous solution was basified and extracted with dichloromethane: the 
free diamine remains in the aqueous phase and the desired monoprotected amine is 
obtained pure from the organic phase, without need of further purification. 
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Scheme 3.3. Reagents and conditions: a) TsCl, Et3N, CH2Cl2, r.t., 16 h, 76%; b) NaN3, DMF, r.t., o.n., 86%; 
c) PPh3, H2O, THF, r.t., 12 h, 96%; d) Boc2O, 0°C – r.t., MeOH, 18 h, 38%. 
 
3.1.3   SYNTHESIS OF CONJUGATES 1, 4 AND 5 
To conjugate the peptidic moiety and the conduction module we used the 
oxazolone method as described previously. Compound 19 was reacted with the 
monoBoc-(pentaoxa)ethylenediaminic chain in CH3CN at reflux temperature for 24 
h giving, after chromatographic purification on silica gel, the desired product with 
84% yield. This precursor was Boc-deprotected with TFA/CH2Cl2 to afford 
compound 1 in quantitative yield (Scheme 3.4).  
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Scheme 3.4. Reagents and conditions: a) TFA/CH2Cl2 1:1, r.t., 4 h, quant.; b) EDC, CH3CN, r.t., i.a., 24 h, 
88%; c) 24, CH3CN, reflux, 24 h, 84%; d) TFA/CH2Cl2 1:1, r.t., 4 h, quant. 
The other conjugates were obtained from precursor 25 by deprotection of the 
N-terminus using catalytic hydrogenation and reaction with the acylchloride of the 
corresponding moiety (27 or 29) in CH3CN at r.t. for 24 h both with 62% yield, 
after purification over silica gel. The acylchlorides were obtained from the 
commercial acids by reaction with SOCl2.66,67 Finally the Boc-protection was 
removed as described above affording compounds 4 and 5 (Scheme 3.5).  
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Scheme 3.5. Reagents and conditions: a) H2 (1 atm), Pd/C (5%), MeOH, r.t., o.n., 80%; b) SOCl2, reflux, 3 h, 
97%; c) SOCl2, reflux, 3 h, 96%; d) 27, Et3N, CH3CN, r.t., i.a., 24 h, 62%; e) TFA/CH2Cl2 1:1, r.t., 4 h, 
quant.; f) 29, Et3N, CH3CN, r.t., i.a., 24 h, 62%. 
 
3.1.4   SYNTHESIS OF CONJUGATES 2 AND 3 
After studying the ionophoric activity of compounds 1, 4 and 5 we decided to 
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design and synthesize two new conjugates carrying different aromatic moieties: one 
with a pyrene-(CH2)2- substituent and one with a phenyl substituent linked to the 
octapeptide N-terminus. The former is a homologous of 1 with a bigger aromatic 
portion and, unlike 5, it is characterized by a higher conformational freedom of the 
pyrene subunit; the latter is the smaller of the series 4-5. 
During the synthesis of compounds 4 and 5 we observed some problems in 
the final acylation step. In particular, some side products with Rf value close to the 
desired product were formed making the purification step really difficult. For this 
reason, in the synthesis of compounds 2 and 3 we decided to invert the order of 
octapeptide functionalization by performing first the acylation of the N-terminus 
and then the conjugation with the conduction module 24. 
The precursor of the aromatic moiety of compound 3 is simply benzoic acid, 
commercially available, whereas the one for compound 2 can be obtained in two 
steps from commercial 1-pyrenecarboxaldehyde as shown in Scheme 3.6:68 
CHO COOH
a
COOH
31 32
b
 
Scheme 3.6. Reagents and conditions: a) malonic acid; py; 100°C, o.n., 78%; b) H2(1 atm), PtO2, 
CH3COOH, r.t., o.n., 93%. 
The aromatic aldehyde was heated at 100°C in pyridine with malonic acid 
overnight yielding the α,β-unsaturated acid 31 which was converted into the 
corresponding saturated acid 32 by catalytic (PtO2) hydrogenation in acetic acid. 
The precursor 17 was Z-deprotected by hydrogenolysis and the free amine 20 
coupled with acid 32 or with benzoic acid using EDC and HOBt as catalyst. After 
purificaton over silica gel, we obtained compounds 33 and 37. These intermediates 
were C-deprotected by treatment with TFA in CH2Cl2 and the free acids were 
converted into the corresponding oxazolones 35 and 39 with EDC. The coupling 
with the conduction module 24 in refluxing CH3CN yielded, after silica gel 
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purification and Boc-deprotection with TFA, the desired compounds 2 and 3 
(Scheme 3.7).   
17 20
a
Aib8
H
N
O
NH2
5
3
O
Aib8
H
N
O
NH2
5
2
O
d, e d, f
Z-Aib8-OtBu H-Aib8-OtBu
Aib8
OtBu
O
Aib8
OtBu
O
33
37
b c
Aib8
Oxl
O
35
Aib8
Oxl
O
39
g, d
i, d
 
Scheme 3.7. Reagents and conditions: a) H2(1 atm), Pd/C(5%), MeOH, r.t., o.n., 80%; b) 32, EDC, HOBt, 
Et3N, CH3CN, r.t., i.a., 3 dd., 37%; c) benzoic acid, EDC, HOBt, Et3N, CH3CN, r.t., i.a., 3 dd., 50%; d) 
TFA/CH2Cl2 1:1, r.t., 4 h, quant.; e) EDC, CH3CN, r.t., i.a., 24 h, 87%; f) EDC, CH3CN, r.t., i.a., 24 h, 91%; 
g) 24, CH3CN, reflux, 24 h, 44%; i) 24, CH3CN, reflux, 24 h, 59%. 
All the final products described in the previous paragraphs were characterized 
by 1H-NMR, 13C-NMR and ESI-MS. The overall yields of final compounds, 
considering the octapeptide 17 as starting material, are reported in Table 3.1:  
Table 3.1. Yields obtained for compounds 2-5. 
Compound Yield 
2 14% 
3 27% 
4 37% 
5 38% 
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Comparing the two different synthetic approaches the one used for 
compounds 4 and 5 gives higher yields. However, purification of these compounds 
was really difficult and required several repeated chromatographic steps. 
Accordingly, on the overall balance between time and yield we can say that the 
synthetic pathway chosen for compounds 2 and 3 is more useful. 
 
3.2   IONOPHORIC ACTIVITY  
3.2.1   METHODS 
3.2.1.1    Liposomes preparation 
The procedure consists first in the formation of a dried lipid film (cake) which 
is prepared by evaporation under an argon flux of a lipid solution in chloroform, in 
our case usually a mixture of egg yolk phosphatidylcholine (EYPC) and egg yolk 
phosphatidylglycerole (EYPG) in 95:5 (mol/mol) ratio. The cake is then swelled 
with the appropriate solution (depending onto the experiment) by rotating the flask 
in a thermostatic bath (40°C if not otherwise indicated) for 30 minutes. This 
operation leads to the formation of a dispersion of multi-lamellar vesicles (MLVs) 
which present an “onion-like” structure. Unilamellar vesicles are obtained by 
subjecting the dispersion first to five freeze-thaw cycles and then to extrusion 
through polycarbonate membranes with controlled diameter pores. In the freeze-
thaw process the lipid dispersion is frozen in liquid nitrogen (-196°C) and 
immediately dipped in a thermostatic bath (40°C if not otherwise indicated) to break 
the MLVs and facilitate the rearrangement in unilamellar vesicles. Large unilamellar 
vesicles (LUVs) are eventually obtained by extrusion of the lipid dispersion through 
a polycarbonate membrane, inserted in an appropriate equipment, under a nitrogen 
pressure (15 bar) (Figure 3.1).62 We normally used 100 nm diameter pore 
membranes and the extrusion process was repeated ten times to produce a 
homogeneous population of liposomes characterized by a medium diameter of 
100±33 nm.69,70  
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There are two general procedures to incorporate ionophores into the vesicles: 
in the first one an aliquot of solution of ionophore in a water miscible solvent is 
simply added to liposomes after their preparation (single side addition); in the second 
one the ionophore dissolved in a low boiling solvent is added before the formation 
of the lipid cake during vesicles preparation (double side addition). Usually we used this 
last method only in the case of 23Na+-NMR studies and in experiments for the 
determination of the ionophore content in liposomes (see below). 
 
Figure 3.1. Methods of liposomes preparation. 
3.2.1.2    Ionophore content assay 
Ion transport activity is strictly related to the real concentration of ionophore 
in the phospholipid bilayer. Therefore, it is important to measure its partition 
coefficient between membrane and water in particular when activities of different 
ionophores have to be compared. However, its determination is not straightforward 
because partition is a dynamic process. Separation of the membrane-bound 
ionophore from the free one have to be fast enough to avoid that, during 
separation, the partition equilibrium moves to the free ionophore, but without 
perturbing too much the system. 
In the protocol we have adopted we used an ultra-filtration kit for 
centrifugation (Microcon® YM-10 filters) equipped with a membrane with a 10000 
Da cut-off. In this way vesicles are separated from the ionophore not partitioned in 
membrane by 25 minutes of centrifugation at 13000 rpm. The content of ionophore 
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in the eluate after separation is then analyzed using different techniques in function 
of its chemical nature. 
If the ionophore contains one or more free primary amines the fluorescamine  
(Fluram®) assay has proved to be quite sensitive and easy to use. Fluorescamine is a 
non-fluorescence molecule which, at pH 9 and r.t., rapidly and selectively reacts (t1/2 
= 100 ÷ 500 ms) with primary amines generating a fluorescent adduct (390 nm 
excitation, 430 ÷ 530 nm emission range). The excess of reagent is hydrolyzed in 
non-fluorescent products with a half-time of several seconds (Figure 3.2).  
O
O
O
O
+ RNH2
Fluorescamine
(non fluorescent)
Fluorophor
+ H2O
t1/2 = 100-500 ms
t1/2 = 5-10 s
Hydrolysis products
(non fluorescent)
COOH
OH
N
O
R
 
Figure 3.2. Reaction of fluorescamine with primary amines at pH 9. 
For this assay an aliquot of eluate containing the ionophore is buffered at pH 9 
and then an excess of fluorescamine, dissolved in acetone is added.71 The 
fluorescence emission is then measured and correlated to the concentration of 
ionophore using a calibration curve obtained by measurements on solutions at 
known ionophore concentration. 
When the ionophore does not contain primary amines but it has some 
cromophores such as, for example, aromatic groups, UV-Vis measurements can be 
used to measure the ionophoric content. Also in this case the construction of a 
calibration curve is required. This method gives, however, less precise results respect 
to the Fluram® assay due to a usually high background adsorbance of the eluate.  
3.2.1.3     23Na-NMR transport assay 
Na+, together with K+, is the cation present at the highest concentration in the 
living cells. Na+ concentration is the direct regulator of the Na+-K+ pump, which is 
involved in the energy processes of the cell;2 moreover, the levels of intracellular 
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Na+ are strictly related to cell proliferation and, therefore, to the mitogenesis and 
oncogenesis.72 Due to this reason, the study of Na+ intra- and extra-cellular 
concentration and its flow through the cell membrane is considerably interesting. 
NMR spectroscopy of 23Na is a useful non-invasive technique to study Na+ 
cation in living cells and also in model systems as liposomes. In order to 
differentiate the resonances of intra- and extra-vesicular Na+ ions a membrane 
impermeable shift reagent has to be used. The shift reagent is added after the liposome 
preparation and, being unable to cross the membrane, it may interact only with Na+ 
ions present in the bulk solution (Na+out) and not with those inside the vesicles 
(Na+in). As a consequence, only the resonance of Na+out is affected (shifted), thus 
allowing the discrimination of the two populations of sodium ions. The shift reagent 
most frequently used is the [Dy(PPP)2]7- complex formed in situ from DyCl3 and 
sodium triphosphate (Na5P3O10, NaPPP).73 The dysprosium complex is quite bulky 
and highly negatively charged and thus is not able to cross the phospholipid double 
layer and remains confined in the external bulk solution. 
To verify if a potential ionophore is able to modify membrane permeability 
and to promote Na+ ions transport through the double layer, a liposomes dispersion 
is prepared using a PC/PG (95:5) lipid mixture in 100 mM LiCl  solution. Usually, 
in this experiment, the ionophore is directly added to the lipids before all the 
operations that led to liposomes formation (double side addition), to favour partition of 
the ionophore in both the phospholipid leaflets of the vesicles. An equal volume of 
shift reagent in a NaCl solution is then added to the liposomes dispersion and the final 
salts concentrations are calculated in order to have the same ionic strength inside 
and outside the liposomes to avoid osmotic shock. 
At zero time, immediately after the shift reagent addition, only Li+ is present 
inside vesicles and, therefore, in the NMR spectrum only the Na+out signal is 
observed. If the ionophore can alter the double layer permeability, Na+ ions cross 
the membrane and exchange with Li+ ions inside the vesicles, thus a high-field signal 
of Na+in ions is observed and the exchange rate constant can be calculated from the 
variation of the area integral of the Na+in signal in function of time (Figure 3.3).  
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Figure 3.3. An example of a 23Na+-NMR experiment. 
3.2.1.4    Calcein-release assay  
The behaviour of amphipathic species in liposomes or in cellular membranes 
strongly depends on the concentration of the compound examined. For example 
Triton® X-100 (Figure 3.4), typically used as detergent and able to lyse liposomes, in 
specific conditions can form channels and, on the other hand, a number of ion 
channels, carriers and pore forming molecules can behave in a detergent-like 
manner at high concentrations and lyse membranes.28 
O
O
H
n
n = approx 9.5  
Figure 3.4. Structure of Triton® X-100. 
Membrane leakage assays allow to distinguish ion transport through channels 
from non-selective leakage through oversized pores.74 Typically, these assays are 
based on the release of a fluorescent dye, such as calcein, trapped in the inner water 
pool of liposomes (Figure 3.5).75,76 Calcein is a large dye which can’t cross the 
double layer due to its polyanionic character; the dye is trapped inside the liposomes 
at a high concentration and in this conditions its fluorescent emission is strongly 
quenched due to a concentration dependent self-quenching process. If calcein is 
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released in the bulk water through large pores or because of membrane lysis, the dye 
is diluted in the bulk water and the fluorescence emission is restored.  
O
O
O
HO OH
N
COOH
COOH
N
HOOC
HOOC
 
Figure 3.5. Calcein structure. 
The experiment is conducted measuring the fluorescence emission of calcein 
entrapped in the inner water pool of liposomes after the addition of increasing 
amounts of ionophore solution. In the case of ion transport through channels, little 
change in fluorescence is observed, whereas the formation of large pores or 
destruction of liposomes results in dye release and consequent increase of its 
fluorescence emission. The final fluorescence value is obtained after complete 
liposomes lysis by Triton® X-100 addition. 
3.2.1.5    Proton permeation assays 
Proton permeation through the phospholipid double layer was investigated 
using the hydrophilic pyrene analogue 8-hydroxypyrene-1,3,6-trisulfonic acid 
trisodium salt (HPTS, pyranine) sensitive to pH changes (Figure 3.6).77 
S
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O
O O
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Na Na  
   Figure 3.6. Pyranine structure. 
The fluorescence intensity (λem = 510 nm) of pyranine is strongly dependent 
upon the ionization degree of the 8-hydroxyl group (pKa = 7.2) and hence upon the 
pH of the medium. The ionization of this group is associated to a pronounced red 
shift in the excitation maximum, from 400 nm (pH 4) to 450 nm (pH 10), whereas 
the position of the emission maximum at 510 nm remains essentially unchanged; as 
a result the intensity of fluorescence emission at 510 nm, exciting at 450 nm, reflects 
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the concentration of the deprotonated species and consequently the pH of the 
medium.78 The correlation between fluorescence intensity and pH is linear from pH 
7 to 8 allowing an easy correlation between emission intensity and pH in this pH-
range.79 
Because of its polyanionic character, pyranine is very soluble in water solutions, 
does not significantly bind to phospholipid vesicles and is unable to cross the 
phospholipid membrane. As a result, it is possible to prepare vesicles, using the 
method described above (paragraph 3.2.1.1), in presence of pyranine (typically 0.1 
mM, 100 mM NaCl, buffer solution pH 7.0), and, after removal of the external 
probe by gel filtration, pyranine remains entrapped within the internal aqueous 
compartment of liposomes. 
Ionophoric activity of a given molecule can be assayed evaluating its ability to 
promote the discharge of a pH gradient across the lipid bilayer. In a typical 
experiment a pH difference of 0.6 units (from 7.0 to 7.6) between the inner water 
pool and the bulk water is established by a rapid injection of a NaOH aqueous 
solution to the liposome suspension (pH shock). Under such conditions the 
ionophoric activity is reflected by an increase in fluorescence intensity with time, 
due to the deprotonation of the hydroxyl group, because of basification of the inner 
water pool which may derive from H+ efflux or OH– influx. In this type of 
experiment these two processes are kinetically equivalent and therefore it is not 
possible to distinguish between them. In absence of ionophores a small increase of 
fluorescence is observed, due to the unassisted slow permeation of protons through 
the double layer; the addition of ionophore speeds up the process in function of its 
concentration and intrinsic activity. At the end of the experiment, as a further 
control, the vesicles are lysed using Triton® X-100 to cause the leakage of pyranine 
and measure the final value of fluorescence (Figure 3.7).  
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Figure 3.7. Kinetic profile of proton permeation in absence of ionophore. 
The fitting of the kinetic traces of ionophoric activity, which normally follow a 
first-order kinetic process, gives the apparent first order rate constants (kobs, s-1) for 
the transport process. These kinetic profiles, when associated to self-assembling 
phenomena of monomeric species leading to the formation of active supramolecular 
aggregates, are usually interpreted by Equation 3.1 proposed by Regen15,80 and 
derived from the well known Hill equation.81 
kobs =
k[monomer]n
K
Equation 3.1 
where: kobs is the observed kinetic rate constant, k is the intrinsic rate constant 
characterizing the ion permeation process and K the dissociation constant of the 
aggregate-monomer equilibrium involving n monomers. Depending on n value we 
can find a linear behaviour (n = 1), positive or negative deviations from linearity (n 
> 1 or n < 1). The observed behaviour is determined by energetic of the formation 
of the supramolecular aggregate: n > 1 values are observed for endoergonic 
association processes in which equilibrium lies far toward the free monomer, 
whereas n ≤ 1 (linear or saturation profiles) values are observed for exoergonic 
processes in which equilibrium lies toward the aggregate.82 Behaviours showing 
positive deviation are considered as an evidence for a cooperative mechanism 
involving a number n of monomers that assemble to form the active pore or 
channel. The interpretation of linear or saturation profiles is not so straightforward 
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because more than one mechanism may lead to these behaviours. For example, a 
monomolecular channel or carrier should lead to a linear activity/concentration 
profile.   
Simple modifications of the standard HPTS assay allow to gain information 
about cation or anion selectivity in the transport process. Cation and anion 
selectivity can be tested in two ways: a) preparing liposomes directly using a MCl 
(with M+ = Li+, Na+, K+, Rb+, Cs+) or NaX (with X– = F–, Cl–, Br–, I–, NO3–, SO42–
, ClO4–, Ac–, Glu) buffer solution and using the same solution in the fluorimetric 
cell for dilution; in this case only the cation or anion under investigation is present 
inside and outside the liposomes; b) preparing liposomes in NaCl buffer solution 
and using in the fluorimetric cell a MCl or NaX solution for dilution; in this case at 
the beginning of the experiment the liposomes are always filled with NaCl and the 
cation or anion under investigation is present only outside the liposome (Matile’s 
protocol83). In both cases the cation selectivity experiments require also the use of 
the appropriate base MOH for pH-shock. The addition of OH– at the beginning of 
the experiment generates a pH gradient that can be discharged by transmembrane 
ion translocations in two possible ways: an antiport of ions carrying the same charge 
or a symport of opposite charged ions. 
In case a) the overall possible processes are four: H+/M+ or OH–/Cl– antiport 
and H+/Cl– or M+/OH– symport (in cation selectivity experiments); H+/Na+ or 
OH–/X– antiport and H+/X– or Na+/OH– symport (in anion selectivity 
experiments) (Figure 3.8). 
M+
Cl-
M+/OH-
H+/Cl-
H+
OH-
antiport symport
CATION SELECTIVITY ANION SELECTIVITY
Na+
X-
Na+/OH-
H+/X-
H+
OH-
antiport symport
 
Figure 3.8. Possible ion traslocation processes in HPTS ion selectivity assays. 
In case b) NaCl is always present inside liposomes and the external salt varies, 
hence there are more ions involved than in case a) and the possible processes 
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present are six: H+/M+, H+/Na+, OH–/Cl– antiport and H+/Cl–, OH–/M+, OH–
/Na+ symport (in cation selectivity experiments); OH–/X–, OH–/Cl–, H+/Na+ 
antiport and OH–/Na+, H+/X–, H+/Cl– symport (in anion selectivity experiments) 
(Figure 3.9). 
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Na+
M+/OH-
H+/Cl-
H+
H+
antiport symport
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Figure 3.9. Possible ion traslocation processes in HPTS ion selectivity assays (Matile’s ptotocol). 
The ion exchanges which do not involve H+ or OH– (detected by pyranine) 
cannot be directly observed, but they can contribute to the ions exchange 
mechanism leading to a more complicated interpretation; nevertheless this protocol 
substantially reports on M+ or X– selectivity (processes involving Cl– and Na+ in 
case b) are negligible due to their lower concentration respect to the other 
anion/cation present). This has been clearly demonstrated by Matile who compared 
the selectivity sequences obtained with the HPTS assay with those obtained from 
electrochemical transport experiments on BLM (black lipid membrane), a method 
widely used to study natural transport systems.83  
3.2.1.6    AMFE (Anomalous Mole Fraction Effect) 
AMFE refers to a lower than expected ionophoric activity found in presence 
of mixtures of ions compared to pure ions.52 Its occurrence indicates that the non-
transported or less efficiently transported ion competes with the better transported 
ion for “binding sites” along the channel inhibiting its transport. AMFE can be 
assayed using HPTS and Matile’s protocol for ion selectivity (see previous 
paragraph) with the only difference that the buffer used to dilute the vesicular 
preparation contains a mixture of transported and non-transported ion with total 
ion concentration remaining the same. Plotting the activity as a function of the 
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transported molar ion fraction, the AMFE is highlighted by a deviation from the 
linear behaviour expected in case of simple additivity. 
3.2.1.7    Halide transport with HPTS assay  
A proof of the presence of an effective halide transport can be obtained 
substituting the pH-shock with a halide gradient in a typical HPTS assay.54 An 
effective halide transport have to be counterbalanced by OH– antiport or H+ 
symport leading in both cases to acidification of the inner compartment of 
liposomes, which is detected by a decrease in fluorescence emission of HPTS 
trapped inside liposomes.  
In this experiment liposomes are loaded with a buffered HPTS solution 
without addition of other salts and the gradient is established by a rapid injection of 
a NaX (with X– = F–, Cl–, Br–, I–, NO3–, SO42–, ClO4–) solution directly in the 
fluorimetric cell. At the end of the experiment, the vesicles are lysed using Triton® 
X-100 to cause the leakage of pyranine and measure the final value of fluorescence. 
3.2.1.8    Halide transport with lucigenin assay 
Lucigenin (bis(N-methylacridinium) nitrate) is a fluorescent probe (λex = 455 
nm, λem = 506 nm) which fluorescence emission is quenched by halide anions. 
Therefore, it can be used to detect directly halides, and particularly chloride 
transport, across the phospholipid bilayer. Necessarily, in this assay, the other 
anions present in solution to buffer the ionic strength must be oxoanions, such as 
for example nitrate, which does not influence lucigenin fluorescence (Figure 
3.10).61,84 
N
N
CH3
CH3
2 NO3
 
Figure 3.10. Lucigenin structure. 
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Because of its polycationic character, lucigenin is very soluble in water, does 
not significantly bind to phospholipid vesicles and is unable to cross the 
phospholipid membrane. As a result, it is possible to form vesicles, using the 
method described above (see paragraph 3.2.1.1), in the presence of lucigenin 
(typically 1 mM, 225 mM NaNO3, buffer solution pH 7.0) and, after removal of 
external probe by gel filtration, vesicles contain lucigenin entrapped in the inner 
water pool. 
To evidence the chloride transport a chloride gradient across membrane is 
established by addition of a NaCl solution to the pre-formed vesicles. In absence of 
ionophores a moderate decrease of fluorescence is observed, due to the slow 
spontaneous permeation of chloride, which is a rather lipophilic anion, through the 
double layer. The addition of ionophore speeds up the process in function of its 
concentration and intrinsic activity. At the end of the experiment, as a further 
control, the vesicles are lysed using Triton® X-100 to cause the leakage of lucigenin 
and to measure the final value of fluorescence. 
3.2.1.9    Vesicles fusion assay 
A further process that can lead to exchange of ions or organic molecules from 
the bulk water to the inner water pool of vesicles and vice-versa is the so called 
liposomes fusion. In the fusion process two or more vesicles collapse to form a 
larger one leading to the mixing of lipids in membrane and potentially to the release 
of matter entrapped into the inner water pool of liposomes. Fusion can be induced 
by amphipathic molecules and in this case it can be mistaken for an ion transport 
process. It is therefore important to verify if the ionophore under investigation is 
fusogenic and this is possible with an assay based on the monitoring of the 
fluorescence resonance energy transfer (FRET) between NBD-PE and Rh-PE 
probes (Figure 3.11). In this experiment two separate populations of vesicles 
(EYPC/EYPG 95:5) are prepared, one containing 1% NBD-PE and the other 
containing 1% Rh-PE (molar fraction respect to the total lipid concentration).85 
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Figure 3.11. Structures of fluorescent phospholipids Rh-PE and NBD-PE. 
In a fluorimetric cell NBD-PE containing LUVs are mixed with Rh-PE 
containing  LUVs and diluted with a pH 7 buffer; emission spectra are recorded in 
the 500-650 nm range (excitation 463 nm) immediately after the addition of an 
aliquot of solution of the ionophore and 5 minutes after every addition.  
Excitation of NBD-PE (463 nm) leads to an emission band at 530 nm which is 
very close to the absorption band of Rh-PE. When the two dyes are in the same 
liposome membrane, their proximity leads, upon excitation of NBD-PE to the 
emission of Rh-PE (λem = 590 nm) and a concomitant decrease of the emission of 
NBD-PE because of the occurrence of FRET between the two systems. Starting 
from two separate vesicle populations containing NBD-PE and Rh-PE, respectively, 
the fusion process lead to one unique vesicle population containing both fluorescent 
labeled lipids. The vesicle fusion is, therefore, indicated by occurrence of FRET 
process between the two dyes. 
3.2.1.10    Effect of membrane fluidity on the transport process 
The methodologies based on NMR and fluorescence assays allow a definition 
of several aspects of the transport mechanism. However, with these experiments it 
is not really easy to discriminate between a pore/channel forming molecule and a 
mobile carrier. In this contest it is useful to investigate the dependence of the 
transport activity from membrane fluidity. It is, indeed, known that a comparison of 
ionophoric activity above and below the phase transition temperature can be used to 
distinguish between an ion carrier mechanism and a membrane-spanning pathway 
essentially because the carrier has to physically move across the membrane.86 Thus, 
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ion transport which occurs via a carrier mechanism is expected to exhibit 
significantly lower rates in the gel phase when the membrane is more rigid as 
compared with those in the fluid phase, because the ionophore is “frozen” and can’t 
freely move through the bilayer. In contrast, ion transport rates are expected to be 
almost independent of the membrane fluidity when a membrane-spanning 
mechanism is operative. 
The liposomes usually used in our experiments are made prevalently by EYPC, 
a phosphocholines mixture extracted from egg yolk and characterized by 
hydrocarbon chains of different length and saturation degree. As a consequence, 
liposomes made by EYPC have a transition temperature from gel to fluid phase (Tc) 
(see chapter 1.1) around 0°C and if the experiments are conducted at 25°C 
membranes are in the fluid phase.  
Because it is not practical to work at a temperature below 0°C, to evaluate the 
importance of membrane fluidity on ionophores activity it is necessary to use 
liposomes with a different lipid composition and characterized by a higher Tc. In 
particular we use as lipid 1,2-dipalmitoyil-sn-glycero-3-phosphocholine (DPPC, 
Figure 3.12), a phosphocholine which has two identical saturated hydrocarbon 
chains and which leads to liposomes with a Tc above r.t. (Tc = 41°C). When 
working with this DPPC liposomes it is important to perform the swelling, thaw 
and extrusion cycles at a temperature above Tc, because the fluid state of membrane 
makes easier these operations.69 Also the ionophore incubation is conducted above 
Tc to allow a better partition of the molecules in the double layer. 
From a comparison of activity of the ionophore in EYPC and DPPC 
liposomes at 25°C when the two membranes are in the fluid and gel state, 
respectively, it is therefore possible to obtain information on the effect of 
membrane fluidity on the transport rates. 
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Figure 3.12. DPPC structure. 
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3.2.2   EXPERIMENTAL RESULTS AND DISCUSSION 
3.2.2.1    Squalamine mimics 
Previous work in our group highlighted a really outstanding activity of 
compound 1 in the transport of Na+ cation, both in absolute terms than relative to 
similar ionophores. The aim of this work was therefore to investigate the structural 
parameters responsible for such activity. 
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Figure 3.13. Structure of compound 1. 
In comparison with other compounds investigated, and in particular with those 
bearing a phosphate group linked to the N-terminus of the Aib peptide, compound 
1 has two main differences both related to the presence of the Z-protecting group: 
a) it is more lipophilic; b) it has a single ionizable moiety (Figure 3.13). These two 
characteristics may, on one side, simply influence the partition of the ionophore in 
membrane due to the presence of the aromatic portion and of the single charge 
(ammonium), and, on the other side, they may affect the geometry of ionophore 
insertion in the double layer, due to the fact that the protonable amine is in a distal 
position respect to the N-terminus. 
To investigate the role played by lipophilicity we prepared analogues of 1 in 
which the peptide N-terminus is acylated with aliphatic acids of variable chain 
length (Figure 3.14).  
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Figure 3.14. Structures of alkyl analogues of 1. 
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In this way the hydrophilic/hydrophobic balance of the ionophore can be 
varied keeping the N-terminus protected and therefore preserving the overall 
geometry and charge distribution of the molecule. 
In Figure 3.15 Na+ transport activity of 1, assessed by 23Na-NMR experiments, 
is compared with those of its alkyl analogues.  
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Figure 3.15. Na+ transport activity of 1 and its alkyl analogues. 
A visual examination of the kinetic profiles of Figure 3.15 shows that all the 
compounds have similar activity. However, it is worth to note that the 
concentration of 1 used in the experiment (0.005 %) is 200 times lower that those of 
the alkyl analogues (1%). This remarks the above stated outstanding activity in the 
transport of Na+ cation of compound 1. 
In any case, ionophoric activity depends on the actual concentration of the 
ionophore in the double layer. Thus, to properly compare different ionophores it is 
necessary to measure their partition in membrane. The fraction of ionophore 
partitioned in membrane calculated as the ratio of membrane bound respect to the 
total ionophore concentration (PR) is reported in Table 3.2. 
Table 3.2. Partition ratios in membrane of 1 and its alkyl analogues. 
Compound PR 
1 0.16 
C2A8PE 0.08 
C6A8PE 0.10 
C16A8PE 0.30 
As expected, among alkyl analogues, C16A8PE has the highest partition ratio, 
while compound 1 is intermediate between C16A8PE and C6A8PE. These partition 
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coefficients were used to calculate the effective concentration of the analogues in 
membrane (Cm, Table 3.3). The intrinsic activity of the ionophore was thus obtained 
dividing the first-order rate constants (kobs, s-1), derived by the kinetic traces fitting, 
by the effective ionophore concentration (Equation 3.2).  
 
The observed second-order rate constant values for the transport process 
(kobs″), which depends only on the nature of the ionophore, and the relative activity 
of ionophores compared to that of the less active compound (C16A8PE) are 
reported in Table 3.3: 
Table 3.3. First and second-order observed rate constants and relative activity of compound 1 and its alkyl 
analogues. 
Compound 103 Cm (M) kobs (s-1) 103 kobs″ (s-1 M-1) Relative activity 
1 8.40 10-5 9.8 10-3 1.17 102 400 
C2A8PE 8.40 10-3 5.2 10-3 6.19 10-1 2.1 
C6A8PE 1.05 10-2 5.5 10-4 5.24 10-1 1.8 
C16A8PE 3.15 10-2 9.2 10-3 2.92 10-1 1 
The data indicate that the difference in activity among alkyl analogues is very 
small with only a slight preference for the short chains, whereas the presence of the 
Z-protecting group in compound 1 guarantees a ca. 400 times higher activity. 
Clearly, the high activity of 1 is not simply matter of hydrophobicity and the Z-
group seems to play some special effect.  
Figure 3.16 reports the dependence of the observed first-order rate constant 
(kobs, s-1) for the transport of Na+ in function of the concentration of ionophore 1. 
In the graph, for practical reason, the analytical concentrations of 1 are used instead 
of the effective concentrations in membrane. However, being the two directly 
related, the shape of the graph is not affected. The activity of 1 increases with its 
concentration and, although the number of experimental points is limited, the 
kinetic profile shows a positive deviation from linearity.  
k obs"  =
kobs
Cm
Equation 3.2  
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Figure 3.16. Compound 1 Na+ transport activity. 
The positive deviation of the kinetic profile in Figure 3.16, although little 
pronounced, may suggest a certain degree of association of compound 1 which may 
self-assemble in membrane to form the active ionophoric species.  
Putting together this suggestion with the observation that the high activity of 1 
is somehow related to the presence of the Z-group and not simply to its 
hydrophobicity, one hypothesis to explain such activity may call for a stabilization of 
the ionophore aggregate in membrane thanks to π-stacking interactions between the 
Z-group aromatic rings. In this view, 1 will dip its hydrophobic unit, represented by 
the Aib peptide, in the double layer forming a cluster stabilized by π-stacking 
interactions, while the polyether chain terminating with the protonated amine will 
interact with the phospholipid polar heads destabilizing the surface of the liposome 
(Figure 3.17).  
 
Figure 3.17. Cartoon illustrating the hypothesis of mechanism for 1.  
To test such hypothesis we prepared a series of 1 analogues in which the 
aromatic portions is varied from phenyl, to naphtalene and to pyrene (Figure 3.18). 
In particular the pyrene moiety was chosen for its peculiar fluorescence properties. 
In fact, when two molecules of pyrene are hold in close proximity the interaction 
between an excited state pyrene and a ground-state pyrene may lead to the 
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formation of an excimer. The excimer fluorescence emission occurs at a 
substantially longer wavelength than monomer pyrene emission and can be easily 
detected.87 In this way if a cluster of ionophores is formed in membrane we may 
aspect to see some excimer emission thus having a direct evidence of the self-
assembling process. Finally we synthesized compound 2 and 3 to evaluate the 
importance of the degrees of freedom of the aromatic moiety, comparing the 
former with 5 and the latter with 1. 
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Figure 3.18. Structures of aromatic analogues of 1. 
To allow a straightforward comparison of activities of these compounds, we 
evaluated first their partition ratios in membrane, reported in Table 3.4. 
Table 3.4. Partition ratios in membrane of 1 and its aromatic analogues. 
Compound PR 
1 0.16 
2 0.96 
3 0.06 
4 0.27 
5 0.83 
As expected the partition ratios increase following the size increase of the 
aromatic moieties with compounds 1 and 3 being the less partitioned and 
compound 2 and 5 being almost completely partitioned in membrane. Also a little 
contribution of the spacer between the aromatic portion and the N-terminal residue 
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of the peptide is present (compare, 1 with 3 and 2 with 5) but this can be simply due 
to the presence of the hydrophobic methylene carbon(s) in the spacer itself. 
The mere effect of the aromatic group size on Na+ transport activity can be 
evaluated from the comparison of compounds 3-5 which represent a structurally 
homologous series (Figure 3.19). On the other hand the importance of the degrees 
of freedom of the aromatic moiety can be appreciated comparing the Na+ transport 
activities of 1 and 2 to 3 and 5, respectively (Figure 3.20).  
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Figure 3.19. Compound 3-5 Na+ transport activities. 
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Figure 3.20. Comparison of 2, 5 and 1, 3 Na+ transport activities. 
The observed second-order rate constant values for the transport process 
(kobs″) in presence of the different ionophores, obtained as described above, which 
reflect the intrinsic activity of ionophores once considered the different partition in 
membrane, are reported in Table 3.5: 
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Table 3.5. First and second-order observed rate constants and relative activity of compound 1 and its 
aromatic analogues. 
Compound 103 Cm (M) kobs (s-1) 103 kobs″ (s-1 M-1) Relative activity 
1 8.40 10-5 9.8 10-3 1.17 102 446 
2 5.25 10-3 3.6 10-3 6.86 10-1 2.6 
3 3.15 10-4 6.0 10-4 1.90 7.2 
4 1.47 10-3 1.1 10-3 6.80 10-1 2.6 
5 4.20 10-3 1.0 10-3 2.62 10-1 1 
Considering the series 3-5, the order of activity pyrene > naphthalene > 
benzene which can be derived from Figure 3.19 is apparently related only to the 
different partioning of the ionophore in membrane. Indeed, inspection of the 
relative activities based on the observed second-order rate constants reported in 
Table 3.5 reveals an opposite trend with the pyrene derivative being the less active 
by more than 7 times respect to the benzene derivative. Thus, the increase of the 
aromatic portion increases the ionophore partition in membrane but it has a 
negative effect on the intrinsic ionophoric activity perhaps hampering the formation 
of a significant number of active aggregates due to the bulkiness of the substituent. 
This explanation is at least partly supported by the failure in the observation of 
excimer emission in the florescence emission spectra of compound 5 (and also 2) 
embedded in the liposome membrane, which apparently excludes the formation of 
clusters of molecules in the case of such compounds. Moreover, the comparison of 
compound 5 to 2 shows that the activity is not strongly influenced by the 
conformational rigidity around the aromatic portion, which might somehow affect 
the geometry of insertion of the ionophore in membrane and the possibility of 
cluster formation.  
Finally, and for certain aspects surprisingly, compound 1 is completely out of 
the series indicating that the observed exceedingly activity is apparently non related 
to the presence of the aromatic group. This finding is clearly in disaccord with the 
hypothesis outlined above. Looking at the chemical structure of 1 in comparison 
with the other analogues and excluding the importance of the aromatic residue the 
only difference lies in the presence of the carbamide moiety. In order to verify the 
role played by this residue we have planned the synthesis of compounds shown in 
Figure 3.21 in which the carbamide oxygen is replaced by a methylene group or the 
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phenyl ring is replaced by an aliphatic carbon chain. The synthesis of this new 
compounds is still in progress.  
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Figure 3.21. Structure of new analogues of compound 1 
The ionophoric activity of compounds 1-5 was investigated also using the 
HPTS assay which respond directly to the transport of H+ (or OH–) ions and 
indirectly gives information on cation and anion transport and selectivity. The 
comparison of the kinetic profiles of compounds 3-5 is reported in Figure 3.22 and 
in the following Figure 3.23 the activities of compounds 1 and 2 are compared to 3 
and 5, respectively. 
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Figure 3.22. Compound 3-5 proton transport activities. 
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Figure 3.23. Comparison of 2, 5 and 1, 3 proton transport activities. 
In Table 3.6 the first-order rate constants and the relative proton activities, 
corrected for the different partitioning in membrane of the aromatic analogues, are 
reported. 
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Table 3.6. Rate constants and relative activity of compound 1 and its aromatic analogues. 
Compound 103 Cm (M) kobs (s-1) 103 kobs″ (s-1 M-1) Relative activity 
1 2.72 10-7 1.0 10-3 3.68 103 5.6 
2 1.70 10-6 2.3 10-3 1.35 103 2.1 
3 1.02 10-7 1.6 10-4 1.57 103 2.4 
4 4.59 10-7 3.0 10-4 6.54 102 1 
5 1.41 10-6 1.2 10-3 8.51 102 1.3 
The picture emerging from the data of Table 3.6 is essentially the same that the 
one obtained in the case of Na+ transport if the trends are considered, but very 
different if the activities ratios are considered. In particular, compound 1 remains 
the most active but in this case its activity is only 5 times higher respect to 5 
compared with a 400 times acceleration of the process observed in the case of Na+ 
transport. The generally less remarkable differences of activity in proton transport 
are also observed among the other analogues. In fact, considering compounds 3-5, 
the phenyl substitution causes only a c.a. two-fold gain in activity in respect to 
naphatalene and pyrene moieties. Furthermore, the activity of 4 and 5 are essentially 
comparable with little predominance of the latter on the former, leading to an 
inversion in the series if compared to Na+ transport activities. A ca. two-fold activity 
is shown by 2 compared to 5, indicating that the effect of the degrees of freedom of 
the aromatic moiety is analogous to that in sodium transport.  
Such difference in the behaviour of the ionophores, and in particular of 
compound 1, in proton and Na+ transport experiments seems to indicate that the 
mechanisms at the basis of the observed ionophoric activity are different. This is 
not surprising because it is known that proton permeation across the membrane 
may occur with mechanisms which are different from other cations permeation (see 
below).   
On the basis of these results an in-depth investigation was concentrated on 
compound 1. Figure 3.24 (on the left) reports the kinetic profiles in the HTPS assays 
obtained at different concentrations of 1. Fitting of these kinetic traces gives the 
apparent first-order rate constants (kobs, s-1) reported in  Figure 3.24 (on the right). 
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Figure 3.24. Compound 1 proton transport activity . 
In absolute terms the proton ionophoric activity is pretty high and, for 
comparison, the rate constant measured with the natural ionophore AmB, which is 
often taken as reference compound, is kobs = 2.3 10-3 s-1 at a 1% concentration. The 
same rate constant is obtained with a concentration of 1 of about 0.05% indicating 
that this ionophore is about 50 times more active than AmB. The activity of 1 
increases with its concentration and the plot of the kobs versus ionophore 
concentration is linear (Figure 3.24, on the right) suggesting that the active 
ionophoric species is monomeric. 
The selectivity in cation and anion transport was investigated using the HPTS 
assay and varying the nature of the cation (Li+, Na+, K+; Cl– counterion) or the 
anion (F–, Cl–, Br–, I–, NO3–, SO42–, ClO4–, AcO–, Glu; Na+ counterion) present in 
solution. Figure 3.25 shows the results obtained with cations and anions.  
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Figure 3.25. Cation (on the left) and anion selectivity (on the right) of compound 1. 
From the inspection of Figure 3.25 it is evident that the activity of compound 1 
little depends on the nature of the cation or anion present in solution with the 
exception of fluoride and acetate which seem to inhibit the transport process. 
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However, these two weakly basic anions show often an anomalous behaviour in this 
assay due to the presence, at the operative pH, of a non-negligible amount of 
indissociated acid which being neutral may freely diffuse through the membrane. 
The overall picture however point a process insensitive to the nature of the cation 
and anion and therefore controlled by H+ or OH– transport. The same behaviour 
have been observed in similar experiments also with ionophore 4 and 5. 
Finally, control experiments have shown that ionophore 1 do not have 
fusogenic properties and that it is not able to form pore large enough to allow the 
transport of the relatively large calcein dye. The results of this latter test are shown 
in Figure 3.26 which reports the fluorescence time course for calcein release upon 
addition of subsequent aliquots of ionophore. In the Figure the arrows indicate the 
time of addition of the aliquots of solution of 1, rising its concentration from 1% to 
5%, and eventually of Triton X-100 which lyses liposomes with complete release of 
the trapped dye. The lytic potential of 1 results negligible even at the high 
concentration of 5% (the maximum concentration used in HPTS experiments is 
0.1%) 
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Figure 3.26. Lytic potential of compound 1. 
To shed light on the nature of ionophoric activity in the HPTS assay we have 
to consider that most of the proton channels transport protons (or OH–) by a 
hydrogen-bonded chain mechanism in which the proton hops from one molecule of 
water to the next. (Grotthuss’ mechanism or “hop-and-turn” transfer).88,89 In this 
view the proton do not physically cross the membrane but there is a sequence of 
proton transfers (hop) between hydrogen-bonded water molecules which are aligned 
 
3. RESULTS AND DISCUSSION 
__________________________________________________________________________________________________________________________________________________________________________ 
 
 70
in rows that connect the outer and inner compartment of the membrane (Figure 
3.27). As a consequence a proton is transferred from one side to the other side of 
the membrane and the system returns to the initial conditions simply with a 
synchronous rotation of the water molecule (turn). The transport of OH– is due to 
the same process but in the opposite direction. 
 
Figure 3.27. Hop-and-turn mechanism. 
In this contest we may visualize the mechanism of proton transfer promoted 
by ionophore 1 and its analogues as indicated in Figure 3.28.  
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Figure 3.28. Pictorial representation of the hypothesis of proton transport mechanism for compound 1. 
The ionophore in monomeric form inserts the hydrophobic portion, and 
probably at least part of the polyether chain, in the double layer with the protonated 
amine anchored on the membrane surface. The ionophore destabilizes the 
membrane favouring the penetration of water and the formation of “water-tubes” 
responsible for the Grotthuss-type transport of proton. The overall process appears 
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to be kinetically controlled by proton (or OH–) transport which is probably 
counterbalanced by Na+ transport, as suggested by the high activity of such 
compounds in the transport of this cation. The small differences in activity between 
the different analogues are probably simply related to slight differences in the 
geometry of insertion, for example in the depth of insertion of the aromatic portion 
in the phospholipid bilayer, which may affect the overall stability of the “water-
tube”.  
In the case of Na+ transport the picture is more complex and admittedly less 
clear. The active ionophoric species seems to be a cluster of molecules and this is 
reasonable in consideration that the Na+ ion transport requires a better defined 
pathway across the membrane in which the ion is solvated by the ionophore. 
However, the mechanism of action of ionophore 1 and the justification for its high 
activity are still evasive. The comparison with analogues bearing different aliphatic 
and aromatic substitutions on the peptide N-terminus excludes the relevance of 
hydrophobicity and of the presence of the aromatic portion in determining the 
observed activity. Inspection of the molecular structure of 1 suggests that the 
presence of the carbamide moiety and in particular its oxygen may play a relevant 
role. This possibility was excluded at the beginning because it seemed unlike that a 
single oxygen atom may have such an effect. However, at the light of the present 
results this hypothesis has to taken in consideration and, accordingly, the synthesis 
of some control compounds is in progress.  
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Figure 3.29. Structures of compounds K1-K3. 
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Compounds K1-K3 are D2d symmetric 1,3-alternate calix[4]arenes provided 
with a set of spermidine chains which have been prepared by Prof. De Riccardis’ 
group at Salerno University (Figure 3.29). K1 and K2 differ for the functionalization 
of the p-phenolic positions: the former carries four benzyloxymethyl substituents 
and the latter four methyl substituents. These compounds are amphipathic 
molecules, because of the presence of a lipophilic scaffold and polycationic chains, 
with different hydrophobic/hydrophilic balance, due to the substitution pattern at 
the p-phenolic positions; K3 is a fully protected neutral Boc-derivative of K1, used 
for control experiments. From molecular mechanic calculations the length of these 
calixarenes derivates in their “extended” conformation is 3.2±0.2 nm, comparable 
to the phospholipid membrane thickness (~3.5 nm). Therefore, they may span 
completely the phosphiolipid bilayer and potentially act as unimolecular channels or 
form barrel-stave aggregates. 
The ionophoric activities of compound K1 and K2 were investigated using the 
HPTS assay. The effect of K1 and K2 on ion transport, is reported in Figure 3.30: 
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Figure 3.30. Compounds K1-K2 proton transport activities. 
Compound K1 shows a high ionophoric activity: the pH gradient is completely 
discharged after about 15 minutes in presence of 1% ionophore and it still shows 
activity at 0.01% concentration; whereas K2 requires a 3% concentration to fully 
collapse the pH gradient in equal times. This lower activity is probably simply 
related to the higher hydrophilicity of K2 which limits its partition in membrane. 
Indeed, the partition ratios in membrane (see Table 3.7) confirm this hypothesis: K2 
is about three times less partitioned in liposomes than K1, while, K3 is near fully 
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partitioned due to the absence of ionizable free amines which are protected with the 
hydrophobic Boc groups. 
Table 3.7. Partition ratios in membrane for K1-K3. 
Compound PR 
K1 0.53 
K2 0.16 
K3 0.98 
Analysis of Figure 3.30 shows that the kinetic profiles are complex, being 
composed by two different processes: an almost instantaneous fluorescence “burst” 
and a subsequent slower increase of fluorescence which follow a first-order rate 
kinetic law. 
Both phenomena are concentration dependent and in Figure 3.31 is reported 
the fluorescence intensity relative to the initial fluorescence “burst” as a function of 
K1 concentration. Clearly, the relative amount of the “burst” increases with the 
concentration of the ionophore and is almost negligible at low concentrations. The 
“burst” is present also in the case of ionophore K2 but is much smaller: about 4% at 
ionophore concentration of 3% and almost negligible at lower concentrations. 
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Figure 3.31. Initial “burst” fluorescence  of compound K1 as a function of concentration. 
Figure 3.32 reports the dependence of the pseudo-first order rate constant 
(kobs, s-1), calculated for the second slower process observed in the HPTS assay, 
from the concentration of K1. 
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Figure 3.32. Dependence of the pseudo-first order rate constant (kobs) from the concentration of K1. 
The rate of the transport process increases with the concentration of 
ionophore following a saturation profile. However, the saturation behaviour is at 
least partly explained with the presence of the fluorescence “burst” which increases 
with the concentration of ionophore. This implies that the second process starts at a 
different value of pH gradient because the burst in fluorescence is due to a partial 
collapse of the pH gradient. Consequently, it is not possible to gain information on 
the mode of action of the ionophore from such kinetic profiles. 
Further evidences of the ionophoric behaviour of compound K1 were acquired 
with the calcein release assay (Figure 3.33). 
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Figure 3.33. Lytic potential of compound K1. 
The figure above reports the fluorescence time course for calcein release, the 
arrows indicate the time of addition of aliquots of solution of K1, increasing its 
concentration from 1% to 5%. The lytic potential of K1 results negligible even at the 
concentration of 5% (the maximum concentration used in HPTS experiments is 
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1%). Moreover, the vesicle fusion assay shows that K1 is not able to induce fusion 
of liposomes. Putting together this data, we can conclude that K1 is responsible of a 
real transport of ions and that the “burst” is not due to lytic or fusion phenomena.  
In the HPTS experiments above illustrated the transmembrane charge 
translocations depend on four possible overall processes: H+/Na+ antiport, OH–
/Cl– antiport, H+/Cl– symport and Na+/OH– symport. Selectivity in ion transport 
was investigated with the HPTS assay and using a low concentration of ionophore 
(K1: 0.03%; K2: 2%) in order to suppress the fluorescence “burst”. This process is 
indeed intrinsically unselective and is observed also with not transported ions (see 
below). 
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Figure 3.34. K1 (0.03%) and K2 (2%) cation selectivity. 
Figure 3.34 reports the cation selectivity determined in presence of only the 
cation under investigation. Inspection of the kinetic profiles attests independence of 
the ion fluxes from group 1 alkali metals, confirming the unfitness of polypositive 
ionophores to transport alkaline cations.90,91 These data are also confirmed by 
23Na+-NMR experiments reported in Figure 3.35, showing that compounds K1 and 
K2 are not able to transport Na+ across the bilayer: 
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Figure 3.35. K1 and K2 Na+ transport activity. 
The observed results imply that the pH gradient decay correlates with OH–
/Cl– antiport or to H+/Cl– symport, excluding the group 1 alkali metals in the ion 
permeation processes.  
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Figure 3.36. K1 (0.03%) and K2 (2%) anion selectivity. 
The results obtained with anions, reported in Figure 3.36, demonstrate efficient 
halide transport (with some selectivity towards iodine and bromide over chloride) 
and low transmembrane conductance of oxygenated anions (ClO4–, Glu, NO3–, 
SO42–).  
With ionophore K2 we have also tested the protocol, proposed by Matile in 
which liposomes prepared in NaCl solution are diluted in a buffer containing the 
ion under study (Figure 3.37). 
 
3. RESULTS AND DISCUSSION 
__________________________________________________________________________________________________________________________________________________________________________ 
 77
Figure 3.37. Cation and anion selectivity for K2 2% (Matile’s protocol). 
These experiments confirm that the transport process is independent from the 
cation used (Li+, Na+, K+, Rb+, Cs+) and displays a similar trend for anions 
selectivity (I–>Br–≈Cl–>>SO42–≈NO3–>>ClO4–≈F–>Ac–). This selectivity sequence 
correlates well with a halide transport based on a lyotropic sequence92,93 (with the 
less hydrated anion transported more efficiently), in which the rate of transport is 
essentially limited by the dehydration cost of the anion. However, the low transport 
rates observed with the little hydrated nitrate ion and some other oxygenated anions, 
suggest, for the last ones, a certain degree of anion binding with the ionophores.  
To further investigate the selectivity mechanism we conducted an experiment 
in presence of HPTS but, instead of apply a pH gradient, we applied a X– gradient, 
obtaining the kinetic profiles showed in Figure 3.38. 
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Figure 3.38. K1 (0.03%) anion transport activity with the HPTS assay. 
The decrease in HPTS fluorescence emission after chloride pulse indicates 
acidification of the inner vesicular compartment consistent with OH–/Cl– antiport 
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or H+/Cl– symport. No effect was observed upon addition of sulphate ion 
confirming that this anion is not transported by ionophore K1. 
We also some investigated the anion selectivity of the “burst” phase of the kinetic, 
observed at high concentration of K1 in presence of chloride as an example of 
transported anion and sulphate as a non-transported anion (Figure 3.39). 
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Figure 3.39: K1 “burst” in presence of a non-transported anion.  
The experiment shows that the fluorescence “burst” is observable also in 
presence of the non-transported SO42– anion and that the relative amount of the 
“burst” increases with the concentration of the ionophore, indicating that this 
process is not anion selective. This behaviour is compatible with a model recently 
proposed by Chiu and co-workers94 in which proton permeation across vesicles is 
considered biphasic. In the first stage the ions flow en mass across the membrane, 
through randomly formed membrane pores (transient-pore model), afterwards a 
slower process takes place, where the permeation is governed by solubility and by 
diffusion of the ions into the bilayer (solubility-diffusion model). In this view the 
“jump” we observe is probably related to a transient-pore mechanism and the 
ionophore will likely stabilize the formation of such pores which are intrinsically 
unselective towards anion and cation transport. 
Ionophoric activity and anion selectivity of the fully protected neutral Boc-
derivative K3 were compared with those of K1 (Figure 3.40).  
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Figure 3.40. Anion selectivity comparison between K1 and K3 (both 0.03%). 
Ionophore K3 transports chloride (red curve) with apparent activity similar to 
K1 (dark-blue curve). However, taking in account the different partition ratio (about 
twice for K3 respect to K1, see above) the real activity of K3 is about half than that 
of K1. More interestingly, K3 shows a much lower selectivity in the transport of 
glutamate (orange curve) and perchlorate (yellow curve) respect to K1 (blue and 
light-blue curves). The selectivity ratios calculated as ratio of activities at 1000 s are 
Cl–/Glu = 9.4 and Cl–/ClO4– = 5.4 for compound K1, Cl–/Glu = 1.3 and Cl–/ 
ClO4– = 1.3 for K3. These data attest the relevance of the cationic spermidine 
chains in the overall transport processes. 
The transport of chloride across the lipid bilayer was independently evinced 
using lucigenin. The results, reported in Figure 3.41, clearly show that K1 transports 
chloride anion across the bilayer.  
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Figure 3.41. K1 chloride transport in lucigenin assay. 
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However, a comparison of the transport data obtained with lucigenin and 
those obtained with HPTS in condition of pH gradient, shows that K1 is, 
apparently, less active in the lucigenin assay conditions, and higher concentration of 
ionophore are required to evidence transport (1-3%). A plausible explanation can be 
an interference of the nitrate anion used in this assay to buffer the ionic strength, 
which is not transported but may compete with chloride for binding to the 
ionophore, thus hampering the ion flux. 
This interpretation is supported by the observation that chloride conductance 
is almost completely suppressed in presence of equimolar concentration of 
perchlorate and glutamate (respect to the added chloride), as shown in the two top 
curves of Figure 3.41, suggesting an interference of these two not transported 
anions. Moreover, the glutamate induced blockage is almost absent with compound 
K3 confirming the lower anion selectivity of compound K3 already reported above 
(Figure 3.42).  
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Figure 3.42. K1-K3 chloride transport comparison in lucigenin assay. 
The blockage effect on K1 chloride transport is confirmed by a substantial 
anomalous mole fraction effect (AMFE) observed with glutamate (Figure 3.43).  
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Figure 3.43. Mole fraction behaviour of compound K1 (0.03%). 
This effect reminds, respectively, the Cl– current reduction induced by 
xenobiotic anions on the cystic fibrosis chloride channel pore,95 and the intrapore 
regulatory activity of the Glu148 in the EcClC channels.21 
In conclusion the ion fluxes induced by ionophore 1, may be visualized as 
reported in Figure 3.44.  
 
Figure 3.44. Pictorial representation of chloride transport across the bilayer for compound K1. 
The cationic hydrophilic domains, once incorporated in the lipid bilayer, are 
supposed to self-associate.96 The aromatic rings, interacting with the lipid domain, 
constitute the driving force for membrane inclusion. Chloride ions bridge the 
aqueous solutions on both sides of the membrane. The Cl– flux is coupled with OH–
/antiport or H+/symport transfer (represented by Grotthus mechanism). The 
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number of the interacting calix[4]arene units and the self-association are, at the 
moment, speculative. The glutamate blockage effect is probably due to the binding 
of the anion to the protonated amines which interrupt the polar conduit responsible 
for the halide transport. 
 
3.2.2.3    CyPLOS - Cyclic Phosphate-Linked OligoSaccharide macrocycles 
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Figure 3.45. Structures of compounds C1-C4. 
Compounds C2-C4 are novel cyclic oligosaccharide analogues, 4,6-linked 
through phosphodiester bonds, named CyPLOS97 (Cyclic Phosphate-Linked 
OligoSaccharide macrocycles) which has been prepared by Prof. Montesarchio and 
co-workers at Napoli University; C1 is a non-macrocyclic monoanionic analogue of 
C4. All these molecules carry on one monosaccharide ring two C11 hydrocarbon 
chains and on the other two tetra(ethylene) glycol (TEG) chains, all linked in 
position 2 and 3 (Figure 3.45). Compounds C2-C4 differ for the number of negative 
charges present on their scaffold: C2 is neutral, C3 has one negative charge and C4 
two negative charges. Our expectation was that these molecules were able to insert 
in the phospholipid bilayer, with the macrocycle floating on the polar membrane 
surface and the alkyl and TEG-chains dipping in the inner core of the phospholipid 
bilayer, thus altering its permeability. 
The ionophoric activity of the CyPLOS derivatives was investigated with the 
HPTS assay and as shown in Figure 3.46 is rather poor except for compound C4 
which is slightly more active. 
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Figure 3.46. Compounds C1-C4 proton transport activities. 
We further examined the activity of two C4 analogues, C5 and C6, in which 
the hydrophobic/hydrophilic balance has been changed inserting four hydrocarbon 
chains (C5) or four TEG chains (C6) (Figure 3.47). 
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Figure 3.47. Structures of compounds C5-C6. 
Among these CyPLOS derivatives, C6 shows the highest ionophoric activity, 
with the pH gradient being completely discharged after about 20 minutes in 
presence of 2% ionophore (Figure 3.48). 
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Figure 3.48. Compounds C4-C6 proton transport activities. 
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This activity may be strictly correlated to the presence of the polyether chains, 
as indicated by the lower efficacy of the mixed derivative C4 and by the almost 
complete inactivity of the tetra-alkylated derivative C5.  
Finally we studied compounds C7 and C8, which are structurally related to C6 
with two main differences: C7 is a linear di-anionic analogue while C8 is a fully 
protected, and therefore neutral, precursor of C6 (Figure 3.49). 
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Figure 3.49. Structures of compounds C7-C8. 
The comparison with compounds C7 and C8 (Figure 3.50) shows that the 
anionic character of C6 and the presence of the macrocycle are not prerequisites for 
activity but both guarantee a ca. two-fold more active compound, with the first 
structural motif somehow more important than the second one.  
0 200 400 600 800 1000 1200
0
20
40
60
80
100
 Control
 C6, 2%
 C7, 2%
 C8, 2%
N
or
m
ali
ze
d 
FI
time, s
 
Figure 3.50. Compounds C6-C8 proton transport activities. 
On the basis of these results, an in-depth investigation was concentrated on 
compound C6. The kinetic traces for the experiments at different concentrations of 
C6 are reported in (Figure 3.51): 
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Figure 3.51. C6 proton transport activity. 
The ionophoric activity of C6 increases with its concentration and the fitting 
of the kinetic traces gives the apparent first-order rate constants (kobs, s-1) for the 
transport process. The activity rate constant increases linearly with the 
concentration of C6, suggesting that the active species responsible for the transport 
process is monomeric. Linear activity/concentration profiles are observed also in 
presence of a monomer/aggregate equilibrium completely shifted towards the 
aggregate. However, the critical aggregation concentration of C6 in CDCl3 is 
between 6 and 8 mM,97 a concentration much higher than the one here used in the 
transport experiments. 
Selectivity in ion transport was investigated with the protocol proposed by 
Matile. The results are illustrated in Figure 3.52 where the kinetic traces are 
corrected for the permeation of the anion or cation under investigation in the 
absence of ionophore.  
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Figure 3.52. Cation selectivity for C6 1% and anion selectivity for C6 0.5% (Matile’s protocol). 
On varying the nature of the cation present in solution among the group I 
alkali metals, the activity is not sensibly affected; on the other hand, anions show an 
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“off-on” selectivity with the halogens (except fluoride), nitrate and perchlorate 
efficiently transported, and fluoride, acetate, glutamate and sulphate little or not 
transported. The insensitivity of the transport rate from the nature of the cation, 
together with the absence of ion flux in the presence of certain anions, where 
however Na+ is present as counterion, suggest that anions and not group I cations 
are involved in the transport process, thus excluding H+/Na+ antiport, and 
Na+/OH– symport from the possible pathways for the pH gradient decay. 
 Accordingly, the experiments of Figure 3.52 (on the left) report on the 
transport of chloride which is present as counterion of all the cations. However, in 
absence of a pH gradient, ionophore C6 is able to transport Na+ as indicated by 
23Na-NMR experiments (Figure 3.53). Therefore, we cannot exclude that in the 
HPTS experiments transport of Na+ not coupled with H+ or OH– is present. 
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Figure 3.53. C6 (1%) Na+ transport activity. 
Selectivity observed with anions is more complex. The apparent rate constants 
for the transport process (kobs, s-1), corrected for anion permeation in the absence of 
the ionophore (k0, s-1), show a clear discontinuity for anion hydration energies 
comprises between those of acetate and chloride ions as shown in Figure 3.54.  
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Figure 3.54. “Off-on” anion selectivity of compound C6.  
Apparently, the anions less lipophilic than chloride are not transported; on the 
contrary, the more lipophilic anions are transported indeed, but with efficiencies 
scarcely depending on their hydration energy. This behaviour seems to exclude 
specific interactions between the transported anions and the ionophore as well as a 
transport process simply controlled by dehydration cost of the anions. Taking into 
account that the pH gradient decay correlates with OH–/X– antiport or to H+/X– 
symport, an alternative explanation for the “off-on” selectivity observed is the 
switching of the transport process rate limiting factor from X– to H+ (or OH–) 
transport on decreasing the anion hydration energy. Highly hydrophilic anions are 
not transported but when the dehydration cost decreases below that of acetate the 
process is controlled by H+ (or OH–) transport and, therefore, all the anions with 
lower hydration energy are transported at a similar rate. This is also suggested by the 
observation that the proton carrier FCCP98 increases the observed rate of transport 
in the case of chloride by a factor of about two (Figure 3.55). 
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Figure 3.55. Influence of FCCP addition on C6 proton transport activity. 
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Finally, the above discussed selectivity data suggest the formation of a poorly 
structured active species with little or non-specific interactions with the transported 
ions (see the little difference of selectivity among the lipophilic anions).  
On the basis of the obtained results, the mode of action of ionophore C6 may 
be visualized as follows: the polar macrocycle lies on the surface of the membrane 
with the four amphiphilic chains inserted in the phospholipid bilayer. In the active 
conformation, the macrocycle anchors the ionophore on the membrane surface 
while the polyether chains destabilize the phospholipid bilayer underneath, forming 
a polar conduit which favours the ion transit (Figure 3.56). 
 
Figure 3.56. Pictorial representation of compound C6 inserted in the membrane. 
We cannot exclude that C6 acts as a molecular carrier because experiments in 
gel phase membranes (DPPC, Tc 41 °C), after incubation of the ionophore above 
phase transition temperature, failed due to the low ionophore partition in such 
conditions: the partition ratio of C6 in DPPC is 0.21 whereas it is 0.95 in 
EYPC/EYPG. This low partition did not allow us to evaluate its transport ability as 
a function of membrane fluidity. The exclusion of a ionophore from the membrane 
in the gel phase has been already observed in the literature.99 However, the 
behaviour of C6 as a carrier appears very improbable due to its molecular structure. 
The overall length of C6 is clearly insufficient to span the entire double layer 
but activity is often observed in such “short” channel forming ionophores.100 
Probably, the disorder in the phospholipid bilayer induced by the polyether chains 
generates a defect in membrane and the ions, when assisted to cross the membrane 
interface and the first part of the hydrocarbon core, find their way to the opposite 
side. The pore formed is, however, not large enough to allow the transit of the 
 
3. RESULTS AND DISCUSSION 
__________________________________________________________________________________________________________________________________________________________________________ 
 89
relatively large calcein dye as indicated by the dye release assay reported in Figure 
3.57 which clearly demonstrate the absence of calcein leakage even at 5% 
concentration of ionophore. 
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Figure 3.57. Lytic potential of compound C6. 
 
3.2.2.4    N-Benzyloxyethylglycine cyclopeptoids 
The compounds illustrated in Figure 3.58 are cyclic α-peptoids formed by a 
variable number of N-benzyloxyethylglycines.  
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Figure 3.58. Structures of compounds A4-A10. 
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These compounds were designed and synthesized by Prof. De Riccardis and 
co-workers as cation selective complexing agents depending on the size of the 
macrocycle.101 The selectivity of the cyclic α-peptoids in the complexation of 
different cations was investigated by De Riccardis’ group using NMR and picrate 
salt extraction experiments. Figure 3.59 illustrate the calculated lowest energy 
conformation for the complex of A6 with sodium. The structure shows the 
encapsulation of the cation within the six carbonyl oxygen in a structure with S6 
symmetry. The formation of such symmetric complex has been confirmed by H1-
NMR studies. 
 
Figure 3.59. Picture of the predicted lowest energy conformations for the complex of A6 with sodium. The 
peptoid bonds display an all-trans geometry (atom type: C gray, N blue, O red, Na magenta). Hydrogen 
atoms have been omitted for clarity. 
Table 3.8 reports the enthalpies of formation (-∆G°, kcal/mol) of the 
complexes between compounds A6-A10 and the alkaline metal cations measured 
with the picrate salt extraction method.  
Table 3.8: ∆G° (kcal/mol) for cyclopeptoid hosts A6-A10 complexing picrate salt guests in CHCl3 at 25 °C. 
The reported values are within ±10% in multiple experiments.  Guest/host stoichiometry for extractions was 
assumed as 1:1 (Compound A4 didn’t show alkaline metal cations complexation ability). 
 − ∆G° (kcal/mol) 
Picrate salt A6 A8 A10 
Li+ 8.1 7.9 7.9 
Na+ 8.9 8.0 7.8 
K+ 8.1 8.2 8.3 
Ru+ 7.7 8.3 8.0 
Cs+ 7.2 8.4 8.0 
The results presented in Table 3.8 show the formation of relatively stable 
complexes and a good degree of selectivity with a peak for Na+ in the case of A6, 
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and a slight preference for Cs+ in the case of A8 and for K+ in the case of A10. The 
data above reported indicate that the cyclopeptoids (except A4) are able to complex 
cations and to extract them in chloroform from a water solution. We therefore 
reasoned that they may also be effective in the transport of cations across the lipid 
bilayer.  
In first experiments we measured the proton permeation using the HPTS assay 
in presence of Na+. The comparison of the kinetic profiles of compounds A4-A10 is 
reported in Figure 3.60. 
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Figure 3.60. Compound A4-A10 proton transport activities in the presence of Na+. 
Cyclopeptoid A6 shows a relevant activity. A control experiment using a 
calcein release assay excludes that this activity is due to lyses of liposomes because 
the release of the dye is negligible even at the high concentration of 5% (the 
maximum concentration used in HPTS experiments is 2.7%). On the contrary, the 
other cyclopeptoids are almost inactive. However, the cyclopeptoids have different 
complexation preferences and, therefore we investigated the transport of all the 
alkaline cations. The results are shown in Figure 3.61 where for simplicity of 
comparison it is reported the activity measured in the HPTS experiment (Matile’s 
protocol) at a fixed time (1000 s) corrected for the background permeation as a 
function of the cations investigated (Li+, Na+, K+, Rb+, Cs+; Cl– counterion). 
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Figure 3.61. Cation selectivity of compounds A6-A10. 
While the low activity of A4 and A10 is confirmed with all the cations 
investigated (Figure 3.61c) A6 and A8 show, respectively, a preference for sodium 
and cesium (Figure 3.61a and 3.61b). Interestingly the activity measured for the 
different cations correlates with the enthalpies of formation (-∆G°, kcal/mol) of the 
complexes as reported in Figure 3.61d. This correlation, which is particularly well 
behaving in the case of A8, indicates that the transport process depends on the 
complexation of the metal ion and that enthalpies of formation below - 8.5 
kcal/mol are required to ensure an effective transport.  
The ability of A6 to transport Na+ ion was independently confirmed with a 
23Na-NMR transport experiment (Figure 3.62). 
 
3. RESULTS AND DISCUSSION 
__________________________________________________________________________________________________________________________________________________________________________ 
 93
0 200 400 600 800 1000
0,0
0,2
0,4
0,6
0,8
1,0
A6, 1%
%
 N
a+
in
t
time, min
 
Figure 3.62. Compound A6 Na+ transport activity. 
The above results suggest that cyclopeptoid A6 (and also A8 but with different 
selectivity) is able to complex the sodium cation and to transport it across the 
phospholipid bilayer acting as a molecular carrier. This ion movement has however 
to be counterbalanced and this may occur via  a symport of an anion or an antiport 
of a cation in a process which discharges the pH gradient increasing the pH inside 
liposomes. Therefore the two possible active processes are a Na+/H+ antiport or a 
Na+/OH- symport. 
To verify if there is an effect of the anions in the transport process mediated 
by A6, the anion selectivity in the HPTS assay was evaluated with Matile’s protocol 
(F–, Cl–, Br–, I–, NO3–, SO42–, ClO4–, Glu; Na+ counterion) (Figure 3.63). 
0 200 400 600 800 1000 1200
0
20
40
60
 F-
 Cl-
 Br-
 I-
 NO3
-
 SO4
2-
 ClO4
-
 Glu
N
or
m
ali
ze
d 
FI
time, s
 
Figure 3.63. Anion selectivity of compound A6. 
Not considering fluoride which is often an exception in this experiment (see 
above), the transport seems not very influenced by the anion present. Even in 
presence of sulphate, which is the most hydrated anion, the transport is comparable 
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to that in presence of halogens. This lack of selectivity indicates that the tested 
anions are not involved in the transport process thus confirming that the pH 
discharge is related to cation/H+ antiport or cation/OH– symport mechanism. 
In order to discriminate between the two processes we conducted an HPTS 
experiment (NaCl) in presence of the proton carrier FCCP (Figure 3.64). 
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Figure 3.64. Compound A6 proton transport activity in presence FCCP proton carrier. 
Addition of FCCP enhances the observed activity indicating that proton 
transport limits the rate of the overall process. We can therefore conclude that A6 
acts as a molecular carrier transporting forward a Na+ ion and backward a proton. 
Finally, a support to the carrier mechanism comes from the experiments in 
DPPC membrane at 25 °C: in this condition when the membrane is in the gel phase 
the transport process is completely suppressed. This strong dependence of the rate 
of the transport on membrane fluidity is a typical signature of a molecular carrier. 
 
3.2.2.5    Guanidinium calixarene conjugates 
We have conducted a preliminary investigation on the ionoforic properties of a 
series of cone calix[4]arenic compounds carrying a C8-alkyl chain at the phenolic 
positions and a variable number of guanidinium moieties in para positions respect to 
the phenolic oxygen (Figure 3.65). 
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Figure 3.65. Structures of compounds D1-D3. 
The comparison of the kinetic profiles obtained with compounds D1-D3 in 
the standard HPTS assay are reported in Figure 3.66. 
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Figure 3.66. Compound D1-D3 proton transport activities. 
Among the different calixarene derivatives only D3 shows an interesting 
activity while the others two are almost inactive. Clearly the number of guanidinium 
moieties is determinant for activity.  
We also verified that the ionophoric activity observed with D3 was not due to 
lyses of liposomes using the calcein assay and testing concentration of ionophore up 
to 5%. In no cases we observed release of calcein.  
We thus concentrated our investigation on compound D3, exploring a range of 
concentrations and calculating the apparent first-order rate constants of the 
transport process (Figure 3.67): 
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Figure 3.67. Compound D3 proton transport activity. 
The activity increases with the concentration of D3 following a sigmoidal 
profile. The interpretation of such profile is complex because it seems that the 
active ionophoric species is not monomeric but at some time, increasing the 
ionophore concentration, the transport rate of this active species remains constant. 
 A tentative explanation of such behaviour may call for a complex aggregation 
equilibrium of the ionophore. For example the ionophore may aggregate in aqueous 
solution and only small aggregates (dimers ?) are able to partition in membrane. 
Increasing the concentration of ionophore the aggregation equilibrium in water 
starts to shift towards larger aggregates which due to the higher charge and larger 
dimensions are not able to partition in membrane. Clearly this is only speculation 
and more studies are required to understand the system. 
Figure 3.68 reports the anion selectivity (F–, Cl–, Br–, I–; Na+ counterion) 
determined with the HPTS assay following Matile’s protocol for calixarene D3. 
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Figure 3.68. Compound D3 (0.05%) anion selectivity. 
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Interestingly the anion selectivity follows an inverse lyotropic series,92,93 with 
the more lipophilic anion less transported. Usually this selectivity sequence is 
ascribed to a specific binding of the anions to the ionophore. 
We finally controlled the effect of membrane fluidity on the transport process 
using the HTPS assay and gel phase DPPC LUVs (Figure 3.69). 
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Figure 3.69. D3 proton activity in gel phase vesicles. 
In the Figure, for comparison, the kinetic profiles obtained with valinomycin (a 
carrier) and amphotericin B (a channel forming molecule) are also reported. The 
inactivity of D3 seems therefore indicate that it acts as a carrier. 
In conclusion the overall picture, although really preliminary, is the following: 
the active species is an aggregate, possibly a dimer, which act as a carrier complexing 
the anions on one side of the membrane and releasing them on the other side. This 
flux is probably balanced by an antiport of OH– transported by the carrier. The 
inverse lyotropic sequence observed indicates a strong interaction between the 
anion and the ionophore and it is therefore reasonable to postulate that the anions 
are transported as counterion of the guanidinium groups.  However, more studies 
are needed to understand the behaviour of a such interesting system.  
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During this Thesis work we had the opportunity to study several compounds 
some time structurally unrelated, but sharing all the ability to transport ions across a 
phospholipid membrane. One family of these compounds derives from previous 
work of our Lab and has been designed and synthesized to verify some mechanistic 
hypothesis formulated to justify the really high ionophoric activity serendipitous 
discovered for an Aib-peptide based ionophore. The other compounds have been 
prepared by other research groups in the framework of a long standing 
collaboration which has as ultimate objective a broad structure/activity investigation 
aimed to define the structural requirements for ionophoric activity. These 
ionophores comprise differently substituted calixarene derivatives and other 
macrocyclic compounds. 
Beside the results obtained in the study of each single class of compounds 
which are illustrated and discussed in the previous chapter, the possibility to 
investigate the ionophoric properties of such a broad bunch of compounds under 
the same set of experimental conditions allowed us to draw some general 
considerations. The first one is somehow minimalist: it is apparently very easy to 
obtain real ionophoric activity, where with “real” we mean a flux of ions across the 
membrane promoted by ionophores without affecting too much the membrane 
structure, thus essentially excluding fusion or lysis of liposomes and a detergent 
effect. Indeed, simply the connection of a hydrophobic residue (macrocyclic or not) 
to a polar residue (often polyether- or polyamine- chains but also charged groups 
such as guanidinium) results in a ionophoric activity, although with different 
efficiency and characteristics.   
Of course attention has to be paid to some issues. The first one is the 
hydrophobic/hydrophilic balance which apparently influences more the partition 
equilibrium of the ionophore than its intrinsic activity. This has been clearly 
demonstrated with the study of the Aib-peptide derivatives showing that, once 
corrected for the effective concentration in membrane, the ionophoric activity of 
the different derivatives is essentially the same. This point is often underestimated in 
the literature bringing sometimes to inappropriate conclusions based on improper 
comparisons. Clearly, intrinsic activity is important from a mechanistic point of view 
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but for real applications such as for example antibiotic activity also the apparent 
efficiency, meant as measured in the experimental conditions, is relevant because it 
determines the dose response parameters. This stresses the importance of a fine 
tuning of the hydrophobic/hydrophilic balance in the putative ionophore. 
A second point which was clear with the study of CyPLOS derivatives is that, 
once preserved the correct hydrophobic/hydrophilic balance, a larger hydrophilic 
portion results in a higher activity. This observation for some aspects is trivial but it 
tells us something on the operative mode of these ionophores. Although it is really 
difficult to get information on the structure of the ionophore and their aggregates in 
membrane and, on the other, this type of studies have not been attempted in this 
Thesis, the opinion that we have maturated is that all the systems we have 
investigated (with the exception of course of the carriers) do not form well structured 
channels but they work destabilizing the portion of membrane in which they are 
inserted and the ions flux occurs through this more permeable patch of bilayer with 
little interactions with the ionophore itself. Support to this view came from the 
generally low ion selectivity observed with the Aib-peptide and CyPLOS derivatives, 
from the little importance of the shape of the molecule (macrocyclic or linear), and 
from the modest effect of the overall length of the ionophore. For example, 
CyPLOS are clearly too short to span completely the phospholipid double layer but 
they act as unimolecular channel forming ionophores. Probably, the disorder 
induced by the CyPLOS TEG chains generates a defect in the membrane and ions, 
when assisted to cross the membrane interface and the first part of the hydrocarbon 
core, find their way to the opposite side. 
The overall picture emerging from these studies is, therefore, that these 
molecules are probably structurally too simple and flexible to form well structured 
channels. Of course there are exceptions and an interesting one is represented by 
the spermidine calixarene conjugates. These molecules show high ionophoric 
activity and, more important, interesting anion selectivity with also blockage effects 
in the case of some non-transported anions. This latter feature is typical of the 
biological channels. The source of this peculiar activity is probably related to the 
more rigid calixarene scaffold and to the presence of the, at least partially 
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protonated, amino groups of the spermidine chains. Likely, the hydrogen-bondings 
or ion-ion interactions of these groups with the transported anions is much stronger 
respect to the ion-dipole interactions between oxygens of the polyether chains of 
the other ionophores investigated and the transported cation (or anion). This 
interpretation is also confirmed by the studies on the guanidinium calixarene 
conjugates which are the other system showing interesting anion selectivity.  
Although in this case the mechanism of action may be different and the 
ionophore probably acts as a carrier, the source of selectivity is the same: a strong 
interaction with the transported ion.  These results are relevant because they show 
that anion selective transport can be achieved also with these relatively simple 
systems and due to the relevance of anions, and particularly chloride, transport in 
several diseases these artificial anion transporters may represent new leads in the 
treatment of such channelopathies. 
Ion selective transport can be achieved also applying the well known principles 
of cation complexation developed by Supramolecular Chemistry which can be 
summarize in the matching of size, in the electronic complementarities between the 
host and the guest, and in the pre-organization of the host structure. This is the case 
of the cyclic α-peptoids that are preorganized structures able to bind alkaline cations 
through ion-dipole interactions with selectivity depending on the ring size. These 
systems act as carriers shuttling the cation from one side to the other side of the 
membrane and represent one of the most classical examples of supramolecular 
function.  
Finally some times a burst of activity is observed. This is the case of the Z-
protected Aib-peptide derivative which shows very efficient Na+ transport at a really 
low concentration. A rough estimation based on the size of liposomes and on the 
lipid concentration indicates that the ionophore is still well active when only one (or 
maximum two) molecule of ionophore is inserted in the liposome membrane. 
Despite several studies the rationalization of this extra-activity is still elusive and this 
tells us that the control of the ionophoric activity is sometime more subtle than that 
we usually believe.  
A further important result of this Thesis work is the acquisition of expertise in 
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several techniques used for the study of the ionophoric activity in liposomes. In 
particular we have exploited methodologies based on the use of fluorescent probes 
which are proved to give valid and user friendly entries to important features such 
as for example selectivity sequences. Ironically, it is the experimental evidence for 
the existence of ion channels as such (rather than the presence of alternative modes 
of transport) that remains most difficult to obtain in vesicles. For this reason these 
types of measurement should be paralleled with electrophysiological data and we are 
now moving in this direction.   
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5.1   SYNTHESIS 
5.1.1   GENERAL PROCEDURES 
Starting materials and reagents purchased from commercial suppliers were 
generally used without purification unless otherwise mentioned. Reactions were 
monitored by TLC on Merck silica gel plates (0.25 mm) and visualized by UV light, 
I2, or by spraying with KMnO4 - H2SO4 or ninhydrin solutions and drying. Flash 
chromatography was performed on Merck silica gel 60 (particle size: 0.040-0.063 
mm) and the solvents employed were of analytical grade. Yields refer to 
chromatographically and spectroscopically (1H- and 13C-NMR) pure materials. 
Melting points were measured with a Büchi SHP-20 apparatus and are not 
corrected. IR spectra were recorded on a Thermo Nicolet Avatar 320 FT-IR 
apparatus. UV-Vis spectra were recorded on a UV-Vis Unicam heλios β 
spectrophotometer. High resolution ESI-MS spectra were performed on a PE-API 
1 mass spectrometer by infusion of 0.1 mg/mL CH3CN solutions. 
The NMR spectra were recorded at room temperature on a Jeol GX-400 
spectrometer (1H at 400 MHz, 13C at 100.5 MHz), a Jeol GX-270 spectrometer (1H 
at 270 MHz, 13C at 67.8 MHz) or  a Varian 500 (1H at 500 MHz, 13C at 125 MHz). 
Chemical shifts (δ) are reported in ppm relatively to the non-deuterated residual 
solvent peak (CDCl3: δH 7.26, δC 77.0; CD3OD: δH 3.30, δC 49.0; DMSO-d6 δH 2.50, 
δC 39.4; D2O: δH 4.82) and the multiplicity of each signal is designated by the 
following abbreviations: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, 
broad. Coupling constants (J) are quoted in Hz.  
 
5.1.2   SYNTHESIS OF THE HYDROPHOBIC UNIT 
5.1.2.1    Synthesis of Z-Aib-OH (6) 
Z
N
H
COOH  
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10 g of H-Aib-OH (MW: 103.12; 0.097 mol) were dissolved in 80 mL of H2O 
and 13.5 mL of Et3N (MW: 101.19; d = 0.727; 0.097 mol; 1 eq) were added. 24.2 g 
of Z-OSu (MW: 249.22; 0.097 mol; 1 eq) dissolved in 60 mL of CH3CN were added 
dropwise. The reaction mixture was stirred at r.t.. After 24h the solution was 
concentrated under reduced pressure to remove CH3CN. 1 mL of 5% NaHCO3 was 
added to the water phase and Z-OSu still present extracted with Et2O (3 x 60 mL). 
The water phase was acidified to pH 3 using 10% KHSO4 and extracted with 
AcOEt (4 x 100 mL). The organic phase was washed with H2O (3 x 80 mL), dried 
over Na2SO4 and the solvent removed under reduced pressure. 16.86 g of 6 (MW: 
237.25; 0.071 mol), as a white solid, were obtained with 73% yield. M. p.: 84 - 85 
°C. Rf: 0.6 (CHCl3/MeOH; 9:1). 1H-NMR (CDCl3, 400 MHz): δ 8.79 (br, 1H, -
COOH); 7.34 (m, 5H, Ph); 5.35 (s, 1H, -CO-NH-); 5.10 (s, 2H, Ph-CH2-O-); 1.54 (s, 
6H, -CH3). 
5.1.2.2    Synthesis of Z-Aib-OtBu (7) 
Z
N
H
COOtBu  
A CH2Cl2 solution (128 mL) of 9.00 g of 6 (MW: 237.25; 37 mmol) and 
concentrated H2SO4 (0.44 mL) was saturated with isobutene and maintained at r.t. 
67 h. The solution was poured in a beaker containing 80 mL of 5% NaHCO3 
aqueous solution and vigorously stirred for 2h to remove isobutene remained. The 
organic phase was separated, washed with H2O (2 x 50 mL),  dried over Na2SO4, 
and the solvent removed under reduced pressure. 10.57 g of 7 (MW: 293.36; 36 
mmol) were obtained with 95% yield. M.p.: 60 °C. Rf: 0.5 (CH2Cl2/MeOH; 9:1). IR 
(KBr): 3371, 1714, 1520 cm-1. 1H-NMR (CDCl3; 400 MHz): δ 7.32 (m, 5H, Ph); 
5.46 (br, 1H, -NH-); 5.08 (s, 2H, Ph-CH2-O-); 1.51 (s, 6H, -CH3(Aib)); 1.43 (s, 9H, 
tBu). 
5.1.2.3    Synthesis of Z-Aib2-OtBu (9) 
Z
N
H
H
N COOtBu
O  
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9.60 g of 7 (MW: 293.36; 33 mmol) were dissolved in 50 mL of anhydrous 
CH2Cl2 and the Z-protection removed using catalytic hydrogenation (H2 1 atm; 5% 
Pd/C) at r.t. overnight. The catalyst was filtered off and the solvent removed under 
reduced pressure. 5.17 g of the free amine 8 (MW: 159.23; 33 mmol) were obtained 
in a quantitative yield. Rf: 0.2 (CHCl3/MeOH; 95:5). 7.72 g of 6 (MW: 237.25; 33 
mmol) were dissolved in 15 mL of anhydrous CH2Cl2; at 0°C under stirring were 
added 4.98 g of HOBt (MW: 153.13; 33 mmol; 1 eq) and 7.48 g of EDC (MW: 
191.70; 39 mmol, 1.2 eq). 5.17 g of 8 (MW: 159.23; 33 mmol; 1 eq) dissolved in 15 
mL of anhydrous CH2Cl2 and 4.5 mL of Et3N (MW: 101.19; d = 0.727; 33 mmol; 1 
eq), needed to maintain pH 8, were added to the solution. The reaction mixture was 
stirred for 3 days at r.t. The reaction mixture was diluted with 500 mL of CH2Cl2 
and washed with 5% KHSO4 (2 x 200 mL), H2O (1 x 100 mL) and 5% NaHCO3 (2 
x 100 mL). The organic phase was dried over Na2SO4 and the solvent removed 
under reduced pressure. 10 g of 9 (MW: 378.46; 27 mmol), white solid, were 
obtained with 82% yield. M.p.: 134 °C Rf: 0.9 (CHCl3/MeOH; 95:5). 1H-NMR 
(CDCl3, 400 MHz): δ 7.36 (m, 5H, Ph); 6.93 (s, 1H, -CO-NH-); 5.41 (s, 1H, -O-CO-
NH-); 5.10 (s, 2H, Ph-CH2-O-); 1.47 (m, 21H: 12H -CH3, 9H tBu). 13C-NMR 
(CDCl3, 100.5 MHz): δ 173.7 (s), 173.0 (s), 155.8 (s), 136.2 (s), 128.4 (d), 128.0 (d), 
127.9 (d), 81.4 (s), 66.4 (t), 56.7 (s), 56.6 (s), 27.7 (q), 25.3 (q), 25.2 (q), 24.0 (q). 
5.1.2.4    Synthesis of Z-Aib2-Oxl (11) 
N
H
Z
O
N
O  
7.95 g of 9 (MW: 378.46; 21 mmol) were dissolved in 30 mL of CH2Cl2/TFA 
1:1. The solution was stirred at r.t. for 6h;  the solvent was removed under reduced 
pressure and the residue co-evaporated several times with Et2O to remove TFA. 
6.67 g of the free acid 10 (MW: 322.36; 21 mmol) were obtained in a quantitative 
yield. The product was suspended in 40 mL of anhydrous CH3CN and 4.43 g of 
EDC (MW: 191.70; 23 mmol; 1.1 eq) were added at 0°C under stirring. The reaction 
mixture was stirred at r.t. for  48 h under argon atmosphere. The solvent was 
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removed under reduced pressure and the residue re-dissolved in CH2Cl2 (250 mL), 
the organic phase washed with 5% KHSO4 (2 x 100 mL), H2O (1 x 100 mL), 5% 
NaHCO3 (2 x 100 mL), H2O (1 x 100 mL), brine (1 x 100 mL) and dried over 
Na2SO4. The solvent was removed under reduced pressure and 6.07 g of 11 (MW: 
304.34; 20 mmol) were obtained with 95% yield. M.p.: 121 °C. Rf: 0.9 
(CHCl3/MeOH; 9:1). 1H-NMR (CDCl3; 400 MHz): δ 7.33 (m, 5H, Ph); 5.34 (br, 
1H, -NH-); 5.07 (s, 2H, Ph-CH2-O-); 1.61 (s, 6H, -CH3); 1.41 (s, 6H, -CH3). 
5.1.2.5    Synthesis of Z-Aib4-OtBu (13) 
Z
N
H
H
N
O
N
H
H
N COOtBu
O
O
 
4.5 g of 9 (MW: 378.46; 12 mmol) were dissolved in anhydrous MeOH and the 
Z-protection removed using catalytic hydrogenation (H2 1 atm, 5% Pd/C) at r.t. 
overnight. The catalyst was filtered off and the solvent removed under reduced 
pressure. The residue was co-evaporated several times with CH3CN to remove 
MeOH. 2.75 g of the free amine 12 (MW: 244.33; 11 mmol; 1.2 eq) were obtained 
with 95% yield. This product was dissolved in 15 mL of anhydrous CH3CN and 
2.87 g of 11 (MW: 304.34; 9.4 mmol) were added, the solution was refluxed for 24h. 
The solvent was removed under reduced pressure and the residue re-dissolved in 
200 mL of CH2Cl2; the organic phase was washed with 5% KHSO4 (4 x 75 mL), 
H2O (2 x 75 mL), NaHCO3 5% (4 x 75 mL), H2O (2 x 75 mL), brine (1 x 100 mL) 
and dried over Na2SO4. The solvent was removed under reduced pressure and 4.44 
g of 13 (MW: 548.67; 8.1 mmol) were obtained with 86% yield. M.p.: 172°C. Rf: 0.4 
(CHCl3/MeOH; 98:2). 1H-NMR (CDCl3, 400 MHz): δ 7.34 (m, 5H, Ph);  7.20 (s, 
1H, -NH-);  7.10 (s, 1H, -NH-);  6.31 (s, 1H, -NH-);  5.20 (s, 1H, -NH-); 5.11 (s, 2H, 
Ph-CH2-O-); 1.46 (m, 33H: 24H -CH3(Aib), 9H tBu). 13C-NMR: (CDCl3, 100.5 
MHz) δ 174.1 (s), 174.0 (s), 173.7 (s), 172.7 (s), 155.8 (s), 136.2 (s), 128.5 (d), 128.3 
(d), 128.1 (d), 79.8 (d), 67.0 (t), 57.1 (s), 56.5 (s), 56.0 (s), 27.8 (q), 25.3 (q), 25.0 (q), 
24.9 (q), 24.7 (q). ESI-MS (MeOH): m/z  549.3 (M+H+), 571.3 (M+Na+), 587.2 
(M+K+). 
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5.1.2.6    Synthesis of Z-Aib4-Oxl (15) 
Z
N
H
H
N
O
N
H
O
O
N
O  
1.16 g of 13 (MW: 548.67; 2.1 mmol) were dissolved in 10 mL of CH2Cl2/TFA 
1:1. The solution was stirred at r.t. for 4h;  the solvent was removed under reduced 
pressure and the residue co-evaporated several times with Et2O to remove TFA. 
1.035 g of the free acid 14 (MW: 492.57; 2.1 mmol) were obtained in a quantitative 
yield. The product was suspended in 20 mL of anhydrous CH3CN and 0.443 g of 
EDC (MW: 191.70; 2.31 mmol, 1.1 eq) were added. The reaction mixture was 
stirred at r.t. for 24 h under argon atmosphere. The solvent was removed under 
reduced pressure and the residue re-dissolved in CH2Cl2 (150 mL), the organic 
phase washed with KHSO4 5% (2 x 80 mL), H2O (1 x 80 mL), 5% NaHCO3 (2 x 80 
mL), H2O (1 x 80 mL), brine (1 x 100 mL) and dried over Na2SO4. The solvent was 
removed under reduced pressure and 0.747 g of 15 (MW: 474.55; 1.57 mmol) were 
obtained with 75% yield. M.p.: 152°C. Rf: 0.9 (CHCl3/MeOH; 9:1). 1H-NMR 
(CDCl3, 400 MHz): δ 7.36 (m, 5H, Ph); 7.31 (s, 1H, -NH-); 6.26 (s, 1H, -NH-); 5.24 
(s, 1H, -NH-); 5.11 (s, 2H, Ph-CH2-O-); 1.45 (m, 24H, -CH3). 
5.1.2.7    Synthesis of Z-Aib8-OtBu (17) 
Z
N
H
H
N
O
N
H
H
N
O
O
N
H
H
N
O
N
H
H
N COOtBu
O
OO
 
1.16 g of 13 (MW: 548.67; 2.1 mmol) were dissolved in anhydrous MeOH and 
the Z-protection removed using catalytic hydrogenation (H2 1 atm, 5% Pd/C) at r.t. 
overnight. The catalyst was filtered off and the solvent removed under reduced 
pressure. The residue was co-evaporated several times with CH3CN to remove 
MeOH. 0.807 g of the free amine 16 (MW: 414.54; 1.94 mmol; 1.3 eq) were 
obtained with 92% yield. This product was dissolved in 5 mL of anhydrous CH3CN 
and added to a solution of 0.747 g of 15 (MW: 474.55; 1.5 mmol) in 15 mL of 
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anhydrous CH3CN, the mixture was refluxed for 24h. The solvent was removed 
under reduced pressure and the residue re-dissolved in 150 mL of CH2Cl2, washed 
with 5% KHSO4 (3 x 50 mL), H2O (1 x 50 mL), 5% NaHCO3 (3 x 50 mL) e H2O (1 
x 50 mL), brine (1 x 100 mL) and dried over Na2SO4. The solvent was removed 
under reduced pressure and 1.2 g of Z-Aib8-OtBu (MW: 889.09; 1.35 mmol) were 
obtained with 86% yield. M.p.: 247°C. Rf: 0.5 (CHCl3/MeOH; 9:1). 1H-NMR 
(CDCl3, 400 MHz): δ 7.62 (s, 1H, -NH-); 7.57 (s, 1H, -NH-); 7.55 (s, 1H, -NH-); 
7.33 (m, 8H: 3H -NH-, 5H Ph); 6.38 (s, 1H, -NH-); 5.43 (s, 1H, -NH-); 5.12 (s, 2H, 
Ph-CH2-O-); 1.47 (m, 57H: 48H -CH3(Aib); 9H tBu). 13C-NMR (CDCl3, 100.5 
MHz): δ 175.6 (s); 175.3 (s); 175.3 (s); 174.4 (s); 174.3 (s); 174.2 (s); 174.2 (s); 174.2 
(s); 156.1 (s); 136.1 (s); 128.6 (s); 128.5 (s); 128.1 (s); 79.6 (s); 67.3 (t); 57.2 (s); 56.7 
(s); 56.6 (s); 56.5 (s); 56.4 (s); 56 (s); 27.8 (q); 25.4 (q); 25.3 (q); 24.9 (q); 24.8 (q); 24.8 
(q); 24.7 (q); 24.7 (q); 24.6 (q); 24.6 (q). ESI-MS (MeOH): m/z 889.6 (M+H+), 
906.7 (M+NH4+), 911.8 (M+Na+), 927.7 (M+K+), 464.5 (M+K+)/2. 
5.1.2.8    Synthesis of Z-Aib8-Oxl (19) 
Z
N
H
H
N
O
N
H
H
N
O
O
N
H
H
N
O
N
H
OO
O
N
O  
174 mg of 17 (MW: 889.09; 0.19 mmol) were dissolved in 3 mL of 
CH2Cl2/TFA 1:1. The solution was stirred at r.t. for 4h;  the solvent was removed 
under reduced pressure and the residue co-evaporated several times with Et2O to 
remove TFA. 163 mg of the free acid 18 (MW: 832.98; 0.19 mmol) were obtained in 
a quantitative yield. The product was suspended in 5 mL of anhydrous CH3CN and 
56 mg of EDC (MW: 191.70; 0.29 mmol, 1.5 eq) were added. The reaction mixture 
was stirred at r.t. for 24 h under argon atmosphere. The solvent was removed under 
reduced pressure and the residue re-dissolved in CH2Cl2 (50 mL), the organic phase 
washed with 5% KHSO4 (2 x 10 mL), H2O (1 x 10 mL), 5% NaHCO3 5% (2 x 10 
mL), H2O (1 x 10 mL), brine (1 x 15 mL) and dried over Na2SO4. The solvent was 
removed under reduced pressure and 140 mg of 19 (MW: 814.97; 0.17 mmol) were 
obtained with 88% yield. Rf: 0.7 (CH2Cl2/MeOH; 9:1). 1H-NMR (CDCl3, 400 
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MHz): δ 7.64 (s, 1H, -NH-);  7.58 (s, 1H, -NH-); 7.37 (m, 8H: 3H -NH-, 5H Ph); 
6.38 (s, 1H, -NH-); 5.43 (s, 1H, -NH-); 5.12 (s, 2H, Ph-CH2-O-); 1.45 (m, 48H, -
CH3). 
 
5.1.3   SYNTHESIS OF THE CONDUCTION MODULE 
5.1.3.1    Synthesis of ditosyl exa(ethylene glycol) (21) 
TsO
O
OTs
5  
1.000 g of exa(ethylene glycol) (MW: 282.33; 3.5 mmol) was dissolved in 20 
mL of CH2Cl2 and 1.28 mL of Et3N (MW: 101.19; d = 0.727; 9.1 mmol; 2.6 eq) 
were added.  A solution of 1.756 g of TsCl (MW: 190.65; 9.1 mmol; 2.6 eq) in 5 mL 
of CH2Cl2 was added dropwise and  the reaction mixture was stirred at r.t. for 16 h. 
The mixture was diluted with 150 mL of CH2Cl2 and the organic phase washed with 
5% NaHCO3 (3 x 50 mL), H2O (2 x 50 mL), brine (1 x 50 mL) and dried over 
Na2SO4. The solvent was removed under reduced pressure obtaining a crude 
product which was purified by SiO2 flash chromatography (0.5% - 4% MeOH in 
CH2Cl2; gradient 0.5%). 1.580 g of 21 (MW: 590.70; 2.7 mmol) were obtained with 
76% yield. Rf: 0.5 (CH2Cl2/MeOH; 98:2). 1H-NMR (CDCl3, 400 MHz): δ 7.77 (d, 
4H, Ar(2,6), J = 8 Hz); 7.32 (d, 4H, Ar(3,5), J = 8 Hz); 4.13 (t, 4H, -OCH2-CH2-
OTs, J = 5 Hz); 3.66 (t, 4H, -OCH2-CH2-OTs, J = 5 Hz); 3.57 (m, 16H, -(CH2-
CH2-O-)4), 2.42 (s, 6H, -CH3). 13C-NMR (CDCl3, 100.5 MHz):  δ 144.7 (s), 132.8 
(s), 129.7 (d), 127.9 (d), 70.6 (t), 70.5 (t), 70.4 (t), 70.3 (t), 69.2 (t), 68.5 (t), 21.5 (q). 
ESI-MS (MeOH): m/z 591.2 (M+H+), 608.3 (M+NH4+), 613.1 (M+ Na+), 629.3 
(M+ K+). 
5.1.3.2    Synthesis of 1,17-diazido-3,6,9,12,15-pentaoxa-heptadecane (22) 
N3 O
N3
5  
1.580 g of 21 (MW: 590.70; 2.7 mmol) were dissolved in 3 mL of anhydrous 
DMF and 0.522 g of NaN3 (MW: 65.03; 8.03 mmol; 3 eq) were added. The solution 
was stirred overnight at r.t.. The solvent was removed and the residue triturated in 
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10 mL of CHCl3. The solid was collected by filtration, washed with 3 mL of CHCl3 
and dried under high vacuum. 0.765 g of 22 (MW: 332.36; 2.3 mmol) were obtained 
with 86% yield. R.f. 0.8 (CHCl3/MeOH; 9:1). IR (neat): 2869, 2107 cm-1. 1H-NMR 
(CDCl3, 400 MHz): δ 3.66 (m, 20 H, -(CH2-CH2-O-)5); 3.39 (t, 4H, -CH2-N3, J = 5 
Hz). 13C-NMR (CDCl3, 100.5 MHz): δ 70.7 (t), 70.65 (t), 70.6 (t), 70.5 (t), 70.0 (t), 
50.7 (t). ESI-MS (MeOH) m/z 350.3 (M+NH4+), 355.2 (M+Na+), 371.2 (M+K+). 
5.1.3.3    Synthesis of 1,17-diamino-3,6,9,12,15-pentaoxa-heptadecane 
(dihydrochloride salt) (23) 
+H3N O
NH3+
5
Cl-Cl-
 
0.765 g of 22 (MW: 332.36; 2.3 mmol) were dissolved in 2.5 mL of THF and 
0.124 mL of H2O (MW: 18.02; 6.9 mmol; 3 eq) were added. To this solution  1.200 
g of PPh3 (MW: 262.29; 4.6 mmol; 2 eq) , were added in small portions. The 
formation of a gas was observed and the reaction was left at r.t. for 12 h. The 
mixture was poured in a beaker containing 100 mL of 5% HCl aqueous solution and 
the triphenylphosphine oxide eliminated by extraction with Et2O (6 x 30 mL). 
Water was evaporated under reduced pressure and the residue dried under high 
vacuum for the complete elimination of water. 0.780 g of 23 (MW: 353.48; 2.2 
mmol) were obtained with a 96% yield. 1H-NMR (D2O, 400 MHz): δ 3.78 (t, 4H, -
OCH2CH2-NH3+, J = 5 Hz), 3.72 (m, 16H, -(CH2-CH2-O-)4), 3.21 (t, 4H, -O-CH2-
CH2-NH3+, J = 5 Hz). 13C-NMR (D2O, 100.5 MHz)δ 69.9 (t), 66.6 (t), 39.5 (t). ESI-
MS (MeOH): m/z 141.1 (M+H+)/2, 163.0 (M+Na+)/2, 281.2 (M+H+), 303.1 
(M+Na+). 
5.1.3.4    Synthesis of N1-tert-butoxycarbonyl-1,17-diamino-3,6,9,12,15-pentaoxa-
heptadecane (24) 
H2N O
NHBoc
5  
1.039 g of 23 (MW: 353.48; 2.94 mmol) were dissolved in 100 mL of 
anhydrous MeOH. 0.9 mL of Et3N (MW: 101.19; d = 0.727; 6.46 mmol; 2 eq) were 
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added and the solution cooled in an ice bath (0°C). Then 350 mg of Boc2O (MW: 
218.25; 1.60 mmol; 0.5 eq) dissolved in 20 mL of anhydrous MeOH were added 
dropwise over a period of 1 h. The reaction was brought to r.t. and stirred for 18h. 
The solvent was removed and the residue re-dissolved in 100 mL of CH2Cl2; the 
organic phase was washed with 5% citric acid aqueous solution (3 x 100 mL). The 
combined aqueous phases were basified until pH 11 with NaOH 5M and extracted 
with CH2Cl2 (3 x 100 mL); then the combined organic phases were dried over 
Na2SO4. The solvent was removed under reduced pressure and 0.428 g of 24 (MW: 
380.48; 1.12 mmol) were obtained with 38% yield. 1H-NMR (CDCl3, 400 MHz): δ 
5.28 (br, 1H, -CONH-); 3.64 (m, 16H, -(CH2-CH2-O-)4); 3.52 (m, 4H, H2N-
CH2CH2-O); 3.31 (m, 2H, -CH2-NHCOO-); 2.86 (m, 2H, -CH2-NH2); 1.44 (s, 9H, 
tBu). 13C-NMR (CDCl3, 100.5 MHz): δ 156.0 (s, -NHCOO-); 79.0 (s, C tBu); 73.1 
(t, -O-CH2-CH2-NH2); 70.5 (t, -(CH2-CH2-O-)4); 41.6 (t, -CH2-NHCOO-); 40.3 (t, -
CH2-NH2); 28.3 (q, -CH3 tBu). ESI-MS (MeOH): m/z 381 (M+H+); 403 (M+Na+). 
 
5.1.4   SYNTHESIS OF CONJUGATES 1, 4 AND 5 
5.1.4.1    Synthesis of N1-(Z-Aib8)-N17-tert-butoxycarbonyl-1,17-diamino-
3,6,9,12,15-pentaoxa-heptadecane (25) 
Z
N
H
H
N
O
O
NHBoc
8 5
 
83 mg of 19 (MW: 814.97; 0.10 mmol) were dissolved in 3 mL of anhydrous 
CH3CN and added to a solution of 50 mg of 24 (MW: 380.48; 0.13 mmol; 1.3 eq) in 
2 mL of anhydrous CH3CN. The reaction mixture was refluxed for 24h. The solvent 
was removed under reduced pressure and the residue re-dissolved in 50 mL of 
CH2Cl2, washed with 5% KHSO4  (3 x 10 mL), H2O (1 x 10 mL), 5% NaHCO3 (3 x 
10 mL), H2O (1 x 10 mL), brine (1 x 15 mL) and dried over Na2SO4. The solvent 
was removed under reduced pressure. The crude product was purified by SiO2 flash 
chromatography (0.5% - 5% MeOH in CH2Cl2; gradient 0.5%) and 102 mg of 25 
(MW: 1195.44; 0.085 mmol) were obtained with 84% yield. Rf: 0.5 (CHCl3/MeOH; 
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9:1). 1H-NMR (CDCl3, 400 MHz): δ 7.68 (m, 3H, -NH-); 7.56-7.51 (m, 2H, -NH-); 
7.42 (m, 1H, -NH-); 7.35-7.29 (m, 5H, Ph); 6.94 (m, 1H, -NH-);  6.54 (m, 1H, -NH-
); 5.09 (s, 2H, -O-CH2-Ph); 3.63-3.50 (m, 20H, -CH2(2, 4, 5, 7, 8, 10, 11, 13, 14, 16)); 
3.42 (m, 2H, -CH2(1)-NH-CO-); 3.28 (m, 2H, -CH2(17)); 1.51-1.32 (m, 57H: 48H -
CH3(Aib), 9H tBu). ESI-MS (MeOH): m/z 1196 (M+H+), 1214.9 (M+NH4+), 
1217.9 (M+Na+), 1233.8 (M+K+). 
5.1.4.2    Synthesis of N1-(Z-Aib8)-1,17-diamino-3,6,9,12,15-pentaoxa-
heptadecane (1) 
Z
N
H
H
N
O
O
NH2
8 5
 
102 mg of 25 (MW: 1195.44; 0.085 mmol) were dissolved in 2 mL of 
CH2Cl2/TFA 1:1. The solution was stirred at r.t. for 4h;  the solvent was removed 
under reduced pressure and the residue co-evaporated several times with Et2O to 
remove TFA. 93 mg of 1 (MW: 1095.33; 0.085 mmol) were obtained in a 
quantitative yield. Rf: 0.2 (CHCl3/MeOH; 9:1). 1H-NMR (CDCl3, 400 MHz): δ 8.15 
(s, 1H, -NH-); 7.78 (s, 1H, -NH-); 7.74 (m, 1H, -NH-); 7.64 (m, 1H, -NH-); 7.59 (br, 
1H, -NH-); 7.45 (s, 1H, -NH-); 7.42 (s, 1H, -NH-); 7.37-7.23 (m, 5H, Ph); 6.22 (s, 
1H, -NH-); 5.10 (s, 2H, -O-CH2-Ph); 3.89 (m, 2H, -CH2(2)); 3.68 (m, 20H: 18H -
CH2(4,5,7,8,10,11,13,14,16), 2H -CH2(1)-NH-CO-); 3.41 (m, 2H, -CH2(17)); 3.14 
(br, 2H, -NH2); 1.52-1.32 (m, 48H, -CH3(Aib)). 13C-NMR (CDCl3, 100.5 MHz): δ 
176.86; 176.84; 176.44; 176.40; 176.19; 176.07; 175.65; 175.44; 156.30; 137.03; 
136.35; 128.55; 127.86; 127.50; 69.89; 69.46; 66.69; 56.34; 56.33; 56.32; 56.30; 56.24; 
40.23; 39.83; 25.00; 24.16. ESI-MS (MeOH): m/z 1096.4 (M+H+), 567.4 
(M+H++K+)/2, 559.4 (M+H++Na+)/2. 
5.1.4.3    Synthesis of 1-naphthoyl chloride (27) 
COCl
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100 mg of 1-naphthoic acid (MW: 172.19, 0.58 mmol) were suspended in 2 mL 
of SOCl2 and the mixture refluxed for 3h. The solution obtained was co-evaporated 
with toluene to eliminate SOCl2 obtaining 108 mg of 27 (MW: 190.63, 0.56 mmol) 
in 97% yield. The crude acid chloride was used without further purification. 
5.1.4.4    Synthesis of N1-(1-naphthoyl-Aib8)-N17-tert-butoxycarbonyl-1,17-
diamino-3,6,9,12,15-pentaoxa-heptadecane (28) 
N
H
H
N
O
O
NHBoc
8 5
O
 
52 mg of 25 (MW: 1195.44; 0.043 mmol) were dissolved in 5 mL anhydrous 
MeOH and the Z-protection removed under catalytic hydrogenation conditions (H2 
1 atm, 5% Pd/C) at r.t. overnight. The catalyst was filtered off and the solvent 
removed under reduced pressure. The residue was co-evaporated several times with 
CH3CN to remove MeOH. 37 mg of the free amine 26 (MW: 1061.31, 0.035 mmol) 
were obtained in 80% yield. This product was dissolved in 0.5 mL of anhydrous 
CH3CN and added to a solution of 9 mg of 27 (MW: 190.63, 0.045 mmol, 1.3 eq) 
and 6 µL of Et3N (MW: 101.19, d = 0.727, 0.045 mmol, 1.3 eq) in 0.5 mL of 
anhydrous CH3CN. The mixture was stirred under argon atmosphere for 24h. The 
solvent was removed under reduced pressure and the residue re-dissolved in 50 mL 
of CH2Cl2, washed with 5% KHSO4  (3 x 10 mL), H2O (1 x 10 mL), NaHCO3 5% 
(3 x 10 mL), H2O (1 x 10 mL), brine (1 x 15 mL) and dried over Na2SO4. The 
solvent was removed under reduced pressure. The crude product was purified by 
SiO2 flash chromatography (1% - 6% MeOH in CH2Cl2; gradient 1%) obtaining 26 
mg of 28 (MW: 1215.48, 0.021 mmol) in 62% yield. Rf: 0.45 (CH2Cl2/MeOH; 9:1). 
1H-NMR (CDCl3, 400 MHz): δ 8.31 (br, 1H, -NH-); 8.10 (br, 1H, -NH-); 7.92-7.81 
(m, 5H: 3H Ar, 2H -NH-); 7.77-7.68 (m, 3H: 2H Ar, 1H -NH-); 7.54-7.45 (m, 4H: 
2H Ar, 2H -NH-); 7.39 (br, 1H, -NH-); 3.52 (m, 22H: 18H -
CH2(2,4,5,7,8,10,11,13,14,16), 2H -CH2(1)-NH-CO-); 3.34 (m, 2H, -CH2(17)); 1.55-
1.24 (m, 57H: 48H -CH3(Aib), 9H tBu). ESI-MS (CH3CN): m/z 1216.7 (M+H+); 
1237.7 (M+Na+); 1253.7 (M+K+). 
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5.1.4.5    Synthesis of N1-(1-naphthoyl-Aib8)-1,17-diamino-3,6,9,12,15-pentaoxa-
heptadecane (4) 
N
H
H
N
O
O
NH2
8 5
O
 
26 mg of 28 (MW: 1215.48, 0.021 mmol) were dissolved in 1 mL of 
CH2Cl2/TFA 1:1. The solution was stirred at r.t. for 4h;  the solvent was removed 
under reduced pressure and the residue co-evaporated several times with Et2O to 
remove TFA. 24 mg of 4 (MW: 1115.36; 0.021 mmol) were obtained in a 
quantitative yield. Rf: 0.15 (CH2Cl2/MeOH; 9:1). 1H-NMR (CDCl3, 400 MHz): δ 
8.29 (br, 1H, -NH-); 8.16-7.98 (m, 2H: 1H Ar, 1H -NH-); 7.88-7.75 (m, 6H: 4H Ar, 
2H -NH-); 7.62 (br, 1H, -NH-); 7.50-7.38 (m, 5H: 2H Ar, 3H -NH-); 3.82 (m, 2H, -
CH2(2)); 3.63 (m, 20H: 18H -CH2(4,5,7,8,10,11,13,14,16), 2H -CH2(1)-NH-CO-); 
3.41 (m, 2H, -CH2(17)); 3.13 (br, 2H, -NH2); 1.51-1.35 (m, 48H, -CH3(Aib)). 13C-
NMR (CDCl3, 100.5 MHz): δ 177.00; 176.90; 176.80; 176.51; 176.41; 176.12; 
176.03; 175.96; 170.79; 134.43; 133.70; 130.83; 130.39; 128.59; 128.39; 127.33; 
126.45; 125.92; 125.50; 70.61; 70.41; 70.12; 69.81; 69.65; 69.43; 69.18; 57.38; 57.19; 
56.66; 56.49; 40.86; 40.21; 26.64; 26.38; 26.27; 25.94; 25.53; 24.80; 24.59; 24.39; 
24.07; 23.56; 22.95; 22.71. ESI-MS (CH3CN): m/z 1116.7 (M+H+). 
5.1.4.6    Synthesis of 1-pyrenecarbonyl chloride (29) 
COCl  
150 mg of 1-pyrenecarboxylic acid (MW: 246.27, 0.61 mmol) were suspended 
in 2 mL of SOCl2 and the mixture refluxed for 3h. The solution obtained was co-
evaporated with toluene to eliminate SOCl2 obtaining 154 mg of 29 (MW: 264.71, 
0.58 mmol) in 96% yield. The crude acid chloride was used as obtained. 
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5.1.4.7    Synthesis of N1-(1-pyrenecarbonyl-Aib8)-N17-tert-butoxycarbonyl-1,17-
diamino-3,6,9,12,15-pentaoxa-heptadecane (30) 
N
H
H
N
O
O
NHBoc
8 5
O
 
38 mg of 25 (MW: 1195.44; 0.032 mmol) were dissolved in 5 mL anhydrous 
MeOH and the Z-protection removed under catalytic hydrogenation conditions (H2 
1 atm, 5% Pd/C) at r.t. overnight. The catalyst was filtered off and the solvent 
removed under reduced pressure. The residue was co-evaporated several times with 
CH3CN to remove MeOH. 28 mg of the free amine 26 (MW: 1061.31, 0.026 mmol) 
were obtained in 82% yield. This product was dissolved in 0.5 mL of anhydrous 
CH3CN and added to a solution of 8 mg of 29 (MW: 264.71, 0.032 mmol, 1.2 eq) 
and 5 µL of Et3N (MW: 101.19, d = 0.727, 0.032 mmol, 1.2 eq) in 0.5 mL of 
anhydrous CH3CN. The mixture was stirred under argon atmosphere for 24h. The 
solvent was removed under reduced pressure and the residue re-dissolved in 50 mL 
of CH2Cl2, washed with 5% KHSO4  (3 x 10 mL), H2O (1 x 10 mL), 5% NaHCO3  
(3 x 10 mL),  H2O (1 x 10 mL), brine (1 x 15 mL) and dried over Na2SO4. The 
solvent was removed under reduced pressure. The crude product was purified by 
SiO2 flash chromatography (1% - 6% MeOH in CH2Cl2; gradient 1%) obtaining 18 
mg of 30 (MW: 1289.56, 0.014 mmol) in 62% yield. Rf: 0.5 (CH2Cl2/MeOH; 9:1). 
1H-NMR (CDCl3, 400 MHz): δ 8.60 (m, 1H, -NH-); 8.22-8.02 (m, 10H: 9H Ar, 1H 
-NH-); 7.91 (br, 1H, -NH-); 7.78-7.69 (m, 3H, -NH-); 7.54 (br, 1H, -NH-); 7.39 (br, 
1H, -NH-); 3.63-3.46 (m, 22H: 20H -CH2(2,4,5,7,8,10,11,13,14,16), 2H -CH2(1)-
NH-CO-); 3.30 (m, 2H, -CH2(17)); 1.56-1.27 (m, 57H: 48H -CH3(Aib), 9H tBu). 
ESI-MS (CH3CN): m/z 1312.7 (M+Na+); 1328.6 (M+K+). 
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5.1.4.8    Synthesis of N1-(1-pyrenecarbonyl-Aib8)-1,17-diamino-3,6,9,12,15-
pentaoxa-heptadecane (5) 
N
H
H
N
O
O
NH2
8 5
O
 
18 mg of 30 (MW: 1289.56, 0.014 mmol) were dissolved in 1 mL of 
CH2Cl2/TFA 1:1. The solution was stirred at r.t. for 4h;  the solvent was removed 
under reduced pressure and the residue co-evaporated several times with Et2O to 
remove TFA. 16 mg of 5 (MW: 1189.44; 0.013 mmol) were obtained in a 
quantitative yield. Rf: 0.2 (CH2Cl2/MeOH; 9:1). 1H-NMR (CDCl3, 400 MHz): δ 
8.59 (m, 1H, -NH-); 8.21-7.82 (m, 11H: 9H Ar, 2H -NH-); 7.67-7.54 (m, 5H, -NH-); 
3.81 (m, 2H, -CH2(2)); 3.64 (m, 20H: 18H -CH2(4,5,7,8,10,11,13,14,16), 2H -CH2(1)-
NH-CO-); 3.43 (m, 2H, -CH2(17)); 3.12 (br, 2H, -NH2); 1.51-1.35 (m, 48H, -
CH3(Aib)). 13C-NMR (CDCl3, 100. MHz): δ 176.88; 176.52; 176.48; 176.13; 175.99; 
175.90; 175.70; 171.12; 132.70; 131.09; 130.52; 130.48; 129.75; 128.91; 128.47; 
128.11; 127.28; 127.15; 126.10; 125.69; 125.46; 124.71; 124.40; 124.30; 70.66; 70.59; 
70.12; 69.78; 69.63; 69.40; 69.14; 57.60; 57.18; 56.70; 56.66; 56.50; 56.47; 56.39; 
56.34; 40.27; 39.84; 26.52; 25.64; 25.61; 25.48; 25.07; 24.93; 24.80; 24.59; 24.54. ESI-
MS (CH3CN): m/z 1190.5 (M+H+). 
 
5.1.5   SYNTHESIS OF CONJUGATES 2 AND 3 
5.1.5.1    Synthesis of 3-(pyren-1-yl)propenoic acid (31) 
COOH
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To a solution of 922 mg of 1-pyrenecarboxaldehyde (MW: 230.26; 4.0 mmol) 
in 2 mL of pyridine were added 2.080 g of malonic acid (MW: 104.07; 20.0 mmol; 5 
eq) and the mixture was stirred at 100°C overnight; then 10 mL of HCl 1.0 M were 
added to cease the reaction. The reaction mixture was filtered obtaining a yellow 
solid. The solid was washed with additional 3 mL of HCl 1.0 M, 10 mL of H2O and 
2 mL of MeOH to eliminate the reagents residues. 852 mg of 31 (MW: 272.30; 3.1 
mmol) were obtained with 78% yield. 1H-NMR (DMSO-d6, 400 MHz): δ 10.85 (br, 
1H, -COOH); 8.71 (d, 1H, Ar-CH=CH-, J = 16 Hz); 8.53 (m, 2H, Ar); 8.38-8.21 
(m, 6H, Ar); 8.12 (m, 1H, Ar); 6.84 (d, 1H, -CH=CH-COOH, J = 16 Hz). 
5.1.5.2    Synthesis of 3-(pyren-1-yl)propanoic acid (32) 
COOH
 
120 mg of 31 (MW: 272.30; 0.44 mmol) were suspended in 40 mL of 
CH3COOH and 12 mg of PtO2 (10% in weight) were added . The mixture was 
stirred at r.t. overnight under H2 atmosphere (1 atm). After the removal of the 
catalyst by filtration, the solution was co-evaporated several times with Et2O to 
remove CH3COOH. The residue was re-dissolved in 50 mL of Et2O and washed 
with H2O (3 x 10 mL) to complete remove CH3COOH. 112 mg of 32 (MW: 274.31; 
0.41) were obtained with 93% yield. 1H-NMR (CDCl3, 400 MHz): δ 8.45-8.11 (m, 
4H, Ar); 8.27 (d, 1H, Ar, J = 8 Hz); 8.08-7.94 (m, 3H, Ar); 7.91 (d, 1H, Ar, J = 8 
Hz); 3.71 (t, 2H, Ar-CH2-, J = 8 Hz); 2.93 (t, 2H, -CH2-COOH, J = 8 Hz). 
5.1.5.3    Synthesis of N-(3-(pyren-1-yl)propanoyl)-Aib8-OtBu (33) 
N
H
H
N COOtBu
O
7
O
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200 mg of 17 (MW: 889.09; 0.23 mmol) were dissolved in 15 mL anhydrous 
MeOH and the Z-protection removed using catalytic hydrogenation (H2 1 atm, 5% 
Pd/C) at r.t. overnight. The catalyst was filtered off and the solvent removed under 
reduced pressure. The residue was co-evaporated several times with CH3CN to 
remove MeOH. 160 mg of the free amine 20 (MW:754.96; 0.21 mmol) were 
obtained in a quantitative yield. To 70 mg of 32 (MW: 274.31; 0.26; 1.2 eq) dissolved 
in 5 mL of anhydrous CH3CN were added 40 mg of HOBt (MW: 153.13; 0.26 
mmol; 1.2 eq) and 50 mg of EDC (MW: 191.70; 0.26 mmol, 1.2 eq). 160 mg of 20 
(MW:754.96; 0.21 mmol) dissolved in 2 mL of anhydrous CH3CN and 37 µL of 
Et3N (MW: 101.19; d = 0.727; 0.26 mmol; 1.2 eq), needed to maintain pH 8, were 
added to the solution. The reaction mixture was stirred for 3 days at r.t. under argon 
atmosphere. The solvent was removed under reduced pressure and the residue re-
dissolved in 50 mL of CH2Cl2, washed with 5% KHSO4  (3 x 10 mL), H2O (1 x 10 
mL), 5% NaHCO3 (3 x 10 mL),  H2O (1 x 10 mL), brine (1 x 15 mL) and dried over 
Na2SO4. The solvent was removed under reduced pressure. The crude product was 
purified by SiO2 flash chromatography (1% - 5% MeOH in CH2Cl2; gradient 1%) 
obtaining 80 mg of 33 (MW: 1011.26; 0.08 mmol) in a 37% yield. Rf: 0.55 
(CH2Cl2/MeOH; 9:1). 1H-NMR (CDCl3, 400 MHz): δ 8.30 (m, 1H, -NH-); 8.17-
7.93 (m, 6H, Ar); 7.75-7.46 (m, 6H: 3H Ar, 3H -NH-); 7.35 (m, 2H, -NH-); 6.61 (s, 
1H, -NH-); 6.32 (s, 1H, -NH-); 3.64 (m, 2H, Ar-CH2-); 2.95 (m, 2H, -CH2-COOH); 
1.53-1.35 (m, 57H: 48H -CH3(Aib), 9H tBu). ESI-MS (CH3CN): m/z 911.3 (M-
OtBu+H+). 
5.1.5.4    Synthesis of N-(3-(pyren-1-yl)propanoyl)-Aib8-Oxl (35) 
H
N
O
N
H
O
O
N
O
6
 
80 mg of 33 (MW: 1011.26; 0.08 mmol) were dissolved in 2 mL of 
CH2Cl2/TFA 1:1. The solution was stirred at r.t. for 4h;  the solvent was removed 
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under reduced pressure and the residue co-evaporated several times with Et2O to 
remove TFA. 76 mg of the free acid 34 (MW: 955.15; 0.08 mmol) were obtained in 
a quantitative yield. The product was suspended in 3 mL of anhydrous CH3CN and 
23 mg of EDC (MW: 191.70; 0.12 mmol, 1.5 eq) were added at 0°C under stirring. 
The reaction mixture was stirred at r.t. for 24 h under argon atmosphere. The 
solvent was removed under reduced pressure and the residue re-dissolved in CH2Cl2 
(50 mL), the organic phase washed with 5% KHSO4 (2 x 10 mL), H2O (1 x 10 mL), 
5% NaHCO3 (2 x 10 mL), H2O (1 x 10 mL), brine (1 x 15 mL) and dried over 
Na2SO4. The solvent was removed under reduced pressure and 65 mg of 35 (MW: 
937.13; 0.07 mmol) were obtained with 87% yield. The product was immediately 
used in the next reaction. Rf: 0.9 (CH2Cl2/MeOH; 9:1). 
5.1.5.5    Synthesis of N1-(3-(pyren-1-yl)propanoyl-Aib8)-N17-tert-butoxycarbonyl-
1,17-diamino-3,6,9,12,15-pentaoxa-heptadecane (36) 
N
H
H
N
O
O
NHBoc
8 5
O
 
65 mg of 35 (MW: 937.13; 0.07 mmol) were dissolved in 2 mL of anhydrous 
CH3CN and added to a solution of 34 mg of 24 (MW: 380.48; 0.09 mmol; 1.3 eq) in 
2 mL of anhydrous CH3CN. The mixture was refluxed for 24h. The solvent was 
removed under reduced pressure and the residue re-dissolved in 50 mL of CH2Cl2, 
washed with 5% KHSO4  (3 x 10 mL), H2O (1 x 10 mL), 5% NaHCO3 (3 x 10 mL), 
H2O (1 x 10 mL), brine (1 x 15 mL) and dried over Na2SO4. The solvent was 
removed under reduced pressure. The crude product was purified by SiO2 flash 
chromatography (0.5% - 7% MeOH in CH2Cl2; gradient 0.5%) and 40 mg of 36 
(MW: 1317.61; 0.03 mmol) were obtained with 44% yield. Rf: 0.55 (CH2Cl2/MeOH; 
9:1). 1H-NMR (CDCl3, 500 MHz): δ 8.45 (br, 1H, -NH-); 8.35-7.91 (m, 7H: 6H Ar, 
1H -NH-); 7.81-7.63 (m, 5H: 3H Ar, 2H -NH-); 7.51 (m, 2H, -NH-); 7.36 (m, 1H, -
NH-); 7.19 (m, 1H, -NH-); 3.62 (m, 22H: 18H -CH2(2,4,5,7,8,10,11,13,14,16), 2H -
 
5. EXPERIMENTAL SECTION 
__________________________________________________________________________________________________________________________________________________________________________ 
 124
CH2(1)-NH-CO-); 3.53 (m, 2H, Ar-CH2-); 3.45 (m, 2H, -CH2(17)); 3.30 (m, 2H, -
CH2-COOH); 1.54-1.43 (m, 57H: 48H -CH3(Aib), 9H tBu). ESI-MS (CH3CN): 
m/z 1340.9 (M+Na+). 
5.1.5.6    Synthesis of N1-(3-(pyren-1-yl)propanoyl-Aib8)-1,17-diamino-
3,6,9,12,15-pentaoxa-heptadecane (2) 
N
H
H
N
O
O
NH2
8 5
O
 
40 mg of 36 (MW: 1317.61; 0.03 mmol) were dissolved in 1 mL of 
CH2Cl2/TFA 1:1. The solution was stirred at r.t. for 4h;  the solvent was removed 
under reduced pressure and the residue co-evaporated several times with Et2O to 
remove TFA. 37 mg of 2 (MW: 1217.49; 0.03 mmol) were obtained in a quantitative 
yield. Rf: 0.20 (CH2Cl2/MeOH; 9:1). 1H-NMR (CDCl3, 500 MHz): δ 8.47 (br, 1H, -
NH-); 8.39-7.93 (m, 8H: 6H Ar, 2H -NH-); 7.82-7.73 (m, 3H, Ar); 7.64 (br, 2H, -
NH-); 7.48 (br, 2H, -NH-); 6.98 (s, 2H, -NH-); 3.86 (m, 2H, -CH2(2)); 3.65 (m, 22H: 
20H -CH2(4,5,7,8,10,11,13,14,16,17), 2H -CH2(1)-NH-CO-); 3.43 (m, 2H, Ar-CH2-); 
3.13 (br, 2H, -NH2); 2.93 (m, 2H, -CH2-COOH); 1.52-1.32 (m, 48H, -CH3(Aib)). 
13C-NMR (CDCl3, 125 MHz): δ 176.92; 176.88; 176.50; 176.12; 135.75; 129.82; 
128.69; 127.47; 127.33; 126.84; 126.81; 126.51; 125.65; 125.50; 124.98; 124.92; 
124.66; 124.39; 123.55; 123.35; 69.93; 69.70; 69.40; 69.13; 57.24; 56.62; 56.57; 56.43; 
56.29; 40.42; 39.84; 37.22; 34.21; 24.76; 24.68; 24.65; 24.35; 24.12. ESI-MS 
(CH3CN): m/z 1218.8 (M+H+). 
5.1.5.7    Synthesis of N-benzoyl-Aib8-OtBu (37) 
N
H
H
N COOtBu
O
7Ph
O
 
200 mg of 17 (MW: 889.09; 0.23 mmol) were dissolved in 15 mL anhydrous 
MeOH and the Z-protection removed using catalytic hydrogenation (H2 1 atm, 5% 
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Pd/C) at r.t. overnight. The catalyst was filtered off and the solvent removed under 
reduced pressure. The residue was co-evaporated several times with CH3CN to 
remove MeOH. 166 mg of the free amide 20 (MW:754.96; 0.22 mmol) were 
obtained in a quantitative yield. To 32 mg of benzoic acid (MW: 122.12; 0.26 mmol; 
1.2 eq) dissolved in 5 mL of anhydrous CH3CN were added 40 mg of HOBt (MW: 
153.13; 0.26 mmol; 1.2 eq) and 50 mg of EDC (MW: 191.70; 0.26 mmol, 1.2 eq). 
166 mg of 20  (MW:754.96; 0.22 mmol) dissolved in 2 mL of anhydrous CH3CN 
and 37 µL of Et3N (MW: 101.19; d = 0.727; 0.26 mmol; 1.2 eq), needed to maintain 
pH 8, were added to the solution. The reaction mixture was stirred for 3 days at r.t. 
under argon atmosphere. The solvent was removed under reduced pressure and the 
residue re-dissolved in 50 mL of CH2Cl2, washed with 5% KHSO4 (3 x 10 mL), 
H2O (1 x 10 mL), 5% NaHCO3 (3 x 10 mL),  H2O (1 x 10 mL), brine (1 x 15 mL) 
and dried over Na2SO4. The solvent was removed under reduced pressure. The 
crude product was purified by SiO2 flash chromatography (1% - 6% MeOH in 
CH2Cl2; gradient 1%) obtaining 95 mg of 37 (MW: 859.06; 0.11 mmol) in a 50% 
yield. Rf: 0.6 (CH2Cl2/MeOH; 9:1). 1H-NMR (CDCl3, 500 MHz): δ 7.80 (m, 2H, o-
Ph); 7.76 (s, 1H, -NH-); 7.63 (m, 1H, p-Ph); 7.59 (s, 1H, -NH-); 7.57 (s, 1H, -NH-); 
7.52 (m, 2H, m-Ph); 7.47 (s, 1H, -NH-); 7.37 (s, 1H, -NH-); 7.34 (s, 1H, -NH-); 6.53 
(s, 1H, -NH-); 6.33 (s, 1H, -NH-); 1.53-1.42 (m, 57H: 48H -CH3(Aib), 9H tBu). 
ESI-MS (CH3CN): m/z 782.4 (M-OtBu+Na+) 
5.1.5.8    Synthesis of N-benzoyl-Aib8-Oxl (39) 
Ph
H
N
O
N
H
O
O
N
O
6
 
95 mg of 37 (MW: 859.06; 0.11 mmol) were dissolved in 2 mL of CH2Cl2/TFA 
1:1. The solution was stirred at r.t. for 4h;  the solvent was removed under reduced 
pressure and the residue co-evaporated several times with Et2O to remove TFA. 89 
mg of the free acid 38 (MW: 802.96; 0.11 mmol) were obtained in a quantitative 
yield. The product was suspended in 3 mL of anhydrous CH3CN and 32 mg of 
EDC (MW: 191.70; 0.17 mmol, 1.5 eq) were added at 0°C under stirring. The 
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reaction mixture was stirred at r.t. for 24 h under argon atmosphere. The solvent 
was removed under reduced pressure and the residue re-dissolved in CH2Cl2 (50 
mL), the organic phase washed with 5% KHSO4 (2 x 10 mL), H2O (1 x 10 mL), 5% 
NaHCO3 (2 x 10 mL), H2O (1 x 10 mL), brine (1 x 15 mL) and dried over Na2SO4. 
The solvent was removed under reduced pressure and 79 mg of 39 (MW: 784.94; 
0.10 mmol) were obtained with 91% yield. The product was immediately used in the 
next reaction. Rf: 0.85 (CH2Cl2/MeOH; 9:1). 
5.1.5.9    Synthesis of N1-(benzoyl-Aib8)-N17-tert-butoxycarbonyl-1,17-diamino-
3,6,9,12,15-pentaoxa-heptadecane (40) 
N
H
H
N
O
O
NHBoc
8 5
O
Ph
 
79 mg of 39 (MW: 784.94; 0.10 mmol) were dissolved in 3 mL of anhydrous 
CH3CN and added to a solution of 50 mg of 24 (MW: 380.48; 0.13 mmol; 1.3 eq) in 
2 mL of anhydrous CH3CN. The mixture was refluxed for 24h. The solvent was 
removed and the residue re-dissolved in 50 mL of CH2Cl2, washed with 5% KHSO4  
(3 x 10 mL), H2O (1 x 10 mL), 5% NaHCO3 (3 x 10 mL),  H2O (1 x 10 mL), brine  
(1 x 15 mL) and dried over Na2SO4. The solvent was removed under reduced 
pressure. The crude product was purified by SiO2 flash chromatography (1% - 5% 
MeOH in CH2Cl2; gradient 1%) and 69 mg of 40 (MW: 1165.42; 0.06 mmol) were 
obtained with 59% yield. Rf: 0.7 (CH2Cl2/MeOH; 9:1). 1H-NMR (CDCl3, 500 
MHz): δ 7.99-7.71 (m, 6H: 5H Ph, 1H -NH-); 7.53-7.43 (m, 5H, -NH-); 7.36 (br, 
1H, -NH-); 7.13 (br, 1H, -NH-); 3.54 (m, 22H: 20H -CH2(2,4,5,7,8,10,11,13,14,16), 
2H -CH2(1)-NH-CO-); 3.32 (m, 2H, -CH2(17)); 1.54-1.43 (m, 57H: 48H -CH3(Aib), 
9H tBu). ESI-MS (CH3CN): m/z 1188.6 (M+Na+). 
5.1.5.10    Synthesis of N1-(benzoyl-Aib8)-1,17-diamino-3,6,9,12,15-pentaoxa-
heptadecane (3) 
N
H
H
N
O
O
NH2
8 5
O
Ph
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69 mg of 40 (MW: 1165.42; 0.06 mmol) were dissolved in 1 mL of 
CH2Cl2/TFA 1:1. The solution was stirred at r.t. for 4h;  the solvent was removed 
under reduced pressure and the residue co-evaporated several times with Et2O to 
remove TFA. 63 mg of 3 (MW: 1065.30; 0.06 mmol) were obtained in a quantitative 
yield. Rf: 0.25 (CH2Cl2/MeOH; 9:1). 1H-NMR (CDCl3, 270 MHz): δ 8.20 (br, 1H, -
NH-); 7.95-7.66 (m, 6H: 5H Ph, 1H -NH-); 7.42 (br, 6H, -NH-); 3.88 (m, 2H, -
CH2(2)); 3.69 (m, 20H: 18H -CH2(4,5,7,8,10,11,13,14,16), 2H -CH2(1)-NH-CO-); 
3.43 (m, 2H, -CH2(17)); 3.14 (br, 2H, -NH2); 1.54-1.40 (m, 48H, -CH3(Aib)). 13C-
NMR (CDCl3, 67.5 MHz): δ 176.66; 176.38; 176.14; 175.89; 168.50; 133.58; 131.81; 
129.10; 128.41; 128.30; 127.73; 69.97; 69.70; 69.29; 57.22; 56.71; 56.61; 56.50; 56.44; 
56.42; 56.40; 40.38; 39.81; 25.35; 25.12; 25.01; 24.92; 24.84; 24.72. ESI-MS 
(CH3CN): m/z 1066.6 (M+H+). 
 
5.2   IONOPHORIC ACTIVITY 
5.2.1   GENERAL PROCEDURES 
L-α-phosphatidyl-DL-glycerol sodium salt (EYPG, 20 mg/mL chloroform 
solution), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine 
rhodamine B sulfonyl) ammonium salt (Rh-PE) and 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) ammonium salt (NBD-
PE) were purchased from Avanti Polar Lipids; egg yolk phosphatidylcholine 
(EYPC, 100 mg/mL chloroform solution), bis(N-methylacridinium) nitrate 
(lucigenin), calcein, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) 
and 8-hydroxypyrene-1,3,6-trisulfonic acid trisodium salt (HPTS) were from Sigma; 
Triton® X-100 and HEPES (4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid) 
were from Fluka; Fluram and L-Glu from Acros; all salts were of the best grade 
available from Aldrich and were used without further purification. 
Ultra-filtration was performed on Microcon® YM-10 filters from Millipore; size 
exclusion chromatography (SEC) was performed using SephadexTM G-75 or pre-
packed columns SephadexTM G-25 M (PD-10) from Amersham Biosciences. 
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Liposome were prepared by extrusion using a 10 mL LipexTM Thermobarrel 
EXTRUDER (Northern Lipids Inc.) connected to a thermostatic bath (25°C). The 
100 nm policarbonate membranes are Nucleopore Track-Etch Membranes from 
Whatman. 
Fluorescence spectra were recorded on Perkin-Elmer LS-50B fluorimeter, 
23Na-NMR-spectra on Jeol GX-270 spectrometer (270 MHz) and UV spectra on 
Unicam heλios β UV-Vis spectrophotometer. All fluorimetric experiments were 
conducted at 25°C, 23Na-NMR experiments were conducted at 27°C. 
The ionophores concentration is given in percent with respect to the total 
concentration of lipid. Mother solutions of ionophores were prepared in methanol. 
Control experiments showed that the amount of methanol added to the vesicular 
suspension in the different experiments (maximum amount 1.6% in volume) did not 
affect membrane permeability.  
 
5.2.2   23Na-NMR TRANSPORT ASSAY  
A mixture of 150 µL of EYPC chloroform solution (100 mg/mL, 20 µmol), 40 
µL of EYPG chloroform solution (20 mg/mL, 1 µmol) and an aliquot of 
methanolic solution of the desired ionophore was first evaporated with argon-flux 
to form a thin film and then dried under high vacuum for 3h. The lipid film was 
hydrated in 1 mL of LiCl solution (100 mM in H2O/D2O 90:10) for 30 minutes at 
40°C. The lipid suspension was submitted to 5 freeze-thaw cycles (-196°C/40°C) 
using liquid nitrogen and a thermostatic bath, and then extruded under nitrogen 
pressure (15 bar) at room temperature (10 extrusions through a 0.1 µm 
polycarbonate membrane). 
In a 5 mm NMR-tube were mixed 350 µL of the lipid dispersion and 350 µL 
of a shift reagent solution (4 mM DyCl3·6H2O, 12 mM Na5P3O10, 40 mM NaCl in 
H2O/D2O 90:10). During the experiment the spectra were recorded every 30 
minutes over 14 h (accumulation in continuo), the areas of the signals were calculated 
with Jeol Delta software. The % of Na+ inside liposome was calculated from the 
known liposome entrapped volume (1.5 %). 
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5.2.3   IONOPHORE CONTENT ASSAY 
The vesicle suspension is prepared in the same way as LUVs for 23Na-NMR 
assays (molcompound/mollipide = 1%), using 1 mL of 100 mM LiCl for hydration. 550 
µL of LUV solution was diluted with 1000 µL of 100 mM LiCl; 500 µL of the 
resulting solution were ultra-filtered on Microcon® YM-10 filters (25 minutes, 20°C, 
13000 r.p.m.). The ionophore content in the eluate after ultra-filtration ([ion]eluate) 
and in the mother solution ([ion]tot) were measured by diluting an aliquot of 100 µL 
in a fluorimetric cell with 400 µL of 100 mM LiCl, 2000 µL borate buffer (pH 9), 
150 µL of 5 % (v/v) Triton® X-100 and 100 µL of 10 mM Fluram® solution in 
acetone. The emission spectra was recorded in the 430-530 nm range (excitation 390 
nm). The maximum of emission intensity was correlated to the ionophore 
concentration using a calibration curve obtained measuring the emission intensity of 
solutions of ionophore at known concentrations (prepared diluting the methanol 
mother solution with a 100 mM LiCl aqueous solution).  
In the case of compounds K3 and C6 the ionophore content in the eluate after 
ultra-filtration was measured by UV-Vis spectroscopy (λ maxK3 : 210 nm; λ maxC6 : 
211 nm) diluting an aliquot of 100 µL in a UV cell with 400 µL of MeOH (blank 
solution: 100 µL LiCl 100 mM+400 µL MeOH). The UV-Vis spectra were recorded 
in the 190-300 nm range. The maximum of emission intensity was correlated to the 
ionophore concentration using a calibration curve obtained measuring the emission 
intensity of methanol solutions of ionophore at known concentrations. The 
ionophore partition ratio in membrane (PR) was calculated using the following 
equation: 
PR =
[ion]tot – [ion]eluate
[ion]tot  
 
5.2.4   CALCEIN-RELEASE ASSAY 
The LUV suspension was prepared as previously described (paragraph 5.2.2) 
except for the addition of the ionophore, using a mixture of 72 µL EYPC 
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chloroform solution (100 mg/mL, 9.5 µmol) and 19 µL EYPG chloroform solution 
(20 mg/mL, 0.5 µmol). The lipid cake was hydrated in 2.0 mL of 50 mM calcein 
solution (1 mM HEPES, pH 7.4). The LUV suspension was separated from 
extravesicular dye by size exclusion chromatography (SEC) (stationary phase: 
column ∅1x25cm Sephadex™ G-75, mobile phase: buffer 1 mM HEPES, 150 mM 
NaCl, pH 7.4) and diluted with the same HEPES buffer to give a stock solution 
with a lipid concentration of 0.4 mM (assuming 100% of lipid was incorporated into 
liposomes). The vesicle suspension (550 µL stock solution) was placed in a 
fluorimetric cell and diluted to 2200 µL with the buffer solution used for 
preparation. The total lipid concentration in the fluorimetric cell was 0.1 mM. 
Calcein emission was monitored at 520 nm with excitation at 490 nm. During the 
experiment 10 µL of 0.22 mM solution of ionophore were added through an 
injector port every 400 s up to 50 µL. Maximal changes in dye emission were 
obtained by lysis of the liposomes with detergent (40 µL of 5% aqueous Triton® X-
100). 
 
5.2.5   PROTON PERMEATION ASSAYS  
5.2.5.1    HPTS assay 
The LUV suspension was prepared as previously described (paragraph 5.2.2), 
except for the addition of the ionophore, using a mixture of 225 µL of EYPC 
chloroform solution (100 mg/mL, 30 µmol) and 60 µL of EYPG chloroform 
solution (20 mg/mL, 1.5 µmol). The lipid cake was hydrated in 1.5 mL of 0.1 mM 
HPTS solution (HEPES 25 mM, 100 mM NaCl, pH 7). The LUV suspension was 
separated from extravesicular dye by size exclusion chromatography (SEC) 
(stationary phase: pre-packed column Sephadex™ G-25, mobile phase: HEPES 
buffer) and diluted with the same HEPES buffer to give a stock solution with a lipid 
concentration of 5 mM (assuming 100% of lipid was incorporated into liposomes). 
104 µL of lipid suspension was placed in a fluorimetric cell, diluted to 3040 µL with 
the same buffer solution used for the liposome preparation and kept under gentle 
stirring. The total lipid concentration in the fluorimetric cell was 0.17 mM. An 
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aliquot of methanolic solution of the ionophore (10-30 µL of the appropriate 
mother solution in order to obtain the desired molcompound/mollipide ratio) was then 
added to the lipid suspension and the cell was incubated at 25°C for 30 minutes. 
After incubation the time course of fluorescence was recorded for 200 s (λex 460 
nm, λem 510 nm) and then 50 µL of 0.5 M NaOH were rapidly added through an 
injector port and the fluorescence emission was recorded for 1200 s. Maximal 
changes in dye emission were obtained by final lysis of the liposomes with detergent 
(40 µL of 5% aqueous Triton® X-100). Fluorescence time course were normalized 
using the following equation: 
FI =
Ft – F0
F∞ – F0
· 100
 
were Ft is the fluorescence intensity measured at time t, F0 is the fluorescence 
intensity at ionophore addition, F∞  is the fluorescence intensity at saturation after 
lyses with Triton. The apparent first order rate constants for the transport process 
were obtained by non-linear regression analysis of the fluorescence data vs. time. 
The fit error on the rate constant was always less than 1%. 
5.2.5.2    Determination of cation selectivity 
The experiment is performed as described above except for the use of the 
appropriate chloride salt (MCl; M = Li+, Na+, K+) in the liposome preparation. The 
base pulse is then obtained by addition of 50 µL of 0.5 M MOH (M = Li+, Na+, 
K+). In this way only the alkaline cation under investigation is present inside and 
outside the liposome. 
5.2.5.3    Determination of anion selectivity  
The experiment is performed as described above (paragraph 5.2.5.1)except for 
the use of the appropriate Na+ salt (NaX; X– = F–, Cl–, Br–, I–, NO3–, SO42–, ClO4–, 
Ac–, Glu) in the liposome preparation. In this way only the anion under 
investigation is present inside and outside the liposome except for OH-. The rates of 
transport of anions have been corrected for the membrane permeability of the 
different anions in the absence of ionophore determined in separate experiments. 
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5.2.5.4    Determination of cation and anion selectivity using Matile’s protocol 
The vesicle suspension (104 µL stock solution, prepared as described above, 
paragraph 5.2.5.1) was placed in a fluorimetric cell and diluted to 3040 µL with the 
appropriate buffer solution (25 mM HEPES, 100 mM MCl with M= Li+, Na+, K+, 
Rb+, Cs+, or 100 mM NaX with X– = F–, Cl–, Br–, I–, NO3–, SO42–, ClO4–, Ac–, Glu, 
pH 7). The total lipid concentration in the fluorimetric cell was 0.17 mM. An aliquot 
of methanolic solution of the ionophore (10-30 µL of the appropriate mother 
solution in order to obtain the desired molcompound/mollipide ratio) was then added to 
the lipid suspension and the cell was incubated at 25°C for 30 minutes. After 
incubation the time course of fluorescence was recorded for 200 s (λex 460 nm, λem 
510 nm) and then 50 µL of 0.5 M MOH (with M= Li+, Na+, K+, Rb+, Cs+ 
depending on the cation present in the extravesicular buffer solution) were rapidly 
added through an injector port and the fluorescence emission was recorded for 1200 
s. Maximal changes in dye emission were obtained by final lysis of the liposomes 
with detergent (40 µL of 5% aqueous Triton® X-100). Fluorescence time courses 
were normalized as previously described. 
5.2.5.5    Anomalous mole fraction effect (AMFE) 
AMFE was assayed using HPTS and Matile’s protocol for anion selectivity (see 
previous paragraph) with the only difference that the buffer used to dilute the 
vesicular preparation contained mixture of chloride and glutamate with total anion 
concentration of 100 mM. 
The fractional activity (Y) was obtained by conversion of the normalized 
fluorescence intensity (FI) using the following equation: 
Y =
FIn – FI0
FImax – FI0
· 100
 
where FIn is the normalized fluorescence intensity measured at a given time in a 
given experiment, FI0 is the normalized fluorescence intensity measured at the same 
time in absence of ionophore, and FImax is the normalized fluorescence intensity of 
the reference value of interest, e.g. the maximum value in a given series. 
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5.2.6   ANION TRANSPORT WITH THE HPTS ASSAY 
The vesicle stock solution was prepared as described for the HPTS assay 
(paragraph 5.2.5.1) but using only HEPES buffer (25 mM, pH 7) without added salt 
for the swelling and for the size exclusion chromatography (SEC). 104 µL of the 
stock solution were placed in a fluorimetric cell and diluted to 3040 µL with the 
same buffer solution used for preparation and kept under gently stirring. The total 
lipid concentration in the fluorimetric cell was 0.17 mM. An aliquot of methanolic 
solution of the ionophore (10-30 µL of the appropriate mother solution in order to 
obtain the desired molcompound/mollipide ratio) was then added to the lipid suspension 
and the cell was incubated at 25°C for 30 minutes. After incubation the time course 
of fluorescence was recorded for 200 s (λex 460 nm, λem 510 nm) and then 50 µL of 
2 M NaX (with X– = F–, Cl–, Br–, I–, NO3–, SO42–, ClO4–), were rapidly added 
through an injector port to establish the anion gradient. The final external 
concentration of NaX was 33 mM. The fluorescence emission was recorded for 
1200 s and the maximal changes in dye emission were obtained by final lysis of the 
liposomes with detergent (40 µL of 5% aqueous Triton® X-100). Fluorescence time 
courses were normalized as previously described. 
 
5.2.7   CHLORIDE TRANSPORT WITH THE LUCIGENIN ASSAY 
The LUV suspension was prepared as previously described (paragraph 5.2.2), 
except for the addition of the ionophore, using a mixture of 300 µL of EYPC 
chloroform solution (100 mg/mL, 40 µmol) and 80 µL of EYPG chloroform 
solution (20 mg/mL, 2 µmol). The lipid cake was hydrated in 2.0 mL of lucigenin 
solution 1 mM (25 mM HEPES, 225 mM NaNO3, pH 7). The LUV suspension was 
separated from extravesicular dye by size exclusion chromatography (SEC) 
(stationary phase: column ∅1x25cm Sephadex™ G-75, mobile phase: buffer 25 
mM HEPES, 225 mM NaNO3, pH 7) and diluted with the same HEPES buffer to 
give a stock solution with a lipid concentration of 6.5 mM (assuming 100% of lipid 
was incorporated into liposomes). The vesicle suspension (187 µL of stock solution) 
was placed in a fluorimetric cell and diluted to 3040 µL with the same buffer 
 
5. EXPERIMENTAL SECTION 
__________________________________________________________________________________________________________________________________________________________________________ 
 134
solution used for the preparation. The total lipid concentration in the fluorimetric 
cell was 0.4 mM. An aliquot of methanolic solution of the ionophore (10-30 µL of 
the appropriate mother solution in order to obtain the desired molcompound/mollipide 
ratio) was then added to the lipid suspension and the cell was incubated at 25°C for 
30 minutes. To the gently stirred mixture were added 50 µL of NaCl 1.46 M 
through an injector port to establish a chloride gradient. The final external 
concentration of NaCl was 24 mM. Maximal changes in dye emission were obtained 
by lysis of the liposomes with detergent (40 µL of 5% aqueous Triton X-100). 
Lucigenin emission was monitored at 506 nm (excitation at 455 nm) during an 
entire experiment period and recorded as a function of time. 
In the case of anion induced chloride transport blockage experiments five 
minutes before the addition of the NaCl solution 50 µL of a 1.46 M solution of 
NaClO4 or glutamate were added to the vesicular suspension containing the 
ionophore. Then 50 µL of NaCl 1.46 M were added and the fluorescence emission 
was recorded as a function of time. The final external concentrations of NaCl and 
NaClO4 or glutamate were 24 mM. 
 
5.2.8   VESICLE FUSION ASSAY 
Ionophore-induced vesicle fusion was monitored using fluorescence resonance 
energy transfer (FRET) between PE-NBD and PE-LRB probes. The LUV 
suspension was prepared as previously described (paragraph 5.2.2), except for the 
addition of the ionophore, using a mixture of 100 µL of EYPC chloroform solution 
(100 mg/mL, 13.16 µmol), 25 µL of EYPG chloroform solution (20 mg/mL, 0.65 
µmol) and a solution of PE-NBD in CH2Cl2 (1.30 mL, 1.06 10-4 M, 1% molPE-
NBD/mollipide). The lipid cake was hydrated in 1.0 mL HEPES buffer (25 mM, 100 
mM NaCl, pH 7). A separated LUV suspension was obtained in the same way using 
a solution of PE-LRB in CH2Cl2 (2.03 mL, 6.81 10-5 M, 1% molPE-LRB/mollipide). 
In a fluorimetric cell 20 µL of PE-NBD containing LUV were mixed with 20 
µL of PE-LRB containing  LUVs and diluted with 3000 µL of HEPES buffer (25 
mM, 100 mM NaCl, pH 7); emission spectra were recorded in 500-650 nm range 
(excitation 463 nm) immediately after the addition of an aliquot of methanolic 
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solution of ionophore (10-30 µL of the appropriate mother solution in order to 
obtain the desired molcompound/mollipide ratio) and 5 minutes after every addition.  
 
5.2.9   EXCIMERS FORMATION ASSAY 
The LUV suspension was prepared as previously described (paragraph 5.2.2), 
except for the addition of the ionophore, using a mixture of 225 µL of EYPC 
chloroform solution (100 mg/mL, 30 µmol) and 60 µL of EYPG chloroform 
solution (20 mg/mL, 1.5 µmol). The lipid cake was hydrated in 1.5 mL of 100 mM 
NaCl solution (HEPES 25 mM, pH 7). The LUV suspension was diluted with the 
same HEPES buffer to give a stock solution with a lipid concentration of 5 mM 
(assuming 100% of lipid was incorporated into liposomes). 104 µL of lipid 
suspension was placed in a fluorimetric cell, diluted to 3040 µL with the same buffer 
solution used for the liposome preparation and kept under gentle stirring. The total 
lipid concentration in the fluorimetric cell was 0.17 mM. An aliquot of methanolic 
solution of 2 or 5 (10-30 µL of the appropriate mother solution in order to obtain 
the desired molcompound/mollipide ratio) was then added to the lipid suspension and 
the cell was incubated at 25°C for 30 minutes. For every concentration, an emission 
spectrum was recorded in 350-650 nm range (excitation 340 nm) after incubation 
and another one after addition of detergent (40 µL of 5% aqueous Triton® X-100) 
to lyse liposomes. 
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 “ I have not failed. I've just found 
10,000 ways that won't work." 
Thomas Alva Edison 
  
“If we knew what it was we were 
doing, it would not be called research, 
would it?” 
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